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Fluorinated products are widely used in pharmaceutical and agrochemical ap-
plications where a large portion of the commercial compounds being developed
contain at least one atom of uorine. Most of the conventional uorination re-
actions require volatile chemicals and are highly exothermic requiring controlled
procedures which are rather costly, produce low yields and exhibit low selectivity
of the moiety accepting uorine. As a result, much attention has been drawn on
enzymatic uorination in a quest to ameliorate these issues.
The only characterized enzyme that mediates direct uorination is the 5'-uoro-
5'-deoxyadenosine (5'-FDA) synthase (a.k.a. uorinase), which uptakes an S -
adenosyl-L-methionine (SAM) molecule and a uorine atom as substrates and
yields 5'-FDA and methionine. Variants of this enzyme have been extensively
studied structurally and functionally with in vitro assays and they exhibit very
high homology, and a similarly slow activity.
In this work, a bacterial in vivo bioreactor is presented, based on a variant of
the enzyme, which is found in Streptomyces sp. MA37 (FlA1). The base host
that has been chosen for the implementation of modications is Escherichia coli
BL21(DE3), which is a host of choice for the over-expression of recombinant
proteins and in some occasions utilized for the construction of novelty bioreactors.
In the case of enzymatic uorination, a few challenges had to be addressed.
v
First of all, E. coli contains an ion channel protein, termed CrcB, which expels
uoride anions out of the cell. Secondly, SAM cannot passively enter E. coli
cells rendering the intracellular molarity of SAM a bottleneck. Last but not
least, the E. coli purine nucleoside phosphorylase, DeoD, has been suggested to
degrade the uorination product, 5'-FDA. Therefore, the modied E. coli strain,
consists of 2 deleted genes (ΔcrcBΔdeoD), the expression of a SAM transporter
from Rickettsia prowazekii and the over-expression of A1. Using this strain, in
vivo production of 5'-FDA to near millimolar concentrations has been conrmed
using an array of chemical analysis methods including High Performance Liquid
Chromatography (HPLC), Fluorine Nuclear Magnetic Resonance (F-NMR) and
High Resolution Mass Spectrometry (HRMS).
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1.1 Organouorines and applications
Fluorinated chemistry refers to the chemistry of compounds that contain at least
one atom of uorine. Specically, organic uorinated chemistry refers to the
compounds with an organic/carbon backbone. The unique characteristics of
the carbon-uorine bond render it very enticing for a number of applications.
One characteristic is the high thermal and metabolic stability of this chemical
bond resulting from its high energy, the highest among all carbon based bonds.
Other attributes include low width of the bond, low electronegativity etc. which
contribute to its thermal stability and hydrophobicity. There are numerous
uorinated compounds that have been synthesized and constitute products or
part of them in everyday life such as refrigerants, uorosurfactants, liquid
crystal displays (LCDs), metered dose propellants. However, the most prevalent
applications occur in biochemistry, agrochemistry and medicinal chemistry.
The application of uorinated carbons is very extensive in agrochemistry with a
percentage of 30-40% of newly developed agrochemicals comprising uorinated
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compounds [11]. The wide use of uorinated compounds in this eld includes
insecticides, pesticides, herbicides and acaricides. A variety of popular uorinated
products that have been developed are uorinated heterocyclic compounds.
Depending on the particular pest that an agrochemical treatment is targeting,
there are several uorinated carbon alternatives categorized per functionality.
Examples of herbicides include uorinated compounds that inhibit catalysis of
lipid sythesis that are essential for cell membrane construction. A category of
fungicides includes compounds that inhibit mitochondrial respiration. Chitin
synthase inhibitors constitute a representative example of insecticides, where
potent uorinated chemicals halt chitin synthesis in insects, a key element of
their exoskeleton [12]. The main functional theme of all these modied uorinated
bioproducts is the inhibitory action of each particular chemical which acts in a
key biochemical pathway of an unwanted organism or cellular process, disrupting
it and ultimately halting its reproduction. This inhibition is made possible from
the extreme hydrophobicity of the uorine - carbon bond leading to lipophilicity
which enhances its bioavailability.
In most cases, the inhibition process involves binding of a uorinated analogue
in an enzyme' s active site. Under normal circumstances, this binding involves a
natural substrate with which the reaction proceeds normally. Substituting one or
more atoms in suitable positions of the natural substrate with uorine, or other
uorinated subgroups, results in the binding of this unnatural substrate in the
active site which cannot be processed by the enzyme leading to inhibition. This
general principle is similar in medical products. After the rst uorine containing
drug, udrocortisone [13] was approved back on 1954 as an anti-inammatory
agent, uorinated compounds have been extensively introduced into the approved
drugs list. Up to 2010, almost 1/3 of the 100 top-selling drugs incorporated
uorine and up to 1/5 of the approved drugs contained at least one molecule of
uorine [14]. Recently, many biological drugs, such as antibodies, have entered
the top selling diminishing the contribution of uorine drugs as top sellers, but
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the overall percentage of newly approved uorine containing drugs, exhibits an
increasing trend reaching up to 30% [15]. A uracil analog, namely 5-Fluoro-
Uracil (5-FU), has been extensively utilized as a chemotherapeutic agent for
the treatment of several forms of cancer. In this case, with the introduction
of a uorine atom in the 5-position of uracil, the latter is transformed to an
anti-metabolite which stops proliferation of cancer cells by inhibiting certain key
enzymes and in turn causing metabolic imbalances that result in DNA damage
[16]. Fluoxetine is a widely used anti-depressant which was rst approved on
1987 and its mechanism of action, termed selective serotonin re-uptake inhibition
(SSRI), is tied to selective inhibition of a small molecule eux channel. The
intricacies of the mechanism are still poorly understood, however the resulting
eect is an increase of the extracellular pool of serotonin, lack of which leads to
neural dysfunction. Generally, the main theme of uorinated organic molecules
is based on the anti-metabolic function of uorine-substituted carbon-hydrogen
bonds of otherwise essential molecules for the function that needs to be blocked
or indirectly promoted.
Most of the conventional procedures involving halogenation often require volatile
chemicals and conditions that are expensive to achieve. In particular, uorine
mediated reactions are highly exothermic and require controlled procedures which
are rather costly and produce low yields [17]. Another drawback of traditional
uorination methods is the low selectivity of the carbon and the bond that will
uptake the uoride. Especially when uorination involves a complex molecule,
which is usually the case when the average complexity of target metabolites is
taken into account, low selectivity becomes a serious issue as the uorine atom
can substitute a larger set of bonds. The purication procedures for the desired
product are added to the list of hurdles. In an eort to tackle with the above issues,
much attention has been recently drawn into enzymatic uorination. In this case,
the reaction is mediated by a particular category of enzymes known as uorinases.
Although uoride is abundant in nature, the natural mechanisms evolved for its
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processing are limited and so are these enzymes, with 5 variants having been
characterized to date, all of them with low performance for large-scale industrial
use. The increasing number of genomes being sequenced will undoubtedly yield
more uorinases (see section 2.3.3), however this does not negate the fact that they
occur rarely. The increasing trend in demand of uorinated products does not
allow mere dependence on nature's generosity for the desired uorinase variants,
therefore, a solution must be searched within the realm of engineered enzymes.
Directed Evolution (DE) is an established method for the creation of improved
variants of an enzyme, or variants with altered functionality (see section 2.2 for
details).
1.2 Objectives
The main purpose of this project is to explore the potential for in vivo uorination
by utilizing the E. coli bacterium, enabling its subsequent use either as a host for
DE or for engineering uorination pathways. While the in vivo participation of the
uorinase has been shown in another actinomycete with compatible metabolism
(see section 2.3.4), there are currently no studies indicating the transfer of this
functionality in an evolutionary distant species such as E. coli. Furthermore, as
demonstrated in a recent review [18], there is no precedent for direct uorination in
E. coli, though the utility of such a metabolic feat has been previously highlighted
[19].
E. coli constitutes a model organism for many types of studies because it has been
extensively studied and well-documented, therefore, the construction of in vivo
uorination can also serve as a convenient genotype-phenotype coupling for DE
studies. The potential of genetic selection using the constructed E. coli will also
be explored. Alternatively, Raman Spectroscopy (RS) will be tested for suitability
as a screening method.
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1.3 Chapter overview
The material and outcomes of this project are organized as follows:
Chapter two consists of a description from a theoretical perspective of the
tools that are extensively utilized in this work and a critical review of the
literature related to biological uorination. First of all, a brief description of
synthetic biology, chassis, the concept of orthogonality and the importance of
regulatory elements is given. An overview of the workow adopted by DE
experiments follows. Then the review of biological uorination with a focus
on the developments of the 4-uorothreonine (4-FT) pathway is presented, also
mentioning the indirect uorination pathways implemented in E. coli. Next,
three methods of gene editing are described for E. coli discussing their pros and
cons. A summary of everyday molecular biology techniques for lab works is given
afterwards. Finally, the basics of RS are outlined.
Chapter three is based on the material published by the author of this work, on
the paper "Analytical approach for the calculation of promoter activities from
uorescent protein expression data" [20]. The introduction highlights qualitative
and quantitative characteristics of promoters and other regulatory elements,
providing reasoning why the metric used from most studies is inaccurate. The
application and improvement of a robust method for growth curve tting based on
Gaussian Processes (GP) is shown followed by the development of a metric which
captures the time-dependent promoter activity based on curve tting of Optical
Density (OD) and uorescence time-series data, also with GP . A Graphical User
Interface (GUI) tool incorporating these methods is presented and validation of
the new metric with experimental data from dierent uorescent proteins is given.
A discussion on other interesting characteristics of bacterial growth curves and a
summary of outcomes and future work nalize this chapter.
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Chapter four contains the rationale and description of modications that are
needed for the realization of in vivo direct uorination with recombinant uorinase
expression in E. coli. Construction of the plasmid accommodating the uorinase
gene and conrmation of high levels of expression are illustrated. Focus is then
moved to the uoride resistance mechanism of E. coli, a selective anion eux
channel, followed by a step-by-step report on its deletion. The same is done for
the purine nucleoside phosphorylase encoded by the deoD gene. Last but not
least, a case is made for the increase of the intracellular pool of SAM, which is
facilitated by expression of a SAM transporter from R. prowazekii. A catalogue
of strains and plasmids used or created in this chapter resides in the end.
Chapter ve deals with the eects that uorinase expression exerts on E. coli
BL21(DE3) by tting experimental growth curves with GP as laid out in chapter
3. Specically, emphasis is given on the quite unusual nding that overexpression
of the uorinase elicits a positive eect on growth which not only persists even
in the crcB deletion strain, but it appears to counterbalance the toxicity of
intracellular uoride. The eect of increasing concentration of extracellular SAM
on strains expressing the SAM transporter is also illustrated and the tolerance of
strains in high levels of SAM is conrmed. The achievement of a major milestone
in this project is then presented, in vivo uorination in E. coli. The necessity of
both crcB deletion and SAM transporter expression is validated through a series
of conrmatory experiments.
Chapter six explores the potential of RS for the detection of intracellular
metabolites. The Raman spectra of key uorination substrates and products,
SAM, 5'-FDA and 5'-chloro-5'-deoxyadenosine (5'-ClDA) are reported. The
ability to monitor SAM instability with RS is also illustrated. Spectral analysis of
E. coli bacteria expressing the SAM transporter and grown in the presence of SAM
in high molarities, show the potential to monitor such intracellular metabolites
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with this microscopy method. Finally, the spectral dierences seen in SAM, 5'-
FDA and 5'-ClDA reveal a characteristic attribute which can be used for future
endeavours in developing a screening method for intracellular production of 5'-
FDA.
Chapter seven concludes the thesis by highlighting the prospects that open up for
future endeavours based on the observations and ndings of each chapter.
8 1.3 Chapter overview
Chapter 2
Background and Methods
2.1 Synthetic biology and tools
Biological systems constitute the next level of material organization. Chemical
reactions are made possible in biology-friendly temperatures and conditions in
which critical reactions for maintenance and replication of these systems, would
not happen. The catalysts for these reactions are chemical compounds themselves
(enzymes) that have acquired a higher level of complexity by arranging chains of
simpler molecules (amino acids) in conformations which create favourable condi-
tions for the reactions to occur. These elaborate polymers are produced within a
boundary-dened contraption (cell) in which a wide-range of interdependent con-
trol mechanisms that have evolved over the course of 4 billion years of evolution.
The set of elements controlling the timing and quantity of protein expression
demonstrate immense complexity and stochasticity, yet they remain incredibly
robust. Synthetic Biology (SB) is a eld which aspires to capture and be able
to recreate this robustness in newly engineered behaviours. The engineering ap-
proach is paramount to SB and a multitude of ways for achieving this are being
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continuously explored. Systems biology, is another eld enforced with under-
standing and mechanistically modelling biological systems. Although, a ow of
knowledge towards SB exists, there is a distinct dierence in that the latter tries
to recreate or modify behaviours which systems biology is devoted to studying.
SB, as an engineering discipline should ideally try to adopt a bottom-up ap-
proach with a predened process for building a system from its constituent parts.
While there have been eorts to create a biological entity, such as a cell, totally
from scratch, leading to some protocell reminiscent structures [21], the utility of
these attempts is still limited. Most of SB is therefore realised in already exist-
ing natural hosts, also referred to as chassis, in harmony with the engineering
view. However, the potentially unwanted interaction with the native procedures
of a host, constitutes a hurdle for the predictability of an engineering approach.
Therefore an important property in SB is orthogonality. An orthogonal process
within a cell is a process which does not inuence the cell's metabolism. This is
achieved either by trial and error or by choosing simpler hosts or hosts that have
been stripped of non-essential genes.
2.1.1 Bacterial Chassis
While there have been many SB studies performed with the use of mammalian
or other eukaryotic hosts, with Saccharomyces cerevisiae being the most used
from that category, the concept of orthogonality laid out above is served better
with simpler (i.e. bacterial) chassis. Therefore, the better part of SB is done in
bacterial hosts. Undoubtedly, the agship of SB is E. coli, a natural choice in
most of SB endeavours, as it is the most well-documented, extensively studied
and modied bacterium, a fact which contributes to its predictability which is
a desirable attribute for SB. Moreover, E. coli is dominantly used for everyday
molecular biology tasks such as plasmid maintenance, cloning, protein extraction.
In the present study, the choice to use E. coli BL21 (DE3) for the implementation
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of modications was made mostly because of the existing publications which
describe uorinase overexpression in this host. A number of attributes render
the BL21(DE3) genotype enticing for implementation of heterologous expression,
hence engineered in vivo activity. First of all, the T7 RNA polymerase along
with the strong inducible promoter lacUV5, constitute an orthogonal expression
system within the cell, which recognises foreign promoter sequences and is able to
produce high quantities of a desired recombinant protein without competing for
native polymerases. Secondly, the Lon and OmpT proteases are deleted, reducing
protein degradation. Third, even the expression of detrimental proteins can be
achieved by the strong control on expression levels from the inducible promoter.
2.1.2 Regulatory elements
The ability of biological systems to maintain their integrity and propagate in a
range of environments is a dening characteristic of life. This is accomplished
by a set of sophisticated control elements which determine the spatio-temporal
organization of biomatter within a living system based on environmental stimuli.
These regulatory elements play a key role in the eort to construct synthetic
systems as they constitute the equivalent of the control circuit in a device. To
further the engineering approach, an eort to standardize modular elements has
yielded the Registry of Standard Biological Parts [22], a database where modular
elementary parts can be submitted. Novel parts are required to follow the
BioBrickTM standard, a protocol which allows their assembly into more complex
devices. Following the above standards, a description language for the assembly
of parts in silico is also being developed, namely SBOL [23].
Regulatory elements are categorized in cis and trans which are terms dening the
controlling element's locality in the DNA sequence compared to the controlled
element. Thus, cis-regulatory elements are those that control a nearby sequence,
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while trans interacts with distant sequences. Of most interest for SB are the rst
and are divided into the following categories:
• Promoters: They are DNA sequences which serve as recognition sites for the
RNA polymerase to attach and initiate transcription of a gene or cluster
of genes (operon). Dierent consensus sequences appear across domains.
Promoters in eukaryotes are complex and they can include elements in a
varying length upstream of the a gene cluster. Bacterial promoters, which
are more frequently used in SB, consist of 2 consensus sequences (based
on nucleotides with the highest probability of appearing) of 6 nucleotides
each that lie 35 to 10 bps before the rst nucleotide of the transcript.
These sequences are of key importance to the strength of each promoter, for
example the synthetic promoters J23100 and J23114 from the Registry of
Biological Parts dier only in 2 bps in the -35 and 1 bp in the -10 position,
yet they exhibit a 10-fold dierence in nal uorescent output.
• Enhancers: These are DNA sequences that with the help of the appropriate
transcription factor (activator) act favourably on the rate of transcription.
• Silencers: Likewise, these regions are bound by another type of transcription
factor (repressor) and reduce transcription rates.
2.2 Directed evolution
The main principle governing natural evolution is simple. Out of a population
of biological entities capable of replicating with random perturbations in their
phenotype, individuals with higher probability of surviving in their environment
will continue to replicate successfully - with higher probability - and at some point
they will become dominant in the population. The controlled application of the
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Figure 2.1: The basic workow of DE [2].
above process in order to achieve a specic phenotypic outcome is called Directed
Evolution (DE). The objective of the process can be either an improvement
to an existing property or an alteration of the function altogether. The set of
possible sequences of a particular number of amino acids is often referred to as
the sequence space, which is an N-dimensional discrete and nite space with 20
possible values in each dimension, where N is the number of amino acids in the
chain. Inside the sequence space there is a sequence that exhibits the optimal
capacity for a particular objective. Starting with a gene which encodes a wild
type protein of interest, the main workow of DE is shown in gure 2.1. The rst
step is the introduction variability in the nucleotide sequence which translates
to variability in the amino acid sequence. The variants obtained from the above
process comprise a mutant DNA library for that particular gene. The next step
is the expression of that DNA library and screening of the resulting proteins for
a particular activity of interest. The protein sequences that show an adequate
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level of activity are selected and prepared for another round which starts from the
initial step of the creation of the mutant library as above, expression, screening
and so on.
There are 3 distinct ways to ensure genotype-phenotype coupling. One approach
is to utilize the natural host of the protein of interest and use its own life
cycle for selection. Another approach is the transformation of hosts that have
been extensively studied and contain the necessary toolkits for high levels of
expression, for example particular strains of E. coli. A third approach, is the in
vitro DE of proteins. Essentially, this approach consists of an in vitro translation
system which is coupled to the cycle of DE instead of living cells, with the
amino acid chain coupled with the corresponding mRNA during the selection
phase for genotype-phenotype linkage [2]. The type and extent of induced
variability during the rst step depends on the type of the protein, the objective
of optimization or alteration and the domain of knowledge around that particular
kind of protein. The most common method is error-prone Polymerase Chain
Reaction (PCR) (epPCR) where the PCR occurs with suboptimal conditions
introducing mutations to random positions on the amino acid chain. Another
method is recombination or DNA shuing, a method borrowed from natural
evolution, where there is a number of parent genes cut in particular positions
and then reassembled in a random manner. Targeted methods include site
directed mutagenesis, where mutagenic primers are designed to import mutations
to specic positions in the gene (low number of mutations) and de novo gene
synthesis, backed up by information acquired from SB approaches (high number
of mutations).
Once the diversication phase is complete, selection of the variants must take
place in order to pick improved variants for a particular objective. This is achieved
with a selection system or screening technique. A robust, high throughput and
error-free method is based on genetic selection. For example, in a competition
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system where the absence of a molecule will lead to a growth defect, selection
will take place directly inside the environment containing dierent clones. Other
screening methods include Fluorescence Activated Cell Sorting (FACS), a high-
throughput method, albeit limited from the necessity of uorescent proteins,
however, coupling a uorescent reporter with the activity of a non-uorescent
substrate can broaden its use.
2.3 Biological Fluorination
Despite the fact that uorine is the most abundant halogen found on earth, it
does not occur analogously as a component of biochemically produced organic
molecules. Several reasons have been proposed such as the insolubility of
minerals containing uorine or the inability of haloperoxidases, the key halogen-
metabolising enzymes encountered in nature, to utilize uoride as a halogen
[8]. This is due to the unique properties of uoride, having the highest
electronegativity and the highest heat of hydration amongst all other halogens,
along with a very low abundance in the oceans, limiting its bioavailability [24].
Another possible reason lies in the evolutionary route towards uoride resistance
mechanisms most of which involve uoride expelling channels (see 4.2), further
reducing its contact with cells. The rarity of biologically produced uorinated
organic molecules has driven research towards identifying these unique pathways
and if possible utilizing biotechnology in order to expand the toolbox of available
uorination methods. Until the early 2000s, the exact uorination mechanism
had yet to be elucidated in spite of the rst study to demonstrate the occurrence
of biological uorination dating back to 40s. The latter illustrated the existence
of Fluoroacetate (FAc) in the leaves of Dichapetalum cymosum [25]. Later in
the 60s a few other instances were highlighted in other plants yielding FAc
and a few derivatives of it [26] [27], [28], [29]. The ability of some plants to
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elaborate uorometabolites is variable and in some cases even detrimental [28]
indicating a non-specic mechanism of catalysis. In other species however this
ability seem to have further evolved exhibiting high amounts of accumulated
uorinated compounds even in the presence of low concentrations of inorganic
uoride, for example the Dichapetalum Braunii demonstrates more a 100-fold
higher concentration of uoroacetic acid in the leaves of young plants than
the inorganic uoride concentration which it is exposed to [30]. The exact
mechanism of uorometabolite accumulation in plants even in these interesting
cases has not been determined yet [31]. The main reason is the diculty in
obtaining plant material and in the variability and unpredictability of observed
uorination in specic plant-derived tissue cultures [32]. It has been proposed that
the unpredictability and gradual loss of ability in synthesizing uorometabolites
from plant tissue cultures is the result of separation from the true source of
the precursor FAc which is produced by soil bacteria [33] a handful of which
are now known to produce uorometabolites, with FAc being the prevalent
end-product by a well characterized pathway with its rst step mediated by
the only enzyme known to perform direct uorination of a biomolecule using
inorganic uoride (see next section). Other instances of uorometabolites include
the Streptomyces calvus broad-specicity antibiotic nucleocidin [34], [35]. The
inherent variability followed by low titres and seemingly spontaneous halt of
uorometabolite production is also evident in this case. A recent study has shown
however that production of the antibiotic is restored with the correction of a defect
in Leu-tRNA(UUA) of the submitted S. calvus strain from the initial study [36].
However, it was reported that an S. calvus variant with a functional tRNA(UUA)
still suered from low titres. The radioisotope incorporations observed during
incubations of this variant, though establishing some metabolic constraints [37],
are inconclusive as to the specics of the putative uorination pathway and cannot
dismiss the possibility of an eect related to the broad-specicity of a particular
enzyme of a dierent main function.
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Figure 2.2: The 4-FT - Fac pathway from S. cattleya.
2.3.1 Fluorometabolites from bacteria: The 4-FT pathway
The rst fully-characterized pathway for the production of uorometabolites is
the Streptomyces cattleya 4-FT - FAc pathway. This actinomycete contains a
cluster of 6 enzymes which process inorganic uoride and SAM yielding FAc and
4-FT. S. cattleya had initially demonstrated the ability to synthesize FAc and
4-FT in the presence of inorganic uoride a few decades back [38], [8] but the
characterization and assignment of the pathway enzymes was accomplished only
during the past decade. In gure 2.2 the S. cattleya pathway is shown. The
pathway itself has been reconstituted in vitro with some replacement homologues
from other organisms which did not appear to hinder the pathway's capacity to
elaborate 4-FT [39]. The rst step of uorinated biosynthesis was found to be a
unique enzyme specically evolved to process inorganic uoride, termed 5'-FDA
synthase or uorinase [40], [41], and comprises the vessel for realization of direct
uorination in E. coli presented in the present work.
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The second step in the pathway is performed by a Purine Nucleoside Phospho-
rylase (PNP) -type enzyme which cleaves the purine base from the molecule and
replaces it with a phosphate group yielding 5-uoro-5-deoxy-D-ribose 1-phosphate
(5-FDRP). Although S. cattleya PNP acts on the 5'-FDA directly to yield 5-
FDRP, the E. coli PNP (deoD-type PNP EC:2.4.2.1) reacts with 5'-uoro-5-
deoxyinosine (5'-FDI) [42], a shunt product of the pathway which is not observed
in vivo, but is found during the cell-free extract mediated activity of the path-
way. This dierence is attributed to some type of compartmentalization [43].
Interestingly, the PNP from S. cattleya bears higher homology with the enzymes
annotated as S -methyl-5'-thioadenosine phosphorylase (MTAP) type rather than
the usual PNPs, with an identity of 38% with the human MTAP and a 35% of ho-
mology with the yeast homologue. On the contrary, E. coli PNP genes (xapA and
deoD) exhibit 23% and 16% of homology respectively and there is no homologue
in E. coli annotated as MTAP.
The third enzyme of the pathway, namely 5-FDRP isomerase, is an interest-
ing case as it bears signicant homology to 5-methylthio-ribose-1-phosphate iso-
merase, which is part of the L-methionine salvage pathway. In fact, the version of
this enzyme found in Bacillus subtilus was found to bear around 35% homology
with several putative Open Reading Frame (ORF)s from Streptomyces coelicolor
and Streptomyces avermitilis.
Incubations of the protein corresponding to S. coelicolor isomerase homologue
with 5-FDRP, were found to elaborate 5-uoro-5-deoxy-D-ribulose 1-phosphate
(5-FDRibulP), product of the third step of the 4-FT pathway. Since it has been
established that the isomerase from S. coelicolor is able to catalyse the third step,
using genome mining the authors of [39] managed to identify an ORF with 75%
homology. This ORF' s product was conrmed to be the 5-FDRP isomerase of
the third step of the uorination pathway.
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Figure 2.3: Alignment of 5-methylthio-ribose-1-phosphate isomerases from S.
cattleya, S. coelicolor, N. brasiliensis, B. subtilis, E. coli and S. cerevisiae. All of
them show at least 30% sequence identity with clearly conserved motifs.
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This series of sequence-homology extrapolation is encouraging for the exploration
of migration of uorometabolite synthesis to other organisms, since apart from
B. subtilus homology with the S. cattleya isomerase, homologues of 5-methylthio-
ribose-1-phosphate isomerase exist in other biotechnologically relevant organisms
such as yeast (≈33%) and E. coli K-12 (≈50%) (see gure 2.3) with a roughly 60%
coverage in all cases. Moreover, the enzyme's function is identical as suggested
by the fact that a similar glucose isomerase can eciently catalyse the reaction 5-
uoro-5-deoxy-ribose (5-FDR) to 5-uoro-5-deoxy-ribulose (5-FDRul) regardless
of uoride substitution in the molecule [44].
The fourth step of the pathway is performed by an aldolase. This enzyme has
been reported to be elusive in its determination for the primary 4-FT host S.
cattleya therefore a replacement fuculose aldolase from S. coelicolor was used
and eciently performed this fourth step of the pathway in vitro. Alignment
of the functional fuculose aldolase reveals 3 similar genes in S. cattleya one of
them exhibiting signicant similarity (≈65%) while the other two are less similar
(≈35%). Again, an E. coli fuculose aldolase protein was included in the alignment
showing somewhat high similarity (≈40%) and the potential compatibility of the
enzyme with pathway rewiring or alternative functionality in this commonly used
bacterium (gure 2.4).
Finally, the last step consists of two enzymes and a crossroad for the pathway.
One enzyme is the uoroacetaldehyde dehydrogenase (SCAT_0945 ), a NAD+
dependent enzyme which shows high anity for uoroacetaldehyde but also
accepts glycoaldehyde and aldehyde with lower specicity. Interestingly, the
yeast aldehyde dehydrogenase was also able to catalyse the reaction albeit with
4-fold less specicity [45]. Interestingly, E. coli accommodates a homologue for S.
cattleya uoroacetaldehyde dehydrogenase, namely aldB bearing 67% of sequence
identity, much higher than that seen between the tested yeast homologue which
shows a less than 40% of homology. Given the broad specicity of all these variant
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dehydrogenases it is highly possible that this native dehydrogenase of E. coli can
also catalyse this reaction. The fact that AldB can catalyse the conversion of
chloroacetaldehyde even more eciently than acetaldehyde (higher Vmax) [46]
also encouraging towards this goal. On the other hand, as also suggested in [39],
the uorothrenonine transaldolase is a unique enzyme in its own right and there
is no sequence with signicant similarity in E. coli or yeast.
Both products of the 4-FT pathway are toxic to bacterial cells. In particular,
FAc is a strong inhibitor of the essential citric acid cycle. Therefore, apart from
the pathway enzymes which mediate catalysis of the reactions required to yield
the end-products, FAc and 4-FT, other enzymes that are critical for S. cattleya
in order to withstand the toxicity of these uorinated molecules are also present
and their function has been elucidated. One example is the uoroacetyl-CoA
thioesterase (FlK) which mitigates FAc toxicity [47]. Until very recently, the
exact inhibitory mechanism of 4-FT had yet to be illustrated. In pioneering work
from Chang et al., it was assumed that 4-FT' s close resemblance to threonine
could lead to misincorporations of the uorinated version during protein synthesis.
By employing bioinformatics analysis, two conserved genes have been discovered
lying within the uorination pathway locus, fthB and fthC, which code for a trans-
acting tRNA editing protein and a 4-FT exporter respectively. Indeed, deletion
of either those genes led to a higher incorporation percentage of the uorinated
amino acid 4-FT in proteins of both mutants. The mutant lacking FthB did not
show any hindrance in growth but its expression in a heterologous streptomycete
did increase its resistance to 4-FT. On the other hand, the strain lacking FthC
showed higher accumulation of 4-FT intracellularly and greater sensitivity when
added 4-FT in the growth medium [48].
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Figure 2.4: Alignment of 3 aldolases from from S. cattleya and fuculose aldolases
from S. coelicolor and E. coli.
2.3.2 The uorinase enzyme
The rst step in the pathway of 4-FT synthesis, as illustrated above is realized by
5'-FDA synthase (or uorinase), the only known enzyme to date that is capable of
catalysing the incorporation of inorganic uoride to biologically relevant organic
molecules. This enzyme has enjoyed much attention in the following years both
because of its uniqueness in catalysis of direct uorination reactions combined
with the biological importance of uorinated chemistry. Immediately after its
discovery the crystal structure has been solved [49] conrming the hexameric
conformation as a dimer of trimers.
The mechanism of action that has been proposed is an SN2 nucleophilic substi-
tution with the uoride anion acting as the nucleophile [50]. Initially, the water
solvated uorine atom at complex with 4 water molecules is passively diused
into the binding pocket and binds to the 2 hydrogens of serine 158 residue of the
uorinase displacing 2 water molecules. SAM then sits upon uoride expelling the
2 remaining water molecules and initiating the nucleophilic attack to the 5-carbon
of the ribose ring substituting sulphur with uoride. The proposed mechanism of
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Figure 2.5: The mechanism of action of the uorinase [3]
action was also strengthened by an experiment where the enzyme was allowed to
equilibrate with one of the substrates rst before addition of the second. When
SAM was added rst, the reaction showed a 6-fold less burst in reactivity and
therefore active-site availability, indicating that the SAM-bound enzymes show
lower anity for uoride presumably because the accepting pore is shadowed [3].
The substrate specicity of the enzyme was also an item of research in subsequent
studies for the identication of potential inhibitors and alternative functionality.
Two molecules similar in structure with SAM were initially tested, both of which
are established inhibitors of SAM-dependent enzymes. First, a by-product itself
of those enzymes, S-Adenosyl-L-Homocysteine which results from the cleavage of
a methyl-group from the sulphur moiety and second, sinefungin which diers from
SAM in that sulphur is replaced with a carbon connected to an amine group. It
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Figure 2.6: The broad halogen specicity of uorinase (top) and the combined
enzyme assay revealing the chlorination mechanism (bottom) [4].
has been shown in assays that contain equal concentrations 0.4 mM of both SAM
and S -adenosyl-L-homocysteine (SAH) (10 mM KF, 7.8 pH, 37 oC), that the en-
zyme loses 95% of its activity, therefore SAH is a strong competitive inhibitor
of the uorinase with a Ki = 29 μM [41]. Furthermore, in another study is has
been shown that SAH binds to the enzyme with 40-fold higher binding anity
than SAM [3]. The latter was an item of concern for the development of in vivo
uorination in E. coli presented in chapter 4, as SAH is also present in E. coli,
albeit in low molarities (1.3 μM reported in [51]) as a result of the action of MTA
nucleosidase which is part of the methionine salvage cycle. Sinefungin, on the
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other hand showed only weak inhibition with 15% loss of activity in equimolar
solutions of SAM and sinefungin.
The uorinase has naturally been studied for substrate anity with other
halogens. Initially, assays with chloride failed to reveal any production of the
chlorinated analogue, 5'-ClDA [41]. However, a later study has shown that
the absence of 5'-ClDA was in fact a result of the equilibrium of the reaction
heavily shifted towards the substrates. With an ingenious approach, including
two more enzymes that irreversibly convert the products of the chlorination
reactions, namely 5'-ClDA and L-methionine to 5'-chloro-5-deoxyinosine (5'-ClDI)
and 2-oxo-acid respectively, the uorinase was proven to possess the capacity to
function as a chlorinase. Moreover, in the same study it has been shown that
halogenation with the uorinase is a reversible reaction and that this reversibility
combined with the preference of uoride over chloride can be used in a two-step
transhalogenation reaction with the uorinase for conversion of 5-ClDA into 5'-
FDA [4]. The only directed evolution study involving the uorinase that has been
reported so far had this two-step reaction as an optimization objective, though
native uorination activity was hindered in the isolated variants [52].
2.3.3 Other uorinase variants
Recently, 10 years after the discovery of the rst uorinase from S. cattleya,
3 more variants have been identied by genome mining [53]. They all showed
high sequence homology (80%-87%) with the uorinase of S. cattleya and among
themselves, and are almost structurally identical, while there is a 21 consecutive
amino acid region which comprises the active site of the enzyme and is conserved
throughout a family of proteins that catalyse the conversion of SAM to adenosine
analogs. The bacterial hosts accommodating the uorinase variant genes are No-
cardia brasiliensis, Actinoplanes sp. and Streptomyces sp. MA37. Recombinant
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Figure 2.7: The alternate route of the uorometabolite pathway in Streptomyces
sp. MA37 involving enzymes fdrA and fdrC.
versions of these enzymes were synthesized and overexpressed in E. coli. Assays
were performed and all these three variants showed higher catalytic eciency
from the one in S. cattleya with most ecient the one from Streptomyces sp.
MA37. Apart from the uorinase homologues, the other pathway enzymes have
also been tested for homology. In all 3 bacteria accommodating variants of the
uorinase, genes coding for putative pathway enzymes have also been found with
more than 50% sequence identities compared to the S. cattleya homologues. The
identication of these genes also raised the possibility of other potential uori-
nated metabolites being elaborated by those bacteria. In N. brasiliensis incubated
with uoride, no uorometabolites were detected and therefore the pathway was
deemed to be inactive. No assays were performed with Actinoplanes sp. as it is
not available in the public domain. The case of Streptomyces sp. MA37 is an in-
teresting one as it not only elaborates uorometabolites, but also accommodates
an alternative route in the pathway leading to a novel uorometabolite (2R3S4S )-
5-uoro-2,3,4-trihydroxypentanoic acid (5-FHPA) as shown in gure 2.7. The two
CHAPTER 2. Background and Methods 27
enzymes employed in the conversion of 5-FDRP to 5-FHPA are products of fdrA
and fdrC. Both of those genes were discovered by sequence homology with the
Salinispora tropica pathway (more details in the next section) fuelled by similar-
ity in the rst two steps with the uorothreonine pathway. Specically salN, the
product of which is able to dephosphorylate 5-ClDRP to 5-ClDR in salinospo-
ramide synthesis, showed a 56% homology with fdrA, therefore it was assumed
that FdrA is the enzyme mediating dephosphorylation of 5-FDRP to 5-FDR. The
second step, found to be catalysed by the product of fdrC (69% identity with
salM ), is the oxidation of 5-FDR yielding 5-uoro-5-deoxy-D-ribono-γ-lactone (5-
FRL) which subsequently yields 5-FHPA by hydrolysis [54]. In another study, it
was discovered that the marine bacterium Streptomyces xinghaiensis was able to
elaborate FAc in a sea salt-dependent manner [55]. This nding led to the dis-
covery of another variant of the uorinase gene in the genome of this bacterium,
following a the same trend of very high sequence identity and structural similarity
with the rst uorinase (84%). Kinetic studies showed that this variant shows
marginally higher catalytic eciency compared to the most ecient uorinase
previously characterized (FlA1 from Streptomyces MA37 - k cat = 0.277 min
−1
instead of 0.260 min−1), but surprisingly higher specicity for SAM, more than
10-fold compared to FlA1 [1]. A total of 5 variants of the uorinase have therefore
been characterized so far and their Michaelis - Menten rates are collectively shown
in table 2.1. The more recently discovered uorinase (FlA4) exhibits a Km = 8.2
mM for uoride as determined with the same assay, but with a steady 500 μΜ
concentration of SAM and increasing uoride 0 - 30 mM.
Except for the above characterized uorinases, a BLAST search on the NCBI
database as of 20/11/2018, produces 4 more ORFs which are predicted to en-
code for uorinases with a sequence identity of more than 50%. Specically, two
sequences, one from the Actinopolyspora mzabensis genome and one from Amy-
colatopsis sp. CA-128772 exhibit identities of 78% and 81% respectively. One
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Fluorinase source Vmax (μM
min−1)











3.88± 0.11 7.04± 0.94 0.277± 0.007 39.5± 1.51
Streptomyces sp.
MA37 (FlA1)
3.63± 0.13 86.0± 11.3 0.260± 0.004 3.02± 0.19
Actinoplanes sp.
N902-109 (FlA3)
2.78± 0.15 43.1± 7.99 0.197± 0.003 4.58± 0.50
N. brasiliensis
(FlA2)
1.77± 0.07 30.4± 4.24 0.128± 0.004 4.22± 0.42
Streptomyces
cattleya (FlA)
1.17± 0.06 29.4± 5.80 0.084± 0.005 2.84± 0.14
Table 2.1: The Michaelis - Menten kinetic constants for the 5 variants of the
uorinase as measured in [1]. The kinetic rates were determined with an assay of
increasing SAM from 0 to 800 μΜ in a saturating concentration of uoride (200
mM). The concentration of protein was 14 μΜ in 20 mM of sodium phosphate buer
(7.8 pH) and a temperature of 37oC.
comes from Peptococcaceae bacterium CEB3 which has a 66% identity and auto-
matically annotated as a chlorinase, and nally one from Thermodesulforhabdus
norvegica with a 55% identity. The alignments are shown in gure 2.8. It would
be surprising if at least the ones with high homology are proven not to catalyse
the well-known uorination reaction. The latter is also strengthened by the fact
that ORFs with homologues of B (MTAP) exist with sequence identities 59%
for A. mzabensis and 53% for Amycolatopsis sp. CA-128772. The same is true for
the 5-methylthio-ribose-1-phosphate isomerase but with somewhat lower identi-
ties (51% and 43%) respectively. For the aldolase enzyme, one out of two putative
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Figure 2.8: Four ORFs encoding putative uorinases from Amycolatopsis sp. CA-
128772, A. mzabensis, Peptococcaceae bacterium CEB3 and T. norvegica.
aldolases of S. cattleya has a high identity homologue (59%) in Amycolatopsis sp.
CA-128772. Finally, homologues of the 4-FT transaldolase that performs the last
step of the pathway exist in both A. mzabensis (62%) and Amycolatopsis sp. CA-
128772 (64%). Evidently, even though the current convocation of uorinases is
quite poor, with more and more sequences being deposited from newly discovered
organisms, more potential uorinases will appear.
2.3.4 Engineered in vivo uorination
The only instance of engineered direct uorination in another living bacterium is
uorosalinosporamide production which was made possible by simply substituting
the salL gene with the uorinase (A) gene [5]. These two genes exhibit the
highest "non-uorinase" sequence identity of 40% and they catalyse virtually the
same reaction with identity of the halogen being the only dierence. Presumably,
the deletion of the salL gene and substitution with A came as a natural choice
for investigating the compatibility of the uorinated analogues in the next steps
of the pathway towards salinosporamide A and they were found indeed to be
compatible yielding the uorinated version of salinosporamide A. The steps are
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Figure 2.9: Substitution of uorinase in the pathway for salinosporamide A
biosynthesis in S. tropica [5].
shown in gure 2.9. Although the latter was elaborated with a 10-fold lower
yield than the wild type yield of salinosporamide A, it was the major product
of the pathway among 5 uorometabolites that were detected. The identity of
those was not elucidated however it is thought that they are close analogues of
uorosalinosporamide as they exhibit similar coupling patterns.
A number of studies reveal the implementation of in vivo uorination pathways
in other broad usage organisms such as E. coli. An interesting case is the pro-
duction of 2-uoro-3R-hydroxybutyrate (FHB) through the in vivo activity of an
engineered pathway beginning with uoromalonate, a non-toxic analog of FAc,
by expressing a malonate transporter protein for intracellular delivery of the
uoromalonate, proceeding with a conversion to uoromalonyl-CoA by a mal-
onate:CoA ligase from Rhodopseudomonas palustris, continuing with production
of acetouoroacetyl-CoA by action of an acetoacetyl-CoA synthase and nally
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production of 2-uoro-3R-hydroxybutyryl-CoA by an acetoacetyl-CoA reductase.
The latter was then either reduced to FHB by hydrolysis from native processes or
polymerization to uorinated poly(hydroxyalkanoate) bioplastics. The amounts
of end-products were lying in millimolar levels after 48h of incubation [56].
2.4 DNA editing techniques
The ability to alter the DNA of any chosen organism from the simplest virus up
to the higher mammalian cells is not only essential for the study of the organism
itself and its genetic elements but also a eld-dening feature for SB. The precision
of DNA editing and reduction of o-site or polar eects from genome editing that
are not tied to the presence of the gene product itself is of outermost importance
for the legitimacy of research ndings. Fortunately, the advancement of available
tools for gene deletion, insertion or modication along with the highly developed
sequencing technology, have made the accurate editing of the genomes of many
organisms routinely achievable and less time-consuming. There is a wide variety
of DNA editing techniques, each of them entailing a large number of variants and
most of them are tailored specically to the organism where editing takes place.
In the following sections, methods for altering the genetic environment of the E.
coli bacterium will be described.
2.4.1 Gene editing by native recombination machinery
E. coli accommodates a system which comprises by set of proteins induced when
DNA damage is detected in the bacterium by appropriate control elements. The
proteins are responsible mainly for DNA repair and their collective function is
called SOS response. Part of this system is the recombination which promotes
repair of damaged gene by replacing with a homologue found "nearby". There
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Figure 2.10: Left: Formation of a single Holliday junction and resolution thereto.
Right: Insertion (A) and excision of a plasmid (B). [6].
is a large number of proteins that are involves in the recombination mechanism
but the key proteins are called RecA and RecBCD. Defects in these genes have
serious repercussions in cell viability with or without induced DNA damage [57].
RecA is particularly important as it creates a complex with ssDNA created
from a probability driven Double Strand Break (DSB) and sweeps through
the chromosome until it nds a large region of homology, usually more than
500bps. At this point the ssDNAs created from the DSBs are paired with the
other sequence and a "Holliday Junction" is created as shown in gure 2.10 -
Left. This native recombination ability can be "tricked" to replace specic DNA
sequences in the chromosome with sequences of choice. In a revolutionary method
released 30 years ago, it was shown that by designing a plasmid which harbours
a temperature-sensitive origin of replication, and accommodates a mutant allele
of a gene to be edited including regions of homology upstream and downstream,
it is possible for this plasmid to be integrated in the chromosome on the 5' or
3' end of the gene by utilizing the innate homologous recombination system.
Specically, the RecA protein is enabled and creates a holliday junction which if
resolved properly results in the insertion of plasmid in the chromosome as shown
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in gure 2.10 - Right. Clones which have managed to integrate the plasmid
are called cointegrates and they are usually selected in LB agar plates with
antibiotic whose resistance is encoded in the plasmid and a temperature which is
not permissive for the normal replication of the plasmid, therefore the surviving
clones are cointegrates. Integration events are rather rare with a frequency of
10−3 - 10−4 because they depend on a DSB happening well within the region of
homology in either strand, a high number of transformants have to be plated for
adequate clones to appear [58].
2.4.2 Gene editing by foreign recombination
Recombineering refers to genetic engineering (i.e. DNA editing) using homologous
recombination techniques that are mediated by recombinant proteins from phages.
Although, genetic engineering using phages is rather old, techniques have been
improved rst by removing elements which cause virulence, thereby permitting the
stable integration of a prophage in the chromosome, and further developed with
isolation of the minimum essential genes that enable recombination functionality.
There are many protocols and variants of this method, however it is based
on three proteins from lambda phage, Exo, Beta and Gam. The essential
materials consist of a tightly controlled expression system for this set of proteins
and the intracellular presence of a double or single stranded DNA (dsDNA
or ssDNA respectively) with tails of around 50 bps, homologous to the target
sequence. In fact, the word "recombineering" itself has been invented after the
rst implementation of the method with dsDNA, by a study which improved
upon the method using ssDNA instead [59]. Exo and Gam operate in concert
and perform the actual recognition and recombination while Gam is responsible
for the suppression of RecBCD, an exonuclease which cleaves linear DNA that is
present in an E. coli cell [60].
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Recombineering is still the most frequently used method in gene editing involving
research in E. coli and an attempt at description of the steps involved will be
attempted in a generic format below. The keen reader can refer to [61] for a more
detailed description.
Step 1) Choice of the DNA sequence to be edited (deleted, substituted or inserted).
Step 2) Obtain the template for editing. This can either be created by simple
PCR, fusion or mutagenic PCR from the source harbouring the foreign DNA, or
obtained directly as synthesized DNA. In these days the latter is a very attractive
choice as a 1000bp DNA sequence can be synthesized for as little as 100 pounds.
The template can be either a selection marker (e.g. antibiotic resistance cassette)
or in case of insertion of a foreign gene or modication of an existing gene, the
modied (or to be inserted) sequence or both.
Step 3) Creation of appropriate primers which apart from the complementary
base pairs with the template carry short (30-50bp) aking homology arms with
the sequence upstream and downstream of the DNA to be edited. Amplication
of the template by PCR using the aforementioned primers. The end product is
the initial template anked with the homology arms.
Step 4) Transformation of the E. coli cells with a plasmid containing 3 genes
for the lambda red functions under the control of a temperature sensitive cI-
repressor. Growth of the transformed strains in 30oC - 32oC up to mid-log phase
and then placement in a 42 oC warm water bath for 15 minutes with a 200 RPM
rotary shaking. This is a pulse-like induction of the lambda phage recombination
machinery. Afterwards, the culture has to be put in a ice cold water bath in order
to restore repression and freeze the state of the cell with the expressed proteins.
Step 5) Transformation of the cells from step 4 with the linear DNA with the
homology arms obtained from steps 1-3. Incubation of the culture in (30oC -
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32oC) and then streak in LB agar plate containing the antibiotic for overnight
incubation. Selection of surviving colonies with the inserted fragment from the
plate.
There are several advantages of this technique. Apart from its relatively quick
implementation time, it can be used in E. coli strains with impaired native
recombination machinery such as recA1, recA13 genotypes typically seen in
cloning strains.
2.5 Molecular biology
The techniques that have been consistently utilized in this work, for bacterial
maintenance, modication and handling are presented below.
2.5.1 Media preparation
E. coli bacteria are grown depending on the type of study in either rich or minimal
medium. LB (Lysogeny Broth) is routinely utilized as a rich medium for E. coli
and contains yeast extract (5 g/L), tryptone (10 g/L) and NaCl (10 g/L). All
cultures in this work were grown on LB unless stated otherwise. Minimal medium
for E. coli (M9) contains the absolute essentials for E. coli growth: a carbon
source (glucose or glycerol 0.4%), MgSO4, CaCl2 and M9 salts (Na2HPO4.7H2O,
KH2PO4, NaCl and NH4Cl). Solid media are used in petri dishes for plating
bacteria and isolating single colonies. Both LB and M9 can be solidied by
adding agar in the above mixtures.
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2.5.2 Gel Electrophoresis
Gel electrophoresis involves separation and visualization of DNA molecules
according to their size. This technique is based on the electro-negativity of DNA
molecules and when placed inside an electric eld, they are attracted towards the
positive pole. The rst step involves creation of the agarose gel, a solidied
substance with wells placed at the top. In this study, all gels were created
with TAE buer (Tris base, Acetic acid and EDTA) adding 1% agarose and
SYBRTMSafe DNA Gel Stain (Thermo Fisher ScienticTM). The apparatus is
very simple and includes a container with two electrodes, one on each end. The
gel is placed into the container which is lled with TAE buer until the gel is
completely submerged into it. The samples to be analysed are placed in the wells
and power cables are attached to the electrodes. Then current (≈ 100 mA) is left
to pass through the TAE buer and the gel for at least 30 minutes. The smaller
sized DNA molecules run faster through the solidied gel, thus DNA bands can
be resolved according to their size. Usually, one or two wells at the edges are
reserved for a DNA ladder which contains DNA of predened sizes serving as a
rule for the rest of the samples. Finally, the bands are visualized by exposure to
UV light which illuminates the DNA stain attached to the molecules.
2.5.3 Plasmid extraction
Plasmid extraction is the process of acquiring ample quantities of plasmid DNA
from lysed E. coli bacterial cells. In this work, all plasmid extractions were
performed with the use of a GeneJET Plasmid Miniprep Kit (Thermo Fisher
ScienticTM). This kit is an adaptation of the widely utilized alkaline extraction
procedure in which chromosomal (but not plasmid) DNA is denatured in a
solution with high alkalinity and then renatures and becomes insoluble upon
neutralization [62]. The process is as follows:
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• Growth of a liquid culture to saturation with the appropriate antibiotic to
ensure plasmid maintenance.
• Centrifuge the culture tubes in 6,000g for 5 minutes. Discard of supernatant
(S/N). After the procedure, bacterial cells are in the form of a pellet located
at the bottom.
• Resuspend the pellet in appropriate buer. This buer also contains RNase
in order to degrade RNA. The solution is now over-saturated in bacterial
cells and completely opaque.
• Add lysis buer (high alkalinity) and invert the tube gently 5-6 times. The
solution becomes transparent and appears viscous.
• Add neutralization buer (low alkalinity) and invert the tube 5-6 times.
The renatured chromosomal DNA appears as white clot in the solution.
• Centrifuge for 5 minutes in >12,000g to pellet cell debris and chromosomal
DNA. Plasmid DNA resides the S/N.
• Transfer of the S/N on the specially designed GeneJET column for the
isolation of plasmid DNA.
• Spin down the solution (1 minute in >12,000g). DNA is trapped in the
column.
• Add wash solution and centrifuge for 1 minute (>12,000g) to clean the
column of unwanted remaining debris (repeat 2 times).
• Finally, DNA is eluted by addition of an elution buer (mostly water),
incubation for 2 minutes and centrifuging in >12,000g for another 2 minutes.
It is important to note that plasmid maintenance is done in specic E. coli strains
which are decient in DNAses (such as DH10B) and recombinases, otherwise
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residual DNAse activity may degrade the DNA after elution in the tube and
incubation in 37 oC. If a plasmid needs to be extracted from a strain containing
DNAses, further purication with a PCR cleaning kit (see 2.5.4) can ameliorate
the problem.
2.5.4 DNA assembly
Construction of plasmids presented in this work has been achieved with the use of
FastDigestTMrestriction enzymes (Thermo Fisher ScienticTM) and the T4 ligase
(NEB). After each reaction, DNA was subjected either to gel electrophoresis
(2.5.2) followed by excision of the desired band and purication with the use
of a Wizard R© SV Gel and PCR Clean-Up System (Promega), or directly to
purication with the same kit.
2.5.5 Chemical transformation
Transformation is the process of DNA uptake from bacterial cells and while
there are species that already posses the ability to uptake extracellular DNA,
termed natural competence, E. coli does not belong in this category. However,
competence can be induced by chemical treatment of non-competent bacteria with
highly concentrated CaCl2. Calcium anions are thought to create pores in the
membrane of E. coli and DNA uptake is then achieved by incubating the chosen
DNA together with the bacteria [63]. The anions bind both in DNA molecules and
lipids in the membrane owing to them both being electronegative, thus bringing
them together and enabling the attachment of DNA in the cell surface, which
otherwise would be dicult due to mutual repulsion. This procedure works better
in a low temperature because the uidity of the cell wall is reduced. The mixture
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is then subjected to a thermal shock which creates thermal currents to the pores
in the membrane enabling the uptake of DNA.
2.5.6 Polymerase Chain Reaction
PCR is one of the most utilized tools in experimental molecular biology and
constitutes a considerable chunk of the underlying experiments in the present
work. This method has been made possible by the discovery, 30 years ago, of a
thermostable DNA polymerase in an extremophile bacterium Thermus aquaticus
(Taq) [64]. In short, starting from a DNA sequence which can be either linear
or circular (template), PCR mediates the in vitro copying of this initial DNA
in many rounds to nally yield a greatly amplied amount (230 − 240) of this
particular sequence.
The materials needed for the PCR process are:
1) An initial DNA template sequence.
2) A thermostable DNA polymerase.
3) Two primers. Short DNA oligonucleotide sequences (18-22 base pairs) to bind
in the primary DNA strand (forward primer) and the complementary strand
(reverse primer).
4) Single deoxynucleotide triphosphates of four types (dATP, dTTP, dGTP,
dCTP) which correspond to the four DNA bases A, T, G and C and are the
substrates accepted by the DNA polymerase to perform elongation of the DNA.
5) A suitable reaction buer
The reaction requires an thermoblock able to robustly control the temperature
and includes the following steps:
40 2.5 Molecular biology
1) Denaturation of the template DNA which is done in 95-98 oC. In these
temperatures the hydrogen bonds between complementary bases break resulting
in single stranded DNA.
2) Annealing of the primers to the single stranded sequences from step 1 (58 - 62
oC).
3) The DNA polymerase binds to the double stranded ends with the primers and
starts the extension process of the complementary DNA strands, nally yielding
two copies of the initial DNA sequence.
4) Repeat from step 1.
The above cycle is repeated 20-40 times and the number is based on several
factors, such as the desired nal quantity of DNA template and the eciency
of the reaction which in turn is inuenced by the quality of the template and
its accessibility by the polymerase, the primer sequences and the specic DNA
polymerase used. Most issues arising in PCR are related to the choice of primers.
These include secondary structure formation, non-specic binding and primer
dimerization, where the forward primer binds to the reverse primer. There are
specic workarounds to alleviate the detrimental eects such as tweaking the
temperature or duration of particular steps, addition of specic chemicals that
prevent secondary structure formation or enhance polymerase eciency, or choice
of another polymerase. However, there are tradeos most of the time. Selecting
the appropriate conditions for a successful PCR is sometimes challenging and this
procedure is termed PCR optimization.
Primer design is the process of specifying two exact nucleotide sequences which
are essential part of step 2. Most of the time, biologists use a simple formula
to specify the primer sequence which is T = 4 x (Number of G or C bases) + 2
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Figure 2.11: Types of scattering as illustrated in [7].
x (Number of A or T bases). This simple formula was routinely used in primer
design as part of this work.
2.6 Raman Spectroscopy
RS has proven to be a powerful diagnostic tool that has been used during the past
decade in biomedical applications and disease diagnosis with novel studies being
produced at an unprecedented rate [65]. An illustration of Raman scattering
is shown in gure 2.11. According to Plank, photons are undivided "packets" of
energy which is determined by their wavelength (λ), or frequency (ν), as E = hc/λ
or E = hν. In principle, if the photonic energy is within an appropriate window,
photons that "hit" a molecule (incidence photons) can be absorbed, exciting the
energy state of atomic (UV range) or molecular bonds (IR range). The latter is the
basis of IR spectroscopy. If a photon is not absorbed, the other possibility is that
it is scattered. There are 3 types of scattering: Rayleigh, stokes and anti-stokes.
Most of the scattered photons emitted by the irradiated substance are of Rayleigh
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type, and have the same wavelength as incidence photons. A tiny fraction (10−7),
is of the other two types. RS measures the Stokes photons generated, in which
case the photon excites the molecule to a "virtual" energy state but some of this
energy is absorbed to a molecular bond as real energy, which is exited to a higher
energy state. The scattered photon loses an equal amount of energy, therefore
appearing shifted to higher wavelengths. Based on the dierence of these shifted
photons the types of molecular bonds of a sample can be elucidated. This is the
basis of RS.
The Raman spectra of bacteria have been extensively used in research to
distinguish between dierent bacterial species which normally exhibit varied
spectra with respect to one or more metabolites [66]. There are Raman setups
that highly enhance the limit of detection by up to ve orders of magnitude [67].
In particular, it has been shown that coherent Raman methods such as Coherent
Anti-Stokes Raman Spectroscopy (CARS) and Stimulated Raman Spectroscopy
(SRS), exhibit an increase in signal of at least 2 orders of magnitude in comparison
to spontaneous Raman scattering when measuring bacterial endospores [68].
Chapter 3
Bacterial growth curve modelling
and promoter quantitation
SB as a eld is based on the mechanistic view of a biological system, and as
such, accurate quantication of the interactions between the basic elements that
comprise this system is vital. There is a large variety of regulatory elements that
constitute several discrete categories according to the type of regulation. Some of
these categories are discussed briey in section 2.1.2.
Promoters in particular have been receiving most of the attention, mainly because
they are the most commonly occurring regulatory element, however this does not
diminish the importance of other regulatory elements, especially when viewed
under the light of novel regulatory network construction. The rate at which
novel promoters are discovered or synthesized is unprecedented, whereas the
characterization procedure still suers from a few bottlenecks, as a novel element
has to undergo experimental validation across dierent hosts and conditions in
order to reliably demonstrate a robustly predicted behaviour. The latter indicates
the need for a high-throughput method in the characterization of novel elements.
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The approaches to experimental characterization can be categorized to direct and
indirect. An example direct approach is the real time quantitative PCR which can
measure the amount of transcript for a particular gene modulated by a regulatory
element. This approach, whilst being suciently accurate, suers in terms of
speed because the procedure requires "destruction" of the sample. A popular
indirect approach for characterization involves Fluorescent Protein (FP). These
proteins, when folded (matured), they reect light in particular wavelengths.
The number of photons reected can be used as a measure of the amount of
proteins that currently reside in the sample. When the gene corresponding to
an FP is tied to a particular promoter (or other regulatory element/network)
it yields a measure of its translational activity. While this approach suers in
accuracy compared to its counterpart, it makes up for speed, because it enables
the continuous monitoring of a growing bacterial culture.
The majority of studies involving experimental validation of regulatory elements
with FPs consistently represent promoter activity as the output of the uorescent
signal normalized to the biomass, which is given by the OD of the culture. The
experimental values are usually obtained from a coupled time-series experiment.
In the following sections, a case will be made for the need of a unied metric which
takes into account several aspects of FPs and the growth of bacteria in a liquid
culture with limited resources. Following the application of simple mathematical
reasoning, an implemented method that describes promoter activity at each time
point will be illustrated. Protein expression and maturation, are modelled as rst-
order dierential equations, taking into account the degradation and maturation
rates of the FPs which need to be known in advance. The promoter activity
is then expressed based on the measured values of uorescence and OD with
a formula derived by mathematical manipulations of the dened quantities and
the dierential equations that comprise the model. Continuous expressions for
uorescence and OD are obtained from GP regression. Validation of the tool
with experimental data from several constructs reveals the potential to eectively
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quantify promoter activities in a time-series manner regardless of the host and
the FP used.
3.1 Mathematical modelling of bacterial growth
curves
In this section, the traditional and latest approaches for the modelling of bacterial
growth are presented including various informative measures that can be extracted
from the growth curves. A detailed analytical description will be given for the
novel approach of using GPs for tting growth curves and an improvement of this
presented in the paper will be highlighted.
Bacterial growth in limited resources has been an object of interest since Monod's
work on growth of bacterial cultures over 60 years ago [69]. Monod adapted a
simple concept, correlating the consumption rate of an essential nutrient with the






where s denotes the current substrate concentration, ks is a constant assigned
to the substrate concentration where the rate of growth is halved and µ0 is the
maximum rate occurring in saturating substrate (s >> ks).
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3.1.1 The Gompertz model
Underlying bacterial growth rate, the direct monitoring of the population of
bacteria permits the experimental measurement of bacterial growth. The OD
of a liquid culture is a widely used metric for accomplishing this. The resulting
time-series of measurements provide the ability to directly model the growth rate
and assign values to it as a function of time. It has been made evident that most
bacteria growing in a liquid of a predened volume comprising of the appropriate
nutrients, follow a sigmoidal trend, indicating that the Monod's law takes eect.
There are several approaches to the modelling and tting of growth curves. A
summary of these can be found in [70]. The mostly utilized model for bacterial
growth is the Gompertz model:
G(t) = K · exp[−exp[µ · e
K
(λ− t) + 1]] (3.2)
The parameters (K, µ, λ) correspond to the maximum growth (K, which is
also denoted as the carrying capacity of the medium), the growth rate during
the exponential phase (µ) and the lag time (λ). These parameters describe
the three stages observed during the bacterial growth. Other simpler models,
such as the logistic function (2 parameters), fail to capture some of the essential
aspects of growth such as the lag time, whilst other more complex, such as the
Richards or Stannard models (4 parameters) do not contribute signicantly in
the accuracy of model tting, while still remaining rigid to divergent behaviours
during growth. This is the reason why one of two methods presented in this
chapter utilizes the Gompertz model. The process of tting of a time-series of
OD measurements to the Gompertz model yields an G(t) as a function of time
where the parameters (K, µ, λ) have been assigned specic values. The tting is
based on the minimization of the mean root squared error, and is performed from
a multi-parametric constrained minimization algorithm provided in MATLABTM .
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The resulting growth functionG(t) can be dierentiated to yield the rate of growth
as a function of time. The derivative is:
dG(t)
dt
= µ · exp[−exp[µ · e
K
(λ− t) + 1] + µ · e
K
(λ− t) + 2] (3.3)
An important aspect of bacterial growth routinely mentioned in relevant research
is the exponential phase of growth, dened as the window of growth where the
bacteria are dividing rapidly in an exponential manner. While it is widely
accepted that the exponential phase involves an interval centred around the
maximum growth, choices for the limits of this interval vary. The algorithmic
approach utilized in the tool presented here, uses as starting value for the
exponential phase the end of the lag phase (t = λ), and as the ending value







3.1.2 Gaussian Process regression for OD
The multi-parametric models utilized for tting bacterial growth curves men-
tioned above such as the simple logistic function or the more complicated Richards
model correctly take into account the underlying biological processes governing
bacterial growth in a limiting nutrient environment; however, due to their rigid-
ity they fail to capture special cases, where particular events during growth alter
proliferation rate. Moreover, when noisy data are produced during OD measure-
ments, the above process of tting, based on the root mean squared error are
unable to take it into account, and therefore, produce erroneous growth curves.
Both of the above occurrences are commonplace in experimental data involving
biology.
Recently, it has been shown that a non-parametric GP -based method can be
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eectively utilised for tting bacterial growth curves and other biologically
relevant time-series data. Swain et al. [71] showed that GPs perform naturally
better when dealing with noisy experimental data, especially in the calculation
of the rst and second time derivatives. In this section, the approach of tting
based on GPs will be described, namely GP regression. Essentially, a GP is
a distribution of functions rather than a strictly dened function. A GP is
characterised by a mean function and a covariance function in an analogous
manner that a (multivariate) Gaussian distribution is fully dened by a mean
vector and a covariance matrix. The main idea behind GP regression is that a
`prior' GP is imposed, which is characterized by a mean m(t) and covariance
k(t, t′), then a regression process is utilized to compute a 'posterior' GP . A
covariance function k(t, t′) gives the prior covariance value between two time
points t and t′. Given some normality assumptions (Gaussian likelihood and
Gaussian noise) the posterior is also a GP , whose mean and covariance can be
calculated analytically. The posterior mean and covariance functions are given in
3.4 and 3.5 correspondingly.
E[f ∗] = K(T ∗, T )[K(T, T ) + σ2I]−1y (3.4)
C [f ∗] = K∗ −K(T ∗, T )[K + σ2I]−1K(T ∗, T )T (3.5)
Let ti be the ith time point of the experimental data and yi be the value of the
OD or uorescence measurement at that time point. Let T = [t1, ..., tN ] be the
training data time points and T ∗ the test data time points. A common choice for
covariance function is the radial basis function dened as:
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Then, the covariance matrix K(A,B), where A and B are vectors of dimensions
N and M respectively, is dened as:
A =





k(aN , b1) . . . k(aN , bM)
 (3.7)
The quantities α and l in the denition of the covariance function in 3.6 are
termed amplitude and length respectively and along with the noise term σ, they
represent the hyperparameters of the covariance function. Their denition can be
performed based either on specic knowledge on the dataset or by performing an
optimization step before the regression which only takes into account the noise
term σ.
A key characteristic of the GP implementation is the ability to include two more
types of information present in experimental data. First of all, any ab initio
knowledge of the behaviour of the data can be included in the prior mean function,
and hence calculation of the predicted mean function. Given a covariance function
k(t, t∗), a GP can be described as:
f(t) = GP (m(t), k(t, t∗)) (3.8)
It is a common practise to consider m(t) = 0 as the prior mean function, in which
case the posterior mean is given by 3.4. This does not impose any limitations
to the nal predictive mean function, but equally does not contain any ab initio
knowledge for inclusion in the model. In the case where there is specic prior
knowledge, it is intuitive to include this within the prior mean function of the
GP . This prior knowledge optimises the GP regression process which is now
being applied to the residuals of the experimental data subtracted from the prior
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curve. In the case of bacterial growth curves, the prior mean can be represented
by the best t of the Gompertz model 3.2 or any other specic model used to
regress OD experimental data. Equation 3.4 is then modied, nally yielding the
following:
E[f ∗] = m(T ∗) +K(T ∗, T )[K(T, T ) + σ2I]−1(y −m(T )) (3.9)
The covariance matrix remains unchanged with the use of the prior mean.
However, the use of a prior mean can introduce a strong bias towards the
predictive mean and should be used with care. The second piece of information
that can be utilised in GP regression is the noise of the data. Typically, the
measurement noise is dened to be invariant for each time point, as a Gaussian
distribution with a standard deviation σ. This assumption generates the noise
term σ2I present in the above equations. The established methodology for
designing experiments of OD and uorescence measurements dictates that both
technical and biological replications of each dierent strain/condition must be
generated. The technical replicates are present in the same plate in dierent wells
with exact same conditions and inoculated from the same liquid culture, while the
biological replicates are run on dierent occasions, starting from separate liquid
cultures again in the same conditions. In this case, the noise term diers for
each time point and may be calculated from the variance between the technical
replicates. The only change to the calculations involving equations 3.4, 3.5 and
3.8 is that a diagonal matrix Σ populated by the variances of the dierent time
points, replaces the term σ2I.
Figure 3.1 shows the resulting models of the tting process using simple Gompertz
tting (3.1a), zero-mean GP tting (3.1b) and Gompertz mean GP tting (3.1c).
In this instance, the GP with a Gompertz prior mean function outperforms
the other models. The experimental data points are drawn from an instance
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Figure 3.1: Fitted experimental data for OD with Gompertz model (top), GP with
zero mean (middle) and GP with Gompertz prior mean (bottom). The combination
of methods in the last case performs better.
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of E. coli DH10B growth on M9 minimal media, with four technical replicates.
Calculations were made with log-likelihood optimisation of the hyperparameters
in both GP cases (3.1b and 3.1c) in accordance with an unmonitored, automated
high-throughput process.
3.2 Mathematical modelling of promoter activi-
ties
This section will devote to the modelling approach that was adopted for the
calculation of promoter activities per OD unit during the exponential phase
of bacterial growth. The full algorithmic approach for the extraction of the
exponential phase will be presented here and the GP approach will be extended
for the uorescent output as well. A presentation of the tool that was created for
this purpose will follow.
The general purpose behind the study presented in this chapter is the denition
of a new metric for the calculation of the activity of a promoter, mainly during
the exponential phase of bacterial growth but not limited to it. The reason why
most studies involving promoter characterization use only the exponential phase
interval for the relevant measurements, is that it has been shown that during
this phase, bacterial growth is optimum, therefore there are no external signals
or factors limiting protein expression, contrary to the lag and stationary phases.
However, using the same argument, the metric proposed here could be used in
time intervals which include parts of the lag and stationary phases, where the role
of particular regulatory elements tied to genes that are known to take part in the
initiation and termination of the exponential phase, can be unravelled.
Recent research involving bacterial growth monitoring and indirect measurements
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Figure 3.2: The input/output le formats and a general illustration of the tool.
of the activity of a gene, enlists devices known as plate readers. These can be
either utilized independently or as a part of a larger high-throughput automated
platform [72] and they combine a set of measurement types that can be performed
independently or concurrently. The typical output of a plate reader constitutes
a set of time-series replicated measurements of the OD and Fluorescence of
bacterial cultures, growing in a microtiter plate consisting of a number of wells,
corresponding to dierent strains and conditions. The reader output is usually
represented in a data-sheet format as shown in gure 3.2.
Traditionally, the promoter activity for each time point has been expressed as
the uorescence intensity uorescence intensity units (FU), in arbitrary units
(FU) divided by the corresponding OD [73], the absorbance of light of a given
wavelength over a dened optical path (dimensionless). The ratio FU/OD is
a proxy for the amount of protein in mature state per cell. Other works have
adopted a more broadly accurate approach by dening the total promoter activity
as the dierence in uorescence between two distant time points divided by the
integral of the function of growth [74]. However, this approach averages the
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behaviour of the promoter over a substantial time course, rendering it suitable
only for regulatory systems that maintain expression of the reporter gene at a
near constant level (constitutive promoters). The new metric proposed in this
chapter, is proven mathematically from previous models. This metric, while
remaining simple in its form, captures the divergence of intensity values for
two Green Fluorescent Protein (GFP) reporters of dierent stabilities, bound
to the same promoter, providing evidence that it is a more accurate metric for
the quantication of promoter activity.
3.2.1 Fluorescence time-series piecewise-polynomial regres-
sion
The implemented algorithm for the calculation of the promoter activity requires
the denition of limits in the exponential phase which is based on the Gompertz
model tting (see section 3.1.1), the OD output and the FU output corresponding
to the time interval of the exponential phase. The FU output is, like OD, a set of
measurements corresponding to particular time points. These can be illustrated
as scatter plot. The promoter activity as will be made evident below, requires
a continuous function corresponding to growth, namely G(t) which is the result
of one of the tting processes to OD data points, presented in 3.1.1 and 3.1.2,
and a continuous function I(t) corresponding to uorescent output which must
be twice dierentiable as the promoter activity form contains both the rst and
second derivatives of uorescence.
Let In, n = 1, ..., N denote the N measurements of the uorescence output of the
liquid culture, corresponding to tn, n = 1, ..., N times as obtained from the plate
reader. Two methods for the computation of I(t) are implemented in this study.
The rst approach relies on the consideration of cubic polynomial functions as
the basis for tting the time-series (In, tn). The best t for uorescence data is
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calculated using a constrained free-knot polynomial approximation with a knot
removal method illustrated in [75], [76]. The choice of cubic polynomials is argued
on the fact that the resulting curve should be at least twice dierentiable and the
second derivative must contain information regarding the maturation process, as
will be evident from the promoter activity formula (see equation 3.22). In eect,
given the uorescence data points, the algorithm's output for I(t) is a piecewise
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3 + bM t
2 + cM t+ dM eM−1 < t ≤ eM
(3.10)
The values of all the polynomial coecients (a1, b1, c1, d1), . . . , (aM , bM , cM , dM),
as well as the time intervals 0, e1, e2, . . . , eM and the number of polynomials M,
are all determined by the algorithm.
3.2.2 Analytical formula for promoter activity
For the calculation of promoter activities, the computational tool presented in
this work is based on previously described deterministic dierential equations [77],
but also taking into account the number of bacteria inside a liquid culture which
changes as a function of time according to G(t). Specically, the model consists
of a system of two rst-order dierential equations that describe the production
of FP of the whole population of cells. The equations used contain the following
elements: P (t) represents the current `non-mature' protein quantity per OD unit
and G(t) is the progression of bacterial growth with respect to time, measured
in OD units. Therefore, P (t)G(t) is the total non-mature protein contained in
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the culture. Similarly, Pm(t) denotes the `mature' protein quantity per OD and




[P (t)G(t)] = A(t)− km[P (t)G(t)]− kd[P (t)G(t)] (3.11)
d
dt
[Pm(t)G(t)] = km[P (t)G(t)]− kd[Pm(t)G(t)] (3.12)
The values of km and kd correspond to maturation and degradation rates,
respectively. Both mature and non-mature versions of the FP are assumed to
be susceptible to degradation. Both parameters (km and kd) are obtainable from







. The degradation time can be thought as the
half-life of the protein and is assumed to be the same in both mature and non-
mature states. The maturation time can be thought as a "sort of half-life" but
with respect to the conversion of the protein from the non-mature to mature
state. These values are characteristic to each dierent FP and must be either
determined experimentally or obtained from literature.
The term A(t) present in 3.11 signies the current FP production rate performed
by the entire bacterial population with respect to time. The promoter activity
per OD then is dened as: Ap(t) = A(t)/G(t). Equations 3.11 and 3.12 are then

















The middle term of the RHS in 3.14 present in 3.13 as well, is also known as
the `dilution term' because it signies the dilution of FP per cell, during cell
growth. For a more intuitive comprehension of the latter, one can imagine a halt
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of the FP production, while the population of the bacteria continues to increase.
That would result in the dilution of already existing protein between the dividing
cells. As mentioned previously, by using a plate reader it is possible to obtain OD
and uorescence values at dened time points, simultaneously. The continuous
function tted upon the time-series measurements of OD, denoted as G(t), and the
continuous function corresponding to the tting of the uorescence measurements,
dened as I(t), are both usually measured in arbitrary (dimensionless) units.
Assuming that the measured uorescent signal is proportional to the current
mature protein quantity in the culture, the equation that describes the relation
of the uorescent signal with the mature protein per OD unit is:
I(t) = G(t)Pm(t) (3.15)






























The dilution term is simplied from the LHS and the RHS of the equation and
Pm(t) is substituted based on equation 3.15 :









The above equation when solved with respect to P (t) yields expression which









For simplicity of the following calculations, let P (t) = Q(t)/G(t), with Q(t) being
the second term of the above product. Substituting P (t) in (3.14) and expanding

























The derivative of P (t) is rearranged in such away so that it is evident that the












Then solving with respect to Ap(t) and substituting Q(t) nally yields:
Ap(t) =




Equation 3.22 constitutes a general expression for the promoter activity as a
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function of time which is based only on the functions G(t) and I(t) obtained by
tting the time-series data for OD and uorescence, along with the degradation
and maturation times. The tool uses the above formula to calculate the promoter
activity at each time point based on user-dened values for the degradation and
maturation times td and tm. Using the same approach, simpler expressions can
be obtained for the promoter activity for the cases, where one of maturation and
degradation rates is omitted or both. When the maturation time of the FP is
extremely rapid (tm < 10min), which is usually the case, the maturation process
is omitted and Pm(t) is equal to P (t). Therefore, 3.14 is not taken into account
and the maturation term kmP (t), is omitted from 3.13. Solving 3.13 with respect





When degradation is negligible, both 3.13 and 3.14 are used, but with the last
terms corresponding to the degradation process omitted, pertaining to the case
when extremely stable FPs are used (td > 24h). Using a similar numerical






Finally, the simplest case corresponds to when both maturation and degradation





The last and simplest case has been used in several studies, either as it is [78],
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[79] or as an integrating function from which total promoter activity between two
time points can be calculated [80].
The functionality of the tool is briey shown in gure 3.2. The input is accepted
in a comma-separated values (CSV) format as indicated, where the biological
replicates are placed one below the other. The tool recognises dierent biological
replicates for one single strain/condition and it dynamically creates separate
tabs that show growth, uorescence and promoter activity corresponding to the
exponential phase. The `update' button starts the procedure, calculating the
promoter activity and FU/OD for the selected strain and plotting the graphs for
each biological replicate and for the average of all the replicates. The promoter
activity calculations are based, as mentioned before, on the values for maturation
and degradation time provided in the user interface. There is also an `export'
functionality present in the tool, which outputs growth, uorescence divided by
OD and promoter activity data points for the selected strain.
3.2.3 Gaussian process regression of uorescence
As illustrated before, the latest method which has been proven in [71] to be
more accurate in the regression of biological relative data is GP regression. In
particular, it has been shown, using synthetic data, that GPs with a radial basis
(eq. 3.6) or a neural network covariance function outperform other regression
methods such as local polynomial regression or smoothing spline. In the case of
the second time-derivative of the underlying latent function which is estimated
by the regression method, the GP based regression with a radial basis covariance
function exhibits the higher accuracy. The latter observation constitutes the
critical reason for our choice of this particular combination (GP with radial basis
covariance function) for implementation in the tool, as the general promoter
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activity formula (eq. 3.22) contains both rst and second time derivatives of
the function.
It has been shown in [81] that the derivatives of GPs are GPs themselves. Starting
with a covariance function as described in equation 3.6, the rst and second time













k(ti, tj) = −∂1k(ti, tj) (3.27)







∂22k(ti, tj) = ∂
2
1k(ti, tj) (3.29)
The predictive mean rst and second derivative functions are therefore:
E[(f ′)∗] = ∂1K(T
∗, T )[K(T, T ) + σ2I]−1y (3.30)
E[(f ′′)∗] = ∂21K(T
∗, T )[K(T, T ) + σ2I]−1y (3.31)
It is evident that the derivatives only exhibits a single dierence with respect to
the mean predictive function 3.4, in eect the rst factor of the RHS. Likewise,
the covariance matrices for the rst and second derivative functions are:
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C [(f ′)∗] = ∂1∂2K
∗ − ∂1K(T ∗, T )[K + σ2I]−1[∂1K(T ∗, T )]T (3.32)
C [(f ′′)∗] = ∂21∂
2
2K
∗ − ∂21K(T ∗, T )[K + σ2I]−1[∂21K(T ∗, T )]T (3.33)
where K∗ = K(T ∗, T ∗) and K = K(T, T ). The diagonals of the covariance
matrices for the predictive mean, the rst and the second derivatives (equations
3.5, 3.32, 3.33) indicate the variances in each time point for the predictions. The
upper and lower bounds (UB and LB, respectively) of the 95% condence interval
can then be calculated as:
UB = E[f ∗] + 2
√
V (f ∗) (3.34)
LB = E[f ∗]− 2
√
V (f ∗) (3.35)
The vector V (f ∗) corresponds to the appropriate covariance matrix.
3.3 Molecular biology methods
This section deals with the molecular biology procedures that were used in the
creation of the validation system for the modelling of growth curves and promoter
activities. Plasmid creation methods, bacterial strains used, media, measurement
equipment, FPs etc., are described here. Most of the work that is reported in this
section was performed by Aitor de Las Heras.
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3.3.1 Strains and growth conditions
The E. coli strains used for the experiments presented in this work are the DH10B
strains carrying dierent promoter/reporter fusions. E. coli strains were grown
in Lysogeny Broth (LB) base media or M9 minimal media supplemented with
the antibiotic kanamycin at a concentration of 50 μg/ml, ampicillin at 50 μg/ml
or chloramphenicol at 30 μg/ml to ensure plasmid maintenance. Strains were
grown in 200 μl of medium at a temperature of 37oC which has been proven to
be optimal for the growth of E. coli and 700 rpm of rotary shaking was used.
Standard molecular biology procedures were carried out according to Sambrook
et al. [82].
Bacterial growth was estimated by measuring the OD of the cultures at a
wavelength of 600 nm (OD600). OD600 and uorescence values were measured
a microplate reader FLUOstar Omega (BMG LabtechTM). Bacterial cultures
were propagated using 200 μl of LB/well. Measurements of uorescence (lex
485 nm, lem 520 nm, gain 1300) and OD600 were obtained using black, 96-well
microplates with at, clear well-bottoms (Greiner). The strains containing the
promoters pPtrc and pPm were induced with IPTG (SIGMA) or m-toluic acid
(SIGMA) respectively, to a nal concentration of 1 mM when they reached the
mid-exponential phase (OD = 0.6).
3.3.2 Construction of plasmids
Plasmids carrying yfp gene controlled by dierent promoters were constructed
as follows: a 749 bp fragment carrying the promoterless Yellow Fluorescent
Protein (YFP) (venus) coding region was amplied by polymerase chain reaction
(PCR) using as a template the pYZ2-123 [83] and primers AM3F/AM4R.
The PCR product carrying the promoterless yfp coding gene downstream of









Table 3.1: Primers for the construction of the uorescent protein expression plasmids
with backbone pRAMv2.
two BsaI sites and anked by PstI/HindIII restriction sites was cloned into
pSEVA331 [84] generating pRAMv2. Two 92 bp fragments containing a strong
(pJ23100) and a weak (pJ23114) constitutive promoter [85] were amplied using
the primers J23Fw/J23Rv and as templates the BiobrickTMparts BBa_J23100
and BBa_J23114, respectively. Another 1589 bp fragment carrying the lacIq
coding gene and Ptrc promoter was amplied using LacIq1Fw/LacIq2Rv primers
and pSEVA434 [84] as a template. Finally, a 1363 bp fragment containing XylS
transcriptional factor coding gene and its cognate promoter Pm was amplied
using the Ara1Fw/XylS5R primers and pSEVA328 as a template [84]. All primers
are shown in table 3.1. These four fragments, which contained pJ23100 and
pJ23114 constitutive promoters and LacIq/Ptrc and XylS/Pm inducible systems
upstream of a strong Ribosome Binding Site (RBS) (BioBrick Part: BBa_B0034),
were then cloned upstream of the yfp gene of pRAMv2 after being digested with
BsaI generating pRAM-J23100, pRAM-J23114, pPtrc and pPm, respectively. All
these plasmids also contain the T0 rho-independent transcriptional terminator of
phage lambda (BioBrick Part: BBa_K864600) downstream of the yfp gene and
were introduced in E. coli DH10B by chemical transformation [82].
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To validate the ability of the model to accurately compute promoter activities
using data obtained with FPs exhibiting dierent degradation rates, E. coli
DH10B was transformed to include two additional plasmids: pJ23100-GFPm3
[72] and pJ23100-GFPlva [86] which carried the constitutive PJ23100 promoter
upstream of the GFPm3 and GFPlva coding genes. Both plasmids carried a strong
RBS (BioBrick Part: BBa_B0034) between the PJ23100 constitutive promoter
(BiobrickTM part BBa_J23100) and the GFP coding genes. The structure of
these plasmids is described in 3.6.
3.4 Experimental validation
This section is devoted in the presentation and discussion of the analysis of the
experimental data that were obtained from the combined OD-uorescence time-
series experiments run on E. coli strains carrying plasmids with dierent kinds
of promoters in combination with dierent fusions of FPs. The data that were
obtained from the full experimental procedure described above, are presented here
in the following gures. The new metric for the promoter activity is compared
with the old and the advantages are highlighted.
3.4.1 Constitutive promoter activity
The promoter activity and FU/OD of two synthetic constitutive promoters was
calculated. One strong (pJ23100) and one weak (pJ23114) [85]. For that purpose,
E. coli strains carrying pRAM-J23100 and pRAM-J23114 were grown on LB and
a combination of OD600/uorescence was recorded every 10 min for 18 hours,
yielding a time-series for OD and uorescence. The resulting time-series data of
three biological replicates were processed with an implementation of the method
of the new metric in MATLABTM. Figure 3.3 - left shows FU/OD, while the
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Figure 3.3: Constitutive promoter output analysis in terms of FU/OD (Left) and
promoter activity (Right) displayed during the exponential phase of E. coli strains
pJ23100 and pJ23114 growing in LB.
promoter activity as computed from the new formula is shown in 3.3 - right.
Both graphs correspond to the exponential phase of growth which is extracted
separately for each biological replicate as described in 3.1.1. The dierences
between promoter activity values of J23114 and J23100 promoters agree with the
relative dierences observed previous works (pJ23114 output has been reported
as 10% of the pJ23100) [85], [87]. Moreover, the new metric outputs a function of
time which describes the promoter activity perturbations during bacterial growth,
rather than a single number that characterizes the overall strength. While the tool
has been conceived to analyse the promoter activity during the exponential phase
of bacterial growth, this approach can be used to identify changes in the activity of
constitutive promoters at the end of exponential phase due to physiological control
elements such as the replacement of the RNA polymerase subunits [88], [89] and
the onset of other biologically important processes tied to the beginning or the end
of the exponential phase. Comparing and contrasting the gures corresponding to
the constitutive promoters, it is evident that the promoter activity in both cases
starts with a relatively high value and steadily drops in an asymptotic manner to
a lower value, following a trend that resembles damped oscillations.
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3.4.2 Inducible promoter activity
Alternative methods for the characterization of the response of promoters have
been reported [74], however, they reect the behaviour of the promoters in a
wide window of time and as such are suitable only for constitutive promoters,
or for experiments that assume a constant activity during a particular time
interval (e.g the activity of an inducible promoter after induction). In the
case of inducible promoters or regulatory systems that exhibit a more complex
translational activity, methods which do not capture the variation over time are
not suitable for their characterisation. The ability of the new metric to illustrate
the promoter activity over time, capturing the variations in a time-series presents
a more suitable method capable of describing the behaviour of such complex
elements.
For purposes of validation of the metric in this context, two dierent inducible
regulatory systems were tested, namely LacIq/Ptrc [90] and XylS/Pm [91]. E.
coli strains carrying pPtrc and pPm were grown in LB medium and OD600
and uorescence measurements were taken every 10 min. Once they reached
mid-exponential phase of growth, inducers (1 mM IPTG or m-toluic acid) were
added to the medium. The results as shown in 3.4 correspond to the average
of three biological replicates. The uorescence and OD data of each replicate
were processed using the implementation of the presented method with MATLAB
for the calculatation of the FU/OD ratio (3.4  left) and promoter activity as
per equation 3.22 (3.4  right). Both graphs correspond to the exponential
phase of both strains, as extracted by the tool. The results indicated that the
LacIq/Ptrc IPTG induction is stronger than the one mediated by m-toluic acid on
XylS/Pm system. Additionally, FU/OD (Fig. 4  left) data showed an increase
of uorescence on induction in both systems as a result of the accumulation of
stable YFP inside the cells. Promoter activity revealed that both regulatory
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Figure 3.4: Inducible promoter analysis. (Left) FU/OD and (Right) promoter
activities displayed during the exponential phase of E. coli strains bearing fusions
of pPtrc and pPm with YFP, growing in LB. Induction of the system occurs at 50
minutes. The promoter activity metric yields more clearly pronounced and perhaps
biologically relevant dynamics about the promoter.
nodes reached a plateau, which is in agreement with the known behaviour of
these regulatory systems [92], [91].
3.4.3 Analysis of promoters using uorescent proteins with
dierent degradation rates
Most of the commonly used uorescence proteins are extremely resistant to
proteolysis [93] with a half-life of 24 h in vivo [94], [95]. This means that they will
persist inside the cell even if their expression is shut down. Variants have been
engineered which have signicantly reduced half-lives [96], [97] with uorescence
shown to more closely follow the prole of mRNA abundance [77]. It follows that
the degradation rates of uorescent reporter proteins used for measuring promoter
activities can have a signicant impact on the nal uorescent output of a liquid
culture. To illustrate this impact, an experiment was designed to include the same
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Figure 3.5: Promoter analysis using two versions of the GFP (left) FU/OD and
(right) promoter activities displayed during the exponential phase of E. coli strains
pJ23100-GFPm3 and pJ23100GFPlva growing in M9. The new metric comes closer
to describing the same activity for the same promoter with dierent FPs.
promoter in the same strains coupled with a stable FP in one instance and an
unstable in another. A way to quantify this impact is embedded in the analytical
method applied for the calculation of promoter activities; the protein degradation
rate is taken into account as shown in equation 3.22. To validate this approach
with reporters of dierent half-lives, two E. coli strains were cultured in minimal
media (M9), carrying the same strong constitutive promoter PJ23100 (BioBrick
part: BBa_J23100 ) followed by a strong RBS (BioBrick Part: BBa_B0034 )
upstream of either a stable GFP (pJ23100-GFPm3) or a short half-life GFP
(pJ23100-GFPlva). The experimental data consist of two biological replicates.
Measurements of OD and uorescence were taken every 10 min for 18 h. Results
of this analysis are shown in 3.5. A comparison is made between the old metric
(3.5  Left) and the metric for promoter activities proposed herein (3.5  Right),
using the same set of data. Regression for the tted curves was performed with
GPs and the results shown correspond to the exponential phase of growth which
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was dened as the interval of four doubling times before and after the maximum
growth. The latter was calculated from the maximum value of the derivative of
the growth curve (d[G(t)]
dt
).
3.5 Interdependence of growth and uorescence
The variation of bacterial growth curves will be explored in this section, the
dierence that it ensues in the nal FP output will be illustrated. A case will be
made again for the changing of metric based on this. This will include detailed
mathematical analysis in MatlabTMwith gures.
3.5.1 Exponential phase duration
It has been made evident by now that the bacterial growth follows a sigmoidal
trend in general, which is a macroscopic emergent behaviour in most biological sys-
tem and a characteristic of population dynamics in a nite resources environment
[98]. The Gompertz model is most times sucient for the description of a typical
bacterial growth, and as mentioned earlier, contains 3 parameters that fully dene
the model. However, bacterial growth is a process that can be inuenced by many
contributing factors in various aspects and even in such a simple growth model
such as Gompertz, there are aspects of growth that are inuenced by a combina-
tion of these parameters. One of these aspects worth looking into is the length
of the exponential phase of growth. Assuming a Gompertz model for growth, the
exponential phase duration can be calculated deterministically from the capacity
(K) and the maximum growth rate (µ). According to equation (3.3) and the limits







the length of the exponential phase is dened as Lexponential = tm − λ. Assuming
λ = 0 for simplicity of the calculations:
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Figure 3.6: Schematic representation of the plasmids used in this study. Cloning
strategy to generate pRAM-J23100, pRAM-J23114, pPrtc and pPm: fragments I, II,
III and IV containing the pJ23100, pJ23114, LacIq/Ptrc and XylS/Pm regulatory
elements and RBS (BBa_B0034) were assembled via Golden Gate reaction into
pRAMv2 vector (Top). Schematic representation of the vectors pJ23100-GFPm3
and pJ23100-GFPlva which carry the pJ23100 promoter and the RBS (BBa_B0034)
upstream of a stable (GFPm3) or an unstable GFP (GFPlva) (Bottom).
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µ · exp[−exp[µ · e
K
tm + 1] +
µ · e
K




Solving the above equation will yield a solution for tm which corresponds to the
length of the exponential phase since we assumed that λ = 0. After simplifying
the above with a few calculations:
e−x+1 + x− 3 = 0 (3.37)
The x above is dened as x = µ·e
K
tm. The solution to this equation is given with
the help of the lambert function, where only the real positive solution is considered
as the only one with physical meaning in our case:
x = W (− 1
e2
) + 3 = 2.841 (3.38)
Therefore, substituting x from above:
Lexponential = tm = 2.841 ·
K
µ · e
= 1.045 · K
µ
(3.39)
In essence, from the above calculations it is proven that the length of the
exponential phase is proportional to the medium capacity (K) and inversely
proportional to the maximum growth rate with a multiplying factor which is
almost equal to one. This result is expected as the maximum growth rate
determines the average growth rate during the exponential phase, which in turn
inuences the time needed for bacteria to reach their maximum density. On the
other hand, the medium capacity corresponds to the maximum density of the
bacteria, therefore a higher value is impacts the time needed to reach that value.
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3.5.2 Fluorescent output during exponential phase and
promoter activity
The above result shows that the exponential phase interval can vary with respect
to the parameters of the model, which themselves are inuenced by many
changing factors during growth, such as temperature, richness in carbon sources,
expression of particular proteins and many other exogenous or endogenous factors.
Considering the ODE model described by equations 3.11 - 3.14 and assuming
that constitutive promoters such as J23100 or J23114, maintain a constant level
of activity during the exponential phase and a switch-like increase of the activity
changing from lag-phase to exponential phase as well as a similarly abrupt
decrease during transition from the exponential phase to the stationary phase,
it will be made evident that the length of the exponential phase plays a pivotal
role in the nal uorescent output. More specically, consider the assumption
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(3.40)
The transition in promoter activities between dierent phases is mediated with a
smooth step function using Hermite polynomials in order for the clade function to
remain dierentiable across all time points. Let a = 75 FU
OD·min as a representative
activity for a strong constitutive promoter which is taken from the average value
from the measurements of the J23100 promoter illustrated in 3.5. For purposes of
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Figure 3.7: Fluorescence output between strains with the same promoter activity
but dierent exponential growth windows. Fluorescence output is signicantly higher
at the end of the exponential phase which may result in misinterpreting the promoter
activity.
simplicity, the maturation and degradation processes of the FPs can be omitted.




Equation 3.41 was obtained from 3.11, 3.15 and the fact that because the
maturation process is omitted, Pm(t) = P (t), therefore, I(t) = P (t)G(t) and
A(t) = Ap(t)G(t).
By integrating equation 3.41 and dividing by OD, the nal normalized uorescent
output as per the old metric is given. As shown in chapter 5, bacterial populations
even from the same species and minor dierences in their genotypes are not
consistent in their nal OD (K) or their max growth rate (µ). Promoter activities
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themselves can of course be inuenced by changes in genotypes but even in the
case that they are not, gure 3.7 shows that the old metric may misinterpret
promoter activities when the maximum growth rates vary. The same is true
for varying nal OD (K) as they both inuence the exponential growth window
length.
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Chapter 4
Strain development for in vivo
uorination and directed evolution
The main purpose of the work described in this chapter is the creation of a
strain which can be utilized as a host for directed evolution experiments of the
uorinase enzyme. Choice of the base host and modications to be implemented
are based on an two - objective goal. One of the objectives is choice/construction
of a suitable host for the genetic selection of high - performing variants of the
uorinase. The second objective is the creation of an in vivo bioreactor for
uorinated products. The host of choice is an E. coli variant, namely BL21(DE3),
which has been extensively utilized for protein overexpression but also for the
creation of novel bioreactors consisting of recombinant protein expression and
other rationally designed alterations of the base host. Modications performed
are:
• The overexpression of a codon-optimized, recombinant version of the highest
performing uorinase enzyme known at the time of implementation.
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• The deletion of a uoride eux pump gene (crcB) which has been shown
to infer resistance to uoride by expelling uoride anions out of the cell.
• The deletion of the PNP gene (deoD), which catalyses the degradation of
adenosine to sugar and phosphate.
• The expression of a SAM transporter in E. coli, a membrane channel
protein which has been shown to actively transport SAM molecules from
the extracellular medium inside the cell.
4.1 Fluorinase expression in E. coli
This section will include the work that has been done, resulting in the overex-
pression of a recombinant codon-optimized uorinase in E. coli BL21(DE3). The
in vivo version of the protein and the creation of the appropriate constructs for
this will be described here as well, including plasmids, primers used, promoters,
strong RBS, terminators etc.
4.1.1 Synthesis of the uorinase gene
The rst step towards expression of the uorinase in E. coli BL21(DE3) is the
synthesis of the uorinase gene corresponding to the highest activity uorinase
as depicted in the study of O'Hagan' s group [53]. The most common approach
for the expression of recombinant proteins in foreign hosts, includes designing
appropriate forward and reverse primers and amplifying the desired gene with
PCR followed by cloning of the gene to an appropriate expression plasmid. Recent
advances in biotechnology however, enable the ordering of DNA sequences in
relatively low prices. The gene synthesis along with the recipient plasmid were
ordered from the GeneArtTM service oered from Thermo Fisher Scientic. This
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service allows for the ordering of synthesized genes accommodated in commercial
constructs (plasmids) that include several features for optimized overexpression
and convenient purication of recombinant proteins. The plasmid chosen for the
accommodation of the uorinase gene (A1) is pET151/D-TOPO R©. This is a
low-copy expression plasmid, with a pBR322 origin of replication controlled by a
ROP protein, and is maintained in the strain by ampicillin resistance selection.
When growing the strains in the antibiotic ampicillin, the presence of the plasmid
inside the strain is ensured. This particular plasmid contains the IPTG - inducible
T7 promoter followed by the lac operator, upstream of the synthesized gene. This
fusion is functional only in E. coli strains containing the T7 RNA polymerase
which is naturally present in T7 bacteriophage and binds selectively on the T7
promoter to initiate transcription. The T7 promoter' s inducible nature along
with its high activity, illustrated in the previous chapter, justies its choice for
overexpression - and optionally, subsequent purication - experiments. The lac
operator is bound by a lac repressor to prevent basal expression in the uninduced
state. The lac repressor, which is expressed constitutively from the plasmid, is
silencing the expression of the uorinase by binding both to the T7-lac promoter
upstream of the uorinase gene, preventing the T7 polymerase from attaching
to the T7 promoter, and by binding to the lacUV5 promoter upstream of the
T7 polymerase gene in the BL21(DE3) chromosome, preventing the expression
of T7 polymerase altogether. However, a minute amount of basal expression still
escapes repression as shown in 3.4. The uorinase gene was synthesized with a
codon-optimization strategy specic for E. coli. This is an established method
for alleviating the bottleneck in expression rate of recombinant proteins, as the
original sequence commonly contains codons that have dierent availabilities in
the native host, which is the case for the uorinase as well, whose native host is
Streptomyces sp. MA37.
The synthesized gene is fused upstream with a 6xhistidine tag, which enables the
optional purication of the protein by binding of the polyhistidine to nickel beads.
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Figure 4.1: Plasmid pET151/D-TOPO including the codon optimized histidine-
tagged A1 gene (Left). Plasmid pET151(-) created with the excision of the A1
gene by restriction from XbaI, serving as negative control (Right). Validation PCR
showing the expected sizes (Middle).
A V5 epitope site follows, which can be used for recognition of the protein by
the anti-V5 antibodies for western blot analysis. Finally, directly downstream of
6xHis and V5, a TEV recognition site resides for the removal of the 6xHis and the
V5 epitope, by TEV protease treatment, a necessary step in order to obtain the
original protein in puried form. Usually, the gene is placed between two dierent
restriction sites as a result of the cloning process, in this case an XbaI and a SacI
site. A custom change was also included, specically the addition of another XbaI
site directly downstream of the sequence which was used to facilitate the one-step
creation of the negative control plasmid. The nal construct is illustrated in gure
4.1.
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4.1.2 Cloning and transformation of strains
The plasmid pET151/D-TOPO accomodating the uorinase as described above
(hereafter referred as pA1-his), was received in a glycerol stock tube containing
the wild-type E. coli K12 with the plasmid. A sterile loop was used to top-
o a small quantity and restrict the bacteria in an LB-agar plate with added
ampicillin up to a nal concentration of 50 μg/ml. The plate was left in 37 oC
overnight and the next day single colonies where picked and transferred to falcon
tubes containing 10ml of LB with ampicillin as previously, and again left to grow
at 37 oC overnight. The liquid culture was subsequently centrifuged in 6000 g
and the pellets were used for plasmid extraction, as described in section 2.5.3
in order to obtain the pA1-his plasmid. The plasmid was then subjected to a
restriction reaction with the enzyme XbaI. The reaction was left to incubate at
room temperature for 1 hour and then it was loaded for gel electrophoresis. The
uncut plasmid was also loaded as a control and the results are shown in gure
4.2. The bands that appear in the lane where the restriction reaction was loaded
are in agreement with the sizes that are expected after the restriction, with the
high molecular weight corresponding to the cut pET151/D-TOPO construct.
The next step was the creation of a negative control plasmid, in eect, the
same backbone but with the uorinase gene removed. To that end, the higher
molecular weight band was cut from the gel with a scalpel, and then puried.
The resulting pure DNA corresponded to a linearised plasmid restricted with
XbaI and as a result, had compatible XbaI sticky ends. The latter enabled
creation of the negative control plasmid with a ligation reaction along with an
appropriate buer and the puried cut plasmid at 5 μg/ml. The reaction was
left to incubate in room temperature for 2 hours, resulting in the connection
of the XbaI sticky ends to produce circular DNA. This one-step creation of the
negative control was made possible by including an additional XbaI site at the end
of the synthesized uorinase gene. A chemical transformation process was then
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Figure 4.2: The pET151/D-TOPO with the histidine tagged A1 gene as extracted
from the strain E. coli K12 and the respective restriction with XbaI. The bands
appearing in the restriction correspond to the expected sizes.
performed, using E. coli DH10B chemical competent cells. The transformation
plates containing LB-agar with 50 μg/ml of ampicillin were left in 37 oC overnight
and the next day, single colonies were picked for colony PCR. The negative control
genotype was validated by using previously designed primers pet151VAL_FW
and pet151VAL_RV (see table 4.1), upstream and downstream of the gene as
shown in gure 4.2. The high molecular weight band (lane 1) corresponds to
the original plasmid and the low weight band (lane 2) to the negative control,
as expected for the amplied DNA lengths of the plasmid with and without the
uorinase gene.
Following the creation of the negative control (hereafter pET151(-)), the trans-
formation of E. coli BL21(DE3) with both plasmids was performed. The same
chemical transformation protocol as above was used and colonies from the result-
ing agar plates were tested with PCR to conrm the successful uptake of both
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Figure 4.3: SDS page gel electrophoresis of the E. coli BL21(DE3) pilot expression
of the uorinase gene under the control of a lacl inducible promoter. Each band
corresponds to samples obtained every one hour and is paired with the negative control
plasmid pET151(-) grown in the same conditions. Optimal expression occurs 5 hours
after induction (t5).
pA1-his and pET151(-) plasmids as before with the expected amplied product
weights.
4.1.3 Validation of uorinase expression
As described in 2.1.1 E. coli BL21(DE3) is the host of choice for recombinant
protein expression due to modications that enable overexpression of proteins by
the inducible high-strength T7 promoter. Both strains that were created from
the above transformation were cultured in the same conditions as follows:
Single colonies of BL21(DE3) with pA1-his and pET151(-) were put separately
in two liquid LB tubes supplemented with ampicillin and left to grow overnight
in 37 oC with 170 RPM shaking to saturation. The next day, two 250 ml asks


















Table 4.1: Primers for the construction and validation of the uorinase expression
plasmids with backbones pET151/D-TOPO and pJ61002. The red colour signies
restriction sites, the blue colour corresponds to sequences inside pJ61002. The brown
colour shows sequences that are part of the codon optimized A1 gene and otherwise
are the pET151/D-TOPO backbone residing sequences.
containing 50 ml of LB and ampicillin were inoculated with 500 μl (1:100) from
the previous cultures and left to grow in 37 oC with 170 RPM shaking until OD
reached a value of 0.7 - 0.8 (approximately 2 hours), which corresponds to the mid-
exponential phase of growth. At that point, IPTG was added (in both cultures)
to a nal concentration of 0.5 mM to induce protein expression. The cultures
were left to grow up to 6 more hours. Every 1 hour the OD of both cultures













Table 4.2: E. coli BL21(DE3) with pA1-his and pET151(-). The OD values
obtained were used for subsequent dilution of the samples to an OD of 1. The
interesting eect of 30% higher growth of the strain expressing the uorinase is also
observed.
was measured (table 4.2) and an additional sample was taken from each culture,
centrifuged in 20,000g for 30 seconds and the pellet was stored in -20 oC for future
validation of uorinase expression. Based on the OD values appropriate aliquots
were taken and diluted with LB up to 500μl and a nal OD of 1 to ensure equal
culture density. The pellets gathered from the above procedure were analysed
with SDS-page gel electrophoresis as follows:
Pellets were resuspended in 80 μl of 1xSDS-page sample buer, put in a ther-
moblock at 100 oC in order to boil for 5 minutes and subsequently left to equili-
brate in room temperature. For each of the time points 10 μl of both samples were
loaded in a hand-crafted SDS-page gel. The gel was left to run for 1 hour and
then subjected to Coomassie blue straining. More specically, it was submerged
to the stain and left to incubate for 1 hour to ensure sucient staining. The
resulting bands are shown in gure 4.3.
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Figure 4.4: Three plasmids facilitating the in vivo version of the uorinase gene:
pJ61002-J23100-A1 (left), pJ61002-J23114-A1 (middle), pA1 (right).
Gel lanes correspond to 6 time points and the samples with pA1-his plasmid are
placed side by side with the pET151(-) negative control. The band of interest
appears in 34 KDa with a clear dierence in intensity in the pA1-his plasmid
compared to the negative control, with the exception of lane 1, probably due
to sample cross-contamination. Therefore, the expression of the enzyme was
validated and the time point showing the highest expression is 5 hours after
induction. This is considered the pilot experiment for expression, which not only
conrms the expression of the recombinant protein but also pinpoints the optimal
duration for purication or for initiating the in vivo reaction.
4.1.4 Alternative strains for uorinase expression
As mentioned above, the synthesized gene was fused upstream with a polyhistidine
tag, a V5 epitope and a TEV recognition site. It has been shown that in certain
occasions enzymic activity is hindered when a polyhistidine tag is present in the
amino acid chain, as reported in [99].
Therefore, to avert the possibility of impairment in the function of the uorinase,
it was deemed necessary to create complementary constructs of the uorinase
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Figure 4.5: Left: Puried restriction of plasmid backbones pJ61002 bearing J23100
and J23114. Puried and restricted PCR amplication of the A1 gene without his-tag
and the B0015 terminator with compatible cohesive ends. Right: Conrmatory gels
of the constructed pJ61002-J23100-A1 and pJ61002-J23114-A1 with appropriate
restriction reactions.
gene without these fusions (in vivo version). To that end, three more plasmids
have been created as shown in gure 4.4. In two of the plasmids, the pJ61002
backbone has been used to accomodate the in vivo version of the uorinase.).
One plasmid harbours a strong constitutive promoter (J23100) and the other
accommodates a weak constitutive promoter (J23114). These plasmids were
initially accommodating the MCherry Red Fluorescent Protein (RFP) protein
used to quantify the promoter activities (see chapter 3). Both versions feature
a strong RBS site and a B0015 strong terminator downstream. The lack
of an appropriate restriction site between the terminator site and MCherry
required an alteration in the strategy for the creation of the in vivo uorinase
constructs. Two sets of primers have been designed, namely FLA1_C_VV_FW,
FLA1_C_VV_RV, B0015_TER_FW and B0015_TER_RV (table 4.1) and
the corresponding products have been amplied with PCR using pA1-his
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and pJ61002 as templates. The rst product (rst two primers) is the in
vivo uorinase fused with SpeI and BamHI restriction sites and the second is
the BamHI-PstI fused B0015 terminator. Following purication of the PCR
products, two restriction reactions were set-up with SpeI-BamHI and BamH I-
PstI enzymes respectively in order to create compatible cohesive ends for the
ligation reaction. The two pJ61002 plasmids were also added in two additional
restriction reactions with enzymes SpeI and PstI, in order to cut out the mCherry
gene and the two linearised plasmid products were subsequently separated with
gel electrophoresis. The bands corresponding to the linearised pJ61002-J23100
and pJ61002-J23114 were then excised from the gel and puried. In gure 4.5,
the respective amplied products in an agarose gel after restriction as well as
the restricted pJ61002 plasmids after purication. These 2 restricted linear
DNA parts were combined with the appropriate restricted plasmids in ligation
reactions to yield pJ61002-J23100-A1 and pJ61002-J231114-A1 respectively.
The third in vivo uorinase expression plasmid uses the same pET151/D-TOPO
backbone but without downstream XbaI site and the A1 gene lacking the his-tag
(pA1). All three plasmids accommodating the in vivo A1 where sequenced with
two additional primers (FLA1_INSEQ_FW, FLA1_INSEQ_RV) both residing
inside the A1 sequence. These were also used in validation PCR to ensure the
correct alignment of the gene.
4.2 CrcB channel and uoride availability
This section will describe the CrcB channel and display the reasoning for deletion
of the gene corresponding to the CrcB channel protein. The procedure for deletion
will be presented here in a detailed manner.
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4.2.1 Inhibition mechanisms of uoride
Fluoride has been shown to induce growth inhibition in bacteria, hence the exten-
sive utilization of uoride-based products for tooth care [100]. The mechanisms
of inhibitions have been studied and include acidogenicity and acidurance [101].
Fluoride anions passively enter the bacterial membrane in the form of HF which is
created from the free protons H+ present in a water solution and free uoride an-
ions where it is again dissociated yielding free uoride anions [102]. The presence
of uoride intracellularly within a range of molarities of the order of mM, acts in
certain enzymes that are essential in the metabolism of bacteria and inhibits their
activities. Two of these enzymes are F-ATPase and Enolase. F-ATPase is a mem-
brane protein which directly controls the acidity of the intracellular environment
by pumping out H+ ions as part of the ATP hydrolysis action. Fluoride anions
inhibit the activity while free H+ cations acidify the intracellular envinronment.
Enolase inhibition from uoride is mediated by the formation of an ATP-like
complex from ADP, free uoride anions and divalent metal ions [103]. As a re-
sult, glucose metabolism is downregulated directly by the enolase participation
in the pathway and indirectly because it produces phosphoenolpyruvate (PEP)
which is essential for the PEP-dependent phosphotransferase system (PTS) by
which glucose is uptaken from the environment. Another enzyme with a possible
contribution in uoride sensitivity is the pyruvate kinase, which is placed in the
glucolytic pathway immediately after enolase, again directly inuencing glucose
metabolism.
4.2.2 Fluoride resistance in bacteria and eukaryotes
Because of the general nature of inhibition mechanisms of uoride, it's toxicity is
evident across all types of organisms. However, the fact that a range of organisms
are naturally tolerant to high concentrations of uoride, has driven research
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eorts towards the identication of uoride toxicity mitigation mechanisms that
those organisms facilitate. Until recently, little was known about the putative
mechanisms of actions or the genes associated with high uoride concentration
tolerance. Three recent studies revealed a wide variety of proteins that play
a key role in dealing with a high uoride concentration challenge in bacterial
or eukaryotic hosts [104], [9], [105]. The identication of these proteins was
made possible by studying uoride specic riboswitches and identifying the genes
whose expression they were controlling. Although they are distant in terms of
phylogeny, the proteins that are produced in response to uoride bear functional
resemblance to CLCs (chloride channels). Protein conserved domain evidence
initially misled to assigning these proteins as anion channels specic to uoride
but in contrast to other CLCs they are F−/H+ antiporters. In essence, these
types of proteins are transmembrane channels that serve as pumps to expel
uoride anions which passively enter the membrane in the form of HF, out of the
intracellular enviromnent. Fluoride antiporters are found in several bacteria [104],
however, E. coli uses an unrelated channel protein termed CrcB to achieve uoride
resistance. Overexpression of the crcB gene augments chromosome condensation,
when expressed along with one or two other genes, leading to increased camphor
resistance which ranges from 10 to 100-fold with respect to levels which are
lethal to organisms under normal growth conditions [106], [107]. That previous
functional focus probably led to the delay in tying this gene to uoride resistance,
which was accomplished only after the discovery of the upstream uoride-specic
riboswitch controlling its expression. The mutant E. coli strain in which the
crcB gene is deleted, exhibits a 200-fold less minimum inhibitory concentration
of uoride than the wild type. The eect of other halides remains unchanged
indicating the very specic nature of this channel to export uoride [9]. The crcB
motif is also encountered in eukaryotic organisms where thousands of homologues
exist [105]. In most occurrences throughout bacterial homologues, CrcB is a small
dual-topology protein of around 100 amino acids comprising four transmembrane
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subunits, and the active channel is formed by a dimer with the two monomers
aligning in opposite orientation through the membrane [108], [109]. On the other
hand, several eukaryotic homologues exhibit a monomeric structure that consists
of two homologous domains probably evolved from a gene fusion event. Later,
it was shown that only one of the two uoride-accepting pores was active in the
monomeric structure indicating an evolved inactive pore in one of the homologous
domains [110].
4.2.3 Intracellular availability of uoride
As mentioned above, the E. coli bacterium in its wild-type contains a FEX
(fluoride export) protein, termed CrcB, which highly increases its viability in
uoride concentrations as high as 200 mM. On the contrary, knockout (KO)s
of crcB in this bacterium exhibit approximately 200-fold more sensitivity in the
uoride anion showing severe inhibition of growth in micromolar concentrations
and complete absence of growth in little more than 1 mM. The uoride exporting
functionality of the protein is indirectly evidenced by the activation of the lacZ
gene placed downstream of the Pseudomonas syringae eriCF uoride riboswitch
[9]. The protein exhibits the same dimeric molecular structure as encountered in
many homologues and is highly ecient in exporting uoride with a k cat of at
least 3x104 s−1 as determined by kinetic studies [111].
The creation of an E. coli host based on the objectives set out in the beginning of
the chapter should follow a very simple rationale: The availability of substrates
in the intracellular medium. With this in mind, studying and the internal mech-
anisms of bacteria that already possess the ability to elaborate uorometabolites
in vivo could provide very useful insight. An initial study with respect to S.
cattleya showed that the uoride uptake - and therefore intracellular availability
- is directly inuencing the in vivo uorometabolite production [8]. The severe
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Figure 4.6: Figure adapted from [8] showing uoride consumption and uo-
rometabolite biosynthesis of S. cattleya incubated in 2 mM uoride.
impediment in growth with little more that 2 mM of potassium uoride (4 days
instead of 2 for full growth) suggests that this bacterium does not include the
same uoride export mechanism that other bacteria do, such as E. coli crcB or
P. syringae eriCF . On the contrary, an interpretation of the kinetics observed in
that same study, suggests that this Gram-positive bacterium is adapting a uo-
ride uptake that is only expressed once the bacterium achieves maximum growth.
This putative uoride uptake system has was also found to be dependent on the
pH of the growth medium. Although the uoride uptake system has also been
assumed after the discovery and characterization of the uorinase enzyme [112],
there is no evidence to date suggesting the existence of a channel or transporter
that mediates uoride uptake.
An alternative interpretation, which is also strengthened by pH dependence, is
that the uoride eux mechanism is simply absent in S. cattleya, hence the severe
inhibition of growth in 2 mM of uoride mentioned in [8]. Fluoride can passively
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Figure 4.7: Figure from [9] showing uoride-dependent activation of the reporter
gene fused with the crcB riboswitch.
enter the membrane in HF form by diusion, a mechanism which is found to
be strongly dependent on pH [113]. The aforementioned study reveals that
the uoride uptake mechanism in uc-absent E. coli bacteria does not involve
a particularly evolved system for uoride inux but rather simply a passive
diusion of HF molecules which are membrane permeable. Moreover, under
lower pH values, the inux and accumulation of uoride intracellularly is higher
leading to a lower value for the ratio of extracellular to intracellular uoride
concentration, which could be misinterpreted as the result of an active uoride
uptake mechanism. The sudden increase in the rate of uoride consumption in S.
cattleya after reaching full growth observed in gure 4.6 could be attributed to
the induction of the pathway leading to uorometabolite synthesis which starts
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consuming the intracellular uoride resulting in an analogous rate of passive
uoride uptake in order to maintain equilibrium.
Combining the above research facts, the deletion of the crcB gene, encoding for
the uoride eux pump was deemed necessary as a natural second step towards
creating an E. coli in vivo uorinating host, since it is logical that if one of
the substrates of the uorinase is being readily exported from the intracellular
environment, the reaction would not be able to start. The high km constant for
uoride which lies in millimolar levels [41], [1], is also a factor which contributes
towards the rationale of this approach, as E. coli cells with a functioning crcB
gene grown in 100 mM of NaF, exhibit activation of a reporter gene bound to a
uoride riboswitch resulting in lower intensity than E. coli cells with a KO crcB
genenotype grown in 1 mM of NaF (gure 4.7).
4.2.4 Creation of the crcB gene KO in BL21(DE3)
In this section, the creation of a crcB KO of BL21(DE3) is described. To the
best of the author's knowledge, this is the rst attempt at KO of crcB for this
genotype and was performed as a continuation step for the strain development
towards in vivo uorination from the uorinase expressing E. coli BL21(DE3)
presented in section 4.1. The method of deletion is described in detail in
section 2.4.1. This particular approach was adopted over others for a variety
of reasons. First of all, it is a scarless method upon completion of the necessary
steps. Once the KO genotype is conrmed no other steps are necessary, while
other more popular methods often leave "scars", for example antibiotic resistance
cassettes. Since most researches will not make the extra eort to remove these
"scars", because it is not necessary for the illustration of a particular result tied
to the respective KO, during distribution of research material there are often
undesired or undocumented scars which hinder the research eorts of the next
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researcher. Another reason for this approach is that it allows for multiple edits
of the chromosome, without the need for removal of left-over markers. Finally,
the utilization of electroporation systems or temperature dependent expression is
optional, steps which are rather sensitive in other methods such as recombineering
[61].
The deletion of crcB follows the protocol rst published by Posfai et.al [114],
which shows the process in E. coli and later adopted for other Gram-negative
bacteria by de Lorenzo group [115]. The rst step towards creation of the knock-
out, is the construction of a particular type of plasmid, which carries homologous
regions of 600-800bp upstream and downstream of the gene to be deleted. In-
between the regions, instead of the full gene, two codons are included, a start
and a stop codon. This is referred to as the deletion genotype and ensures an
in-frame deletion to avoid polar eects. These plasmids should have a particular
characteristic: they must not be able to replicate in the deletion host. Assuming
that the plasmid contains a particular antibiotic resistance cassette, the clones
which survive and grow in this antibiotic are the ones where the homologous
regions have been recognized by the recombination machinery of the host and
have integrated the plasmid in the chromosome. The initial method by Posfai
utilized plasmids than carry either a temperature-sensitive origin of replication
or an R6K replicon. The vector with the temperature sensitive replicon will not
replicate above 37 oC, while the R6K replicon needs the pir gene in order to
replicate. In both cases, plasmids can be maintained in cloning strains either
with growth below 32 oC or in particular strains which carry the pir gene. The
process of plasmid integration is shown in gure 2.10.
The backbone plasmid that was used for the creation of this suicide vector is the
pSEVA612S [116] and was kindly provided by Victor de Lorenzo in a cc118-λpir
strain. The plasmid isolation was challenging because of the nature of this strain
which contains DNAses (see table 4.7). The problems have risen in particular









Table 4.3: Primers for the construction/sequencing of the pSEVA612S-crcB deletion
plasmid and for validation of integration in the BL21(DE3) chromosome. Red colour
signies restriction sites, brown colour corresponds to sequences inside homologous
regions upstream and downstream of crcB. The green colour shows sequences that
are part of genes.
during the initial extraction which ended up either with no visible bands before
or after the restriction step, probably due to DNAse activity. After a lot of
repetitions, the problem was solved by subjecting the eluate from the extraction to
an extra purication process, using a gel/PCR purication kit, which presumably
removed the DNAses.
The plasmid containing the deletion genotype was created as follows:
Four primers were designed. One forward primer starting at the beginning of the
leftmost homologous region including a BamHI restriction site (P1_DCRCB_FW
in 4.3). One reverse primer containing the immediate upstream region of the crcB
gene plus the start codon (GTG) and an 11bp tail which consists of the stop
codon (TAA) and 8bps into the crcB downstream region (P2_DCRCB_RV).
One forward primer with the stop codon plus the immediate region downstream
of crcB, including a tail with the start codon and 8bps into the upstream region of
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Figure 4.8: (a) Amplication of the pSEVA612S with the insert of crcB deletion
locus in lanes 6 and 7. (b) Restriction of the plasmids with BamHI and XbaI show
the expected sizes of the inserts.
crcB (P3_DCRCB_FW). Finally, a reverse primer at the ending of the rightmost
homologous region with an added XbaI restriction site(P4_DCRCB_RV).
Two separate PCR reactions were prepared with pairs of primers in the sequence
described above (P1_DCRCB_FW, P2_DCRCB_RV and P3_DCRCB_FW,
P4_DCRCB_RV), resulting in two amplied fragments of 584 and 730 base
pairs respectively. After purication of these fragments they were added to a new
"fusion" PCR reaction. The dierence in this alteration of the procedure is that
instead of one template, two templates with an overlapping region are added. The
rationale is that during denaturation and re-annealing, the overlapping regions
will anneal and extend to create the complete template, which comprises the
deletion genotype. Primers P1_DCRCB_FW and P4_DCRCB_RV are also
added to the reaction in order to amplify the complete template. The tails
included in the second and third primer were designed in such a way that the
overlapping region consists of 22 bps and exhibits the same Tm as the pair
of primers added. The resulting PCR product with the deletion phenotype
was puried and subjected to a restriction reaction with enzymes XbaI and
BamHI. The pSEVA612S plasmid was also subjected to restriction with the
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same enzymes in a separate reaction. To avoid non-specic digestion of the
fragments, the reactions were left to incubate in room temperature for 2 hours.
After purication of the reaction, the fragments were put together in a ligation
reaction and left to incubate overnight in room temperature. The reaction tube
was then placed in 65 oC to inactivate the ligase and then used for transformation
of competent E. coli cc118-λpir cells. The pSEVA621S is a gentamicin(Gm)
resistant plasmid, therefore trasformed colonies were selected in a Gm plate and
Gm - resistant colonies were picked and subjected to colony PCR with primers
P1_DCRCB_FW and P4_DCRCB_RV. The resulting gel is shown in 4.8a.
Successfully created (and transformed) plasmids correspond to lanes 6 and 7. The
bands appearing in other lanes, apart from lane 4, correspond to amplication of
the chromosomal region which contains the crcB gene, hence appear higher due
to larger size of the amplicon, whilst the lower sizes appearing in lanes 6 and 7
correspond to amplication from the plasmid fragment missing the crcB gene. To
further validate the insertion of the deletion phenotype, plasmids were extracted
and subjected to a restriction reaction with the aforementioned enzymes. The
resulting gel is shown in 4.8b. Lanes 1,2,3 and 4,5,6 are duplicates. Lanes
2,5 correspond to uncut plasmid, lanes 3,6 correspond to cut plasmid with 1
restriction enzyme and lanes 4,7 correspond to restriction with both enzymes,
where the 2 fragments are of the expected size. Moreover, for the denitive
validation of the plasmid sequence, both positive plasmids were sequenced and
the one corresponding to lane 7 was found as an error-free match.
The next step involves the integration of the constructed pSEVA612S-ΔcrcB
plasmid in the chromosome. Two separate methods of plasmid delivery are
described in [116], namely electroporation and conjugation. The latter was
chosen as the most ecient method of these two. Conjugation is a process
in which cells bearing the F plasmid (F+) create a pilus and connect to other
bacteria which do not bear the plasmid without the plasmid (F−) making the
transfer of genetic material possible. In this study, a form of conjugation called
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Figure 4.9: Red circles correspond to the "fried-egg" (L-form) phenotype. All
bacteria from the plate showing this morphology were tested with PCR and found
to be recombinants (and T7 polymerase positive), whilst all others (blue circle) were
found to be T7 negative and non-recombinants.
triparental mating is used, in which apart from the donor and the recipient
strain, a helper strain is also used to assist the transfer of genetic material from
the donor to the recipient. In essence, the bridging between the recipient and
the donor and the transfer functions are provided by the helper. The origin of
transfer (oriT ) present in pSEVA612S enables the mobilization of this plasmid
from the conjugation machinery. This variant of conjugation is useful, as it is
often undesirable to maintain cloning strains in a conjugative (F+) form. The
implementation in this work is an alteration to the original procedure described
in [116]. In particular, the aforementioned study describes delivery of the plasmid
to Pseudomonas putida cells which is the recipient (R) strain, with the donor
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(D) and helper (H) strains being E. coli. This makes the nal selection step
rather straight-forward with cultivation of the nal conjugation mixture in M9
minimal medium with citrate as a carbon source which cannot be metabolized
by E. coli. In this implementation all strains are E. coli complicating the nal
selection step. For this process to work with BL21(DE3) recipient cells, the
antibiotic resistance marker of pA1-his plasmid already existent in this strain
was used, along with the subtle observation that there is a visible dierence
in the phenotype of E. coli BL21(DE3) compared to cc118-λpir. Initially, the
conjugation mixture was prepared as described in [116] but in the nal selection
step, an LB agar plate both gentamicin and ampicillin was used instead of an
M9 + citrate. The pSEVA612S plasmid contains an oriT which permits the
plasmid to be transfered through the conjugative bridge, while pA1-his does not
contain the oriT sequence, therefore in theory, using an Ap + Gm plate the only
colonies that should appear are BL21 (DE3) with the additional Gm resistance
from the pSEVA612S that managed to move from cc118-λpir to BL21 (DE3)
and integrate to the chromosome of the latter. Along with the full conjugation
mixture (D+H+R), the following combinations were also tested: D, H, R, D+R,
D+H, H+R in Ap+Gm plates. Apart from the plates corresponding to D+H+R,
colonies appeared in the plate corresponding to D+R as well, probably due to
rare events of pA1-his plasmid uptake by cc118-λpir cells. In the D+H+R plate
however, there was a visible dierence in some colonies as shown in 4.9. A number
of those which exhibited the dierent form were restreaked and undergone colony
PCR. To our surprise, all colonies with the dierent morphology were cointegrates,
while colonies that had the same morphology as in the D+R plates, were not.
This result indicates that it is possible to select cointegrates by visual inspection
of the selection plate. The pSEVA612S plasmid is inserted as a linear fragment
with the homologous region residing either in the beginning or in the end of the
fragment, based on the position of insertion to the chromosome. Depending on
which region of the chromosome is recognised by the recombinases (upstream
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Figure 4.10: Integration of pSEVA612-ΔcrcB plasmid upstream or downstream of
the target locus. Left Recombinant (Top) and Right Recombinant (Bottom) with the
respective primers and validation gels.
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or downstream) the plasmid is integrated either upstream (left recombinant)
or downstream of the chromosome's respective region (right recombinant). To
conrm the integrate' s position, primers were designed upstream (P1_VAL)
and downstream (P2_C_VAL_RV) of the homologous region. Each colony
was tested by PCR with two pairs of primers (P1_VAL, P4_DCRCB_RV) and
(P1_DCRCB_FW, P2_C_VAL_RV). The resulting gel and the sizes of the
bands corresponding to these pairs determine the position of the integrate in the
chromosome as shown in gure 4.10. The cointegrates were further tested to
validate that they were BL21(DE3) and not cc118-λpir cointegrates, although
this would be highly unlikely in cc118 cells due to the modied recA1 genotype
modication which reduces recombination eciency. The main dierence between
BL21(DE3) and cc118-λpir is the T7 polymerase and this has been tested with a
number of cointegrate colonies, with primers designed inside the T7 polymerase
gene. As shown in gure 4.10, 3 left recombinant, 1 BL21(DE3) unmodied and 4
cc118 colonies were tested for amplication of the fragment corresponding to T7
polymerase and all of them showed the expected result. Following conrmation
of the integrate's location, colonies were isolated corresponding to both right and
left recombinants and chemical competent cells were created. These were then
transformed with the kanamycin resistance plasmid pSEVA228S which contains
the meganuclease I-SceI enzyme under the control of the xylS/Pm promoter.
After introduction of the plasmid, the left and right recombinants were grown
as a liquid culture in LB with kanamycin and expression of the I-SceI enzyme
was induced with the addition of m-Toluic acid to a nal concentration of 1
mM. This step involves the creation of two DSBs by the enzyme in the two I-
SceI sites present in the integrated fragment. These DSBs in turn induce a SOS
response which is resolved either by homologous recombination leading to one of
the genotypes present (wild type or ΔcrcB), or by cell death. This step mediates
an eective selection for the resolutes as well. This deletion method was rst
illustrated with the presence of one DSB in the chromosome [114]. However,
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Figure 4.11: Negative selection of Gm sensitive clones. Two colonies (red circles)
are missing in the Gm plate and the corresponding colonies (blue circles) in the plate
w/o antibiotics were picked as resolutes.
according to [115], the addition of one more I-SceI site increases DSB resolution
eciency. The surviving resolute cells will be Gm sensitive because the DSBs will
have released the Gm resistance cassette fragment from the chromosome, hence
Gm is not added during the induction of I-SceI cleavage. Following induction
of cleavage, appropriate dilutions of cells were prepared in agar plates without
antibiotic. After overnight growth, 100 colonies (50 from left and 50 from right
recombinants) were re-streaked in two plates, one without antibiotic and one with
Gm. Each of the 100 colonies was isolated in both plates corresponding to the
same numbered position. This is the negative selection step which would indicate
which colonies are Gm resistant and which not, with the latter corresponding to
resolutes. A dilution from the previously grown liquid culture was passed into a
new tube with LB, kanamycin and 1 mM of m-Toluic acid for another round of
overnight growth and colony picking. After 6 passes, two distinct Gm-sensitive
colonies appeared as shown in gure 4.11. Both colonies were subjected to PCR
with the pair of primers P1_C_VAL_FW and P2_C_VAL_RV and were found
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Figure 4.12: PCR validation of the KO genotype in the resolutes picked as indicated
in gure 4.11.
to contain the crcB KO genotype as shown in gure 4.12. In order to validate
the crcB KO phenotype, these colonies were re-streaked and placed in liquid LB
with 3 mM of KF, in which no growth was visible after 2 days. Furthermore, to
cure plasmids that would still potentially reside in this strain, such as pA1-his
or pSEVA228S, the strain was put in a liquid culture and left to grow overnight,
diluted and grown again in several passes. Then colonies were put in plates with
no antibiotic, Kn and Ap separately and those found to be sensitive in both
antibiotics were picked.
The number of passes that were needed until the two crcB KO positive clones were
obtained is much closer to the spontaneous recombination rate of 1.7x10−3 [114].
A much more robust resolution of the cointegrates was expected, indicating that
the DSB from cleavage of the I-SceI sites was not properly induced. A number
of possible reasons could lead to this eect. Incomplete induction of expression
of the I-SceI meganuclease, plasmid instability of pSEVA228S or absence of the
correct I-SceI sites from the integrate are some of them. The outcome of the
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method however did not change, despite this set-back, fact which constitutes one
more argument for its choice.
4.3 Purine nucleoside phosphorylase and adeno-
sine degradation
PNP is a term which describes a variety of enzymes which, as the self-explanatory
name suggests, accept a purine nucleoside, namely adenosine, deoxyadenosine, in-
osine, deoxyinosine, guanosine, deoxyguanosine or chemically similar compounds,
and a phosphate as substrates yielding α-D-ribose 1-phosphate and the respec-
tive base. In several organisms, it is encountered as part of the purine salvage
pathway which mediates the production of purine monophosphates as an alter-
native to normal purine synthesis, where the latter is compromised or missing in
the rst place. In higher mammals (rats, humans), PNP is expressed in many
dierent tissues but is mostly found in the liver and is produced by hepatocytes.
Mutations in the PNP gene lead to an disorder known as PNP deciency which
is autosomal recessive. Individuals with this disorder show symptoms of CNS
impairment and immunodeciency. Human PNPs signicantly dier from bacte-
rial ones structurally and although they accept the same substrates in their key
function in purine metabolism and mediate the same reactions, bacterial PNPs
exhibit a broader substrate specicity, fact which led recent endeavours towards
the development of a suicide gene therapy for cancer treatment. The main theme
behind this strategy is the activation of prodrugs by cleavage from E. coli PNP
but not from its human counterpart. By expressing this PNP in cancer cells,
toxicity of the activated prodrug which is otherwise inert in normal tissue, kills
o the cancer cells. [117].
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4.3.1 The purine nucleoside phosphorylase as part of the
4-uorothreonine pathway
The second step in the uorometabolite biosynthesis pathway of S. cattleya is
mediated by an enzyme which accepts 5'-FDA, the product from the direct
uorination reaction, and a phosphate, producing Adenine and 5-FDRP, therefore
it is a classic PNP. Evidence for this step were found by incubating cell free
extracts of the aforementioned bacterium in the presence of 5-FDRP which yielded
the nal product of the pathway, suggesting that the 5'-FDA is processed by a
PNP [42]. Sequence similarities and prediction by homology, suggested that the
ORF directly upstream of A1 corresponded to this putative PNP and denitive
proof was provided by assays with the product of this ORF. In particular, the
partially puried product from cell-free extract performed phosphorolysis of 5'-
FDA yielding 5-FDRP [47]. The gene corresponding to this enzyme was therefore
assigned the name B. In four other occurrences of the uorometabolite pathway
(B, B1-B4), the corresponding gene is either directly adjacent or very close
to the related uorinase gene and with sequence similarities that range from
59%-74%. In most of these cases, where the pathway is active (i.e. producing
uoroacetate) [53], [55], position and similarities of the enzyme suggest that it
has been evolved specically to process the product of the nearby uorinase gene.
Evolution drift, responsible for the inactivation of the pathway in N. Brasiliensis
or Actinoplanes sp. N902-109, has not displaced this gene much further away as
is the case with other genes of this pathway. It is worth noting that the enzyme
is also a catalyst for adenosine although with a much lower eciency than its
uorinated analogue.
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4.3.2 The E. coli purine nucleoside phosphorylase(s)
There are two dierent PNPs present in the wild type E. coli, and the respec-
tive genes are termed deoD and xapA. The product of deoD is a homohexamer
with a broad substrate specicity. Although its function as part of the purine
salvage pathway processing of inosine to yield hypoxanthine leading to degraded
purines, there is also high reactivity with adenosine, guanosine and some inter-
esting uorinated substrates such as 2-uoro-adenosine (F-Ado) and 2-uoro-2-
deoxyadenosine (F-dAdo) [118] but not xanthosine which is processed by the
product of xapA. On the other hand, xapA cannot process adenosine or de-
oxyadenosine but can process inosine, guanosine and their deoxy-counterparts.
Interestingly, catalysis of the phosphorolysis of the uorinated purine nucleosides
F-Ado and F-dAdo by the DeoD-type PNP, exhibits higher anities and e-
ciencies attributed to stronger van der Waals bonds with the respective active
site residues [119], [120]. The product of deoD (termed pup in earlier studies) is
vital for the metabolism of purine nucleosides such as adenosine and deoxyadeno-
sine and mutants for this gene do not grow in the presence of each one of these
metabolites as sole carbon sources [121].
4.3.3 Rationale and creation of the deoD KO in E. coli
BL21(DE3)
The broad spectrum of substrates accepted by both of the PNP enzymes present
in wild type E. coli but especially the compatibility of the DeoD-type PNP with
uorinated analogs of adenosine and deoxyadenosine indicates the possibility
that other uorinated analogs such as 5'-FDA might be degraded as well by
this particular phosphorylase. On the other hand, XapA type expression is only
induced in the presence of xanthosine [120] and xanthosine is not produced up











Table 4.4: Primers for the construction/sequencing of the pSEVA612S-deoD
deletion plasmid and for validation of integration in the BL21(DE3) chromosome.
Red colour signies restriction sites, brown colour corresponds to sequences inside
homologous regions upstream and downstream of crcB. The green colour shows
sequences that are part of genes. Blue colour indicates sequences that reside in
the pSEVA612S plasmid (used for sequencing).
to less than micromolar scale by E. coli growing in a standard glucose-based
medium. Adenosine (or deoxyadenosine), an inducer of deoD [122], is however
detected during growth of E. coli [123]. Moreover, a recent study for the directed
evolution of the uorinase reported the deletion of the E. coli PNP enzyme to
avoid degradation of the product 5'-FDA during high-throughput analysis of cell-
free extracts [52]. Although no ample justication or data supporting this position
were presented in the latter, it was determined that deletion of deoD for the
avoidance of 5'-FDA degradation would be a prudent course of action nonetheless.
The same methodology was utilized for the deletion of the deoD gene as described
in section 4.2.4, with a modication in the step of the suicide plasmid delivery.
For completeness of the strain modications included in this work, both E.
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coli BL21(DE3) and its ΔcrcB counterpart were subjected to this procedure.
Primers were designed as before (see table 4.4) with appropriate restriction sites
(EcoRI and BamHI) and the fusion template including the ΔdeoD genotype was
amplied. The resulting linear construct and plasmid pSEVA612S were subjected
to separate restriction reactions. After restriction and purication from the
reactants, plasmid pSEVA612S and the linear fragment of the deoD KO genotype
were conrmed with electrophoresis. Ligation of these fragments followed,
resulting in the desired pSEVA612S-ΔdeoD plasmid, which was delivered to
cc118-λpir cells by chemical transformation. Colony PCR was performed in the
transformed bacteria and gel visualization indicated correct sizes in most colonies.
Plasmid extraction was performed from 4 positive colonies and a restriction with
the pair BamHI, EcoRI followed to further validate the correct insert sizes.
Sequencing was subsequently performed in two of these plasmids yielding complete
correspondence with the theoretical sequence.
For plasmid delivery in the strain and integration to the chromosome, the
previously used method of conjugation could not be repeated for strain MK009
(table 4.8) because of the acquired phenotype F+ from the previous deletion,
which forbids conjugative transfer of plasmids to these strains. Therefore,
chemical transformation was used. The caveat of this approach is that chemical
transformation eciency is up to 1000-fold less than electro-transformation. For
this reason, the reaction masses of both cells and DNA were scaled up 20-fold,
while incubation time was increased by a factor of 2, with respect to chemical
transformation for normal plasmid delivery. A small number of left and right
recombinant colonies were obtained for both the unmodied BL21(DE3) and the
MK009 strain. Genotypes were conrmed with gel electrophoresis as with the
previous deletion with appropriate primers designed upsteam and downstream of
the homologous regions, paired with the respective forward or reverse primer. As
a next step, one recombinant from each strain was transformed with pSEVA228S
to mediate the two DSBs in the I-SceI sites. Based on the experience of the
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Figure 4.13: Strains BL21(DE3) (Lane 1), MK009 (Lane 2), MK021 (Lane 3) and
MK017 (Lane 4) amplied with primer pairs P1-DEOD-KO-US-FW, P2-DEOD-KO-
DS-RV (ΔdeoD test primers) and P1_C_VAL_FW, P2_C_VAL_RV (ΔcrcB test
primers). All combinations of KOs are conrmed.
previous deletion which required 5 cycles of growth until 2 Gm-sensitive colonies
appeared, in this instance, after induction of the xylS/Pm promoter with m-Toluic
acid for I-SceI meganuclease expression, the strain was subjected to 5 cycles of
overnight growth. Restriction of colonies to Gm and antibiotic-free agar plates
showed that all colonies were Gm sensitive. This was a rst indication that
the meganuclease worked as expected contrary to the previous deletion round.
Gel electrophoresis did not reveal any KO genotypes after two repetitions of
the process. The incubation was then run for only one overnight cycle. Again
almost all colonies were Gm-sensitive but this time a number of colonies with
KO-genotypes were obtained however, much less than 50 percent. This is an
indication that the ΔdeoD phenotype grows at a disadvantage to unmodied
strains and is also the reason why incubation for more cycles results in dilution
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of the KO-genotype colonies. The two strains bearing the deletion ΔdeoD were
then grown in the absence of antibiotic to cure the pSEVA228S plasmid as before.
Finally, they were tested with colony PCR along with the BL21(DE3) strain as
shown in gure 4.13 where strains ΔdeoD and the double deletion ΔcrcBΔdeoD
are illustrated. To the best of our knowledge, the latter is the rst implementation
of this double KO strain.
4.4 SAM transporter expression and the full-mod
strain
The nal step of the creation of the modied host for in vivo uorination will
be described here, namely SAM transporter expression. The work that has been
done will be described and an explanation of how the expression of this membrane
protein will enable the increase of intracellular SAM by its addition to the medium
in higher molarities, will be included.
The nal modication towards the creation of the in vivo enzymatic production of
uorine-containing biomolecules by E. coli, is the establishment of the availability
of the precursor biomolecule for this reaction at high enough intracellular concen-
trations, namely SAM - also referred to as S -adenosyl methionine or AdoMet.
SAM is produced by a type of enzyme known as methionine adenolyltranferase
(MAT) from ATP, methionine and water in an Mg2+ or K+ dependent activity,
molecules which are readily available in the intracellular space. There enzymes
can be found in almost every instance of life with the exception of some parasites
that uptake SAM from their hosts [124]. Moreover, the high sequence homology
between bacterial and eukaryotic MAT enzymes is an indication of the general
nature of the proccess in all life domains [125]. SAM is a key ingredient in a
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variety of biochemical processes in living cells. It is commonly utilized in methy-
lation of DNA, RNA, proteins, phospholipids and neurotransmitters acting as
the main methyl donor in enzymes known as SAM-dependent methyltransferases.
SAM is also involved in other pathways such as polyamine synthesis, yielding
5'-methylthioadenosine (MTA) and in radical-based catalysis such as biotin pro-
duction.
4.4.1 The importance of SAM in E. coli
SAM production in E. coli follows the same trend described above by a MAT-
type enzyme produced by the metK gene. Previous studies (see [126]) stated
the existence of another copy of this gene in the chromosome of E. coli K12
adjacent to metK but further analysis did not corroborate this nding, indicating
an isolated duplication event to the studied strains. The importance of SAM in E.
coli is paramount, as illustrated by the fact that complete deciency of the metK
gene results in non-viable E. coli cells. Furthermore, addition of SAM in the
extracellular growth medium does not ameliorate this eect, an observation that
proves the lack of membrane permeability in E. coli for SAM molecules contrary
to yeast [127]. A partially disrupted metK variant, termedmetK84, with an "A to
G" replacement in the promoter region of the transcribed sequence, has been used
in several studies for the determination of the essential SAM-dependent metabolic
step whose suppression hinders growth. Regulation of the SAM pool from low to
negligible levels was achieved by supplying the inducer leucine for this mutated
promoter to the growth medium in dierent amounts. The resulting cells have
shown growth defects in conditions of limiting SAM. Specically, cells exhibited
a peculiar phenotype with increased lament lengths indicating that the cell wall
division process was disrupted. Restoration of normal growth was made possible
by an external supplementation of the metK gene [128]. Later it has been shown
that SAM plays a pivotal role in the assembly of a protein complex termed "septal
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ring" which performs division of the wall of elongating E. coli cells [129]. The
secondary eect of increase in the mutation rate, under limiting SAM conditions,
had been proposed and initially disproved [130], however excessive limitation in
SAM availability, leads to somewhat increased mutation rate by the activity of
deoxycytosine methylase [131].
4.4.2 SAM as a substrate for halogenases and duf-62 pro-
teins
Apart from the essential pathways in which SAM participates, there are enzymes
directly utilizing SAM for the production of secondary metabolites. The uori-
nase A1 utilized in this study is a representative example. Other enzymes include
chlorinase SalL from S. tropica which is part of the pathway leading to salinospo-
ramide A, a bioactive compound demonstrating cytotoxic activity and used as
an anticancer agent [132]. The uorinases that have been characterized and SalL
share around 35% of sequence identity and their compatibility and mechanistic
relatedness is also demonstrated by the genetic substitution of the chlorinase in
the S. tropica with the uorinase from S. cattleya, resulting in the formation of the
uorinated analog of salinosporamid A, namely uorosalinosporamid [5]. It ap-
pears that SAM-dependent halogenases are rare occurrences of the general family
annotated as domains of unknown function-62 (duf-62) consisting of more than
200 proteins most of which are uncharacterized. Apart from the halogenating
enzymes of this family, a number of duf-62 proteins have been analyzed and their
function is the hydrolysis of SAM yielding adenosine and L-methionine utilizing
an S2N nucleophilic attack mechanism in which water acts as the nucleophile
[133]. Phylogenetic studies also suggest the common evolutionary ancestry of all
duf-62 proteins despite the divergence of the halogenases towards a more specic
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role. The close similarity of tertiary and quaternary structure of the characterized
duf-62 enzymes strengthens this hypothesis even further [134].
4.4.3 SAM transporters
Although the main source of SAM in all domains of life is synthesis from the activ-
ity of MAT enzymes, in several eukaryotic and prokaryotic paradigms, SAM per-
meability through the membrane has been illustrated. For example, S. cerevisiae
has the capacity of SAM transport from the extracellular medium by special-
ized membrane proteins or general diusion based systems [135]. This molecule
however is not membrane-permeable in certain bacterial species, therefore, spe-
cic membrane proteins have been evolved that confer this functionality as is the
case with other important biomolecules. Cellular organelles such as mitochon-
dria, which have a distal evolutionary relation to bacteria also lack the ability to
transport SAM by diusion but rely on their host-cells for the essential supply
of SAM facilitating SAM transporter functionality. Two mitochondrial examples
include the S. cerevisiae Sam5p, part of the mitochondrial carrier family which
counts 35 members in yeast genome, hence its sub-cellular location [136] and the
Homo Sapiens SAMC which was discovered from database homology search by its
sequence similarity to the yeast orthologue, although the latter does not employ
an substrate-exchange mechanism as SAMC does [137]. Evidence also suggests
that other hetero-metabolite dependent organelles facilitate SAM transport sys-
tems such as chloroplasts, for example the Arabidopsis Thaliana SAMT1, which
is a counter-transport system exchanging SAM for SAH [138].
Any bacterial species that happen to develop such a metabolic route would have
to exhibit a symbiotic (such as mitochondria/chloroplasts) or parasitic relation,
with their host cells serving as SAM supplying pools. It therefore constitutes
no surprise that species which have evolved this elaborate system are mainly
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pathogens that reside in eukaryotic hosts and they did so by being exposed to an
external supply of SAM. Indeed, two examples of bacterial SAM transporters
that have been characterized include the R. prowazekii RP076 [124] and the
Chlamydia trachomatis L2 CTL843 [139]. Both of these bacteria are pathogenic
parasites and reside intracellularly in eukaryotic cells. The R. prowazekii has been
described as the most closely related organism to mitochondria, which are thought
to have been integrated to the cell cycle forming a symbiotic relation [140]. In
addition to being unrelated in terms of homology, the two transporters' main
functional dierence, apparently common among instances of SAM transporting
enzymes, is the ability of the chlamydial CTL843 to exchange SAM for SAH,
whilst rickettsial RP076 performs one-way transport. The rickettsial transporter
was rst identied in an R. prowazekii strain whose genome sequence revealed a
nonsense stop codon mutation in the single metK gene, suggesting the inability
of this strain to synthesize SAM on its own. Since SAM is an essential metabolite
in all life domains this nding suggested the presence of a transporter which
can mediate SAM uptake from the host cell's cytoplasm. On the other hand,
genomic analysis of several Chlamydia species showed the absence of both SAM
synthesis and SAH detoxication genes. These are both examples of reductive
evolution commonly seen in parasitic organisms [141]. The complementation
of SAM synthesis deciency with SAM transport was investigated in E. coli
by the expression of both of the above transporting enzymes. The resulting
ΔmetK strains expressing these systems became SAM auxotrophs showing the
compatibility of these transport systems with E. coli [142], [139]. Moreover,
the dual SAM uptake/SAH exporting ability of the chlamydial transporter was
illustrated by the deletion of the MTA/SAH nucleosidase, the enzyme responsible
for maintaining low SAH levels. This deletion confers growth hinderance in E.
coli, and is partially restored by the expression of the chlamydial transporter. The
long lament phenotype under SAM starvation conditions described above, was
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also found to be gradually restored in E. coli ΔmetK strains expressing the SAM
transporter with increasing SAM concentration in the growth medium [143].
4.4.4 R. prowazekii SAM transporter expression in E. coli
The decision of using the SAM transporter from R. prowazekii was based on qual-
itative rather than quantitative facts. Although the latter were also favourable
for the rickettsial SAM transporter, it was dicult to make a direct comparison
of kinetic properties as the plasmids, promoters, sequences, codon optimizations
and growth media dier in each study [135], [139]. On a qualitative basis, the
rickettsial transporter is an energy-dependent one-way transporter from the ex-
tracellular to the intracellular environment, while the chlamydial transporter is
mainly a SAM/SAH antiporter, showing minute energy-dependent one-way ac-
tivity. This is also illustrated by the fact that the rickettsial transporter, when
expressed in E. coli, maintains a linear rate of SAM uptake for 20 minutes while
the chlamydial transporter shows a decline in rate of uptake after the rst minute.
This is consistent with the SAM/SAH antiporter activity since SAH remains at
low concentrations in E. coli by the activity of SAH/MTA nucleosidase. Addi-
tionally, optimal E. coli growth is achieved with an addition of 17.5 μM of SAM in
the LB medium, while growth of E. coli ΔmetK with the chlamydial SAM trans-
porter is suboptimal even in the presence of 1 mM SAM. Last but not least, the
rickettsial transporter displays a uniport type of activity (extracellular to intra-
cellular only), which results in a concentration ratio (inside to outside) of higher
than 10, contrary to the chlamydial transporter's antiporter functionality which at
best can achieve a ratio of 1. The SAM transporter gene including a strong RBS
site upstream, was ordered and synthesized as a gBlockTM from IDT technologies
using codon optimization resulting in the same amino acid sequence as the rick-
ettsial transporter. The vector used for accommodating the gene is pSEVA631











Table 4.5: Primers for the construction and validation of the SAM transporter
expression plasmid with backbone pSEVA631. The red colour signies restriction
sites, the blue colour corresponds to sequences inside pSEVA631. The brown colour
shows sequences that are part of the codon optimized SAM transporter gene.
[84] featuring a pBBR1 medium copy number origin of replication and a gentam-
icin resistance cassette. The plasmid was extracted from an E. coli DH5a strain
and subjected to restriction with BamHI and PstI. The synthesized gene was
amplied with primers P1_SAMT_FW, which contains the priming sequence
and a tail with a BamHI site and the J23100 promoter, and P2_SAMT_RV
with a tailing PstI. The resulting PCR product was also restricted with BamHI
and PstI and then put together with the restricted pSEVA631 to a ligation reac-
tion yielding the construct pSEVA631-SAMT. Apart from primers R24_FW and
F24_RV residing upstream and downstream of the fused gene, two more primers
were also constructed, namely SAMT_INSEQ_FW and SAMT_INSEQ_RV as
shown in table 4.5. These both reside inside the SAM transporter recombinant
sequence and they are useful not only for additional coverage during sequencing,
but also for validation of the presence and correct alignment of the gene inside
the plasmid by PCR. In parallel, as an alternative and in order to validate the
functionality of the synthesized SAM transporter phenotypically, the strain with
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Figure 4.14: Plating in Ampicillin + Gentamicin and only Gentamicin plates.
Growth of clone 7 in the latter and not in the former, shows that competitive
replacement of plasmid pMW1402 with pSAMT took place successfully in strain
MOB1490 (now MOB100S) validating the functioning phenotype of pSAMT.
a deleted metK gene facilitating the SAM transporter within the ampicillin resis-
tant plasmid pMW1402, was kindly provided by Prof. Wood. The strain' s given
designation is MOB1490 [142]. Using a negative selection replacement strategy,
the plasmid pSEVA631-SAMT featuring our own version of the SAM transporter
replaced the ampicillin resistant construct initially providing the SAM transport
functionality. The replacement was achieved rst by transforming MOB1490 to
include pSEVA631-SAMT making the strain both Ap + Gm resistant. Then after
several growth cycles in LB liquid (Gm), colonies were grown and isolated in LB
agar plates (Gm). Several of the colonies were picked and restreaked in both Ap
+ Gm and just Gm plates (the same colony in the same position in both plates).
The idea is that since only Gm is included during growth cycles the pMW1402
Ap resistant plasmid featuring the working SAM transporter would be diluted
and lost only if the synthesized SAM transporter residing in pSEVA631-SAMT is
functional. Therefore, any colonies that are Ap sensitive are the ones that have
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Figure 4.15: PCR products conrming all modications. Lane 1 corresponds
to primer pair (P1_C_VAL_FW, P2_C_VAL_RV). Lane 2: primer pair (P1-
DEOD-KO-US-FW, P2-DEOD-KO-DS-RV). Lane 3: primer pair (pet151VAL_FW,
FLA1_INSEQ_RV). Lane 4: primer pair (R24_FW, SAMT_SEQ_IN_RV).
lost the pMW1402 plasmid and these would grow on the Gm plate but not in
the Gm + Ap plate. Indeed a "winner" appeared and validated by inoculation of
an Ap and a Gm liquid LB tube as shown in gure 4.14. This last modication
concludes the rationally chosen strategy for creating an in vivo uorometabolite
producing E. coli which, to the best of our knowledge and at the time of this
development was novel. Strains that have been developed as described in previ-
ous sections were transformed with the pSEVA631-SAMT plasmid. The resulting
strains MK015 (BL21(DE3) ΔcrcB + pA1 + pSAMT) and MK019 (BL21(DE3)
ΔcrcBΔDeod + pA1 + pSAMT) are of particular interest and a conrmatory
PCR was performed in two dierent colonies with the corresponding gel illustrat-
ing all modications shown in gure 4.15. Other strains with a BL21(DE3) base
genotype were also constructed for in order to serve as controls and for measuring
each modication's contribution to the result. All strains utilized or constructed
for this work are shown in tables 4.7 and 4.8.
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Plasmid Backbone Features Source or
Reference
pRK600 RK2013 [144] oriV(ColE1), RK2(mob+ tra+)
CmR
[116]
pJ61002 - oriV(colE1) ApR [72]
pSEVA612S pEMG [115] oriV(R6K), lacZα fragment with
two anking I-SceI recognition sites
GmR
[116]
pSEVA631 pBBR1MCS oriV(pBBR1) GmR [84]
pSEVA228S pSW-I [115] I-SceI expressing plasmid,














Contains the A1 gene with 6xHis










Same as pA1-his without 6xHis
tag ApR
This work
p100-A1 pJ61002 J23100 promoter, Strong RBS,
B0015 Term. carrying A1 gene
ApR
This work
p114-A1 pJ61002 J23114 promoter, Strong RBS,
B0015 Term. carrying A1 gene
ApR
This work
p100-SAMT pSEVA631 J23100 promoter, Strong RBS,
B0015 Term. carrying SAM
transporter GmR
This work
Table 4.6: List of plasmids used in this study.






MG1655 K-12 strain F λ ilvG rfb-50 rph-1 GeneArtTM
DH5α MG1655 F- λ- endA1 glnX44(AS) thiE1 recA1
relA1 spoT1 gyrA96(NalR) rfbC1 deoR
nupG Φ80(lacZΔM15) Δ(argF-lac)U169
[116]
cc118 K-12 strain araD139 Δ(ara, leu)7697 ΔlacX74
phoAΔ20 galE galK thi-1 rpsE rpoB
argE(Am) recAl pSEVA228S (KnR)
[116]
cc118-λpir cc118 λpir pSEVA612S (GmR) [116]
HB101 K-12 (mostly) F- λ- hsdS20(rB- mB-) recA13 leuB6(Am)
araC14 Δ(gpt-proA)62 lacY1 galK2(Oc)
xyl-5 mtl-1 thiE1 rpsL20 glnX44(AS)
pRK600 (SmR CmR)
[116]
DH10B MG1655 F λ (StrR) endA1 deoR+ recA1 galE15




BL21(DE3) B strain F ompT gal dcm lon hsdSB(rBmB)









MOB1490 BW25113 ΔmetK pMW1402 pMW1484
ApR KnR RifR
[142]
MOB100S BW25113 ΔmetK pSAMT pMW1484
GmR KnR RifR
This work
Table 4.7: List of strains used in this study.





MK001 MG1655 pA1-his ApR GeneArtTM
MK002 DH10B pET151(-) ApR This work
MK003 BL21(DE3) pA1-his ApR This work
MK004 BL21(DE3) pA1 ApR This work
MK005 BL21(DE3) p100-A1 ApR This work
MK006 BL21(DE3) p114-A1 ApR This work
MK007 BL21(DE3) pET151(-) ApR This work
MK008 BL21(DE3) pSAMT pA1 GmR ApR This work
MK009 BL21(DE3) ΔcrcB This work
MK010 BL21(DE3) ΔcrcB pA1 ApR This work
MK011 BL21(DE3) ΔcrcB p100-A1 ApR This work
MK012 BL21(DE3) ΔcrcB p114-A1 ApR This work
MK013 BL21(DE3) ΔcrcB pET151(-) ApR This work
MK014 BL21(DE3) ΔcrcB pSAMT GmR This work
MK015 BL21(DE3) ΔcrcB pSAMT pA1 GmR ApR This work
MK016 BL21(DE3) ΔcrcB pSAMT pET151(-) GmR
ApR
This work
MK017 BL21(DE3) ΔcrcBΔdeoD This work
MK018 BL21(DE3) ΔcrcBΔdeoD pSAMT GmR This work
MK019 BL21(DE3) ΔcrcBΔdeoD pSAMT pA1 GmR
ApR
This work
MK020 BL21(DE3) ΔcrcBΔdeoD pSAMT pET151(-)
GmR ApR
This work
MK021 BL21(DE3) ΔdeoD This work
Table 4.8: List of strains used in this study (continued).
Chapter 5
The eects of uorinase expression
in E. coli
This chapter consists of growth curve experiments showing how expression of
the uorinase aects growth of several engineered E. coli strains. The growth
curves will be tted using GP (see chapter 3). In several circumstances, Analysis
Of Variance (ANOVA) was performed to show statistical signicance of the
results. It should be noted that the type of media and conditions used for
extrapolation of growth characteristics from GPs, do not aect the usability of
the method, since, as mentioned in section 3.1.1, the trend of growth remains
sigmoidal independently of the growth medium used, as long as it is limited (not
replenished).
Expression of the uorinase in E. coli has been frequently performed in a number
of studies, mostly in the form of overexpression by a strong inducible promoter
in order to isolate ample quantities of the protein for other experiments such
as in vitro assays for the determination of enzyme kinetics, crystal structure
or others (see section 2.3). However, to the best of our knowledge, no studies
that describe the in vivo functionality (or absence thereof) in E. coli or reveal
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any eects that the expression exerts in the viability of the cell, apart from
the fact that the protein could be readily puried. The closest match to in
vivo uorination has been reported in a DE study where a cell-free extract has
been used to assess the enzyme's eciency in a "relatively" high-throughput
manner [52], which also pointed the author towards deletion of E. coli PNP.
The aforementioned study also validated the choice of E. coli as a host for DE
experiments but it was deemed that the establishment of in vivo uorination
would be a further enabling step, as it would open-up several possibilities for
improved variant selection apart from the slow and sample-destructive techniques
that are normally employed in enzyme optimization. Once the in vivo production
of the uorinated product of the enzyme is established, pathway engineering
can reveal routes that yield directly measurable responses, therefore accelerating
the DE workow. Additionally, direct in vivo uorination in E. coli is itself
an enabling platform for other downstream applications such as organouorine
production from bioreactors. In DE (section 2.2), the simplest and most ecient
screening method is genetic selection. If the in vivo uorination is assumed to take
place, the mitigation of uoride toxicity by the incorporation of uoride anions to
SAM yielding 5'-FDA was visualized as a plausible mechanism of action for the
selection of the highest performing variants as exhibiting a survivability advantage
thus becoming gradually dominant in a mixed population. However, in E. coli,
as in many other industrially-utilized micro-organisms, uoride eux channels
already alleviate its negative eects simply by pumping it out of the cell (see
section 4.2). The eciency of this mechanism is tremendous, featuring a rate
of eux of more than 30,000 uoride anions per second [111]. In comparison
to the turnover of uorinase (0.0043 s−1) the eect of the latter (if any) would
be negligible as uoride eux constitutes a competitive process 107 times more
ecient in terms of uoride turnover. Thus, any identication of a positive (or
otherwise) eect of the uorinase in the presence of uoride, would have to be
made on the ΔcrcB strain expressing the uorinase gene, specically, MK010
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from table 4.8, otherwise the eect of uorinase would be masked. The idea is
that the ux of uoride anions towards 5'-FDA would be benecial for the cell, as
it would alleviate toxicity from uoride assuming that 5'-FDA is produced within
the cell, that 5'-FDA is not toxic for the cell and that there is a mechanism
that expels 5'-FDA from the cell or a process that converts 5'-FDA to another
non-toxic uorinated compound which is itself exported in order to maintain a
quasi-steady state equilibrium which would result in a steady uoride turnover
rate.
5.1 Growth curves of BL21 (DE3) with uorinase
expression
5.1.1 Protein overexpression side eects in E. coli
The overexpression of recombinant proteins in E. coli or yeast is an established
technique for analysis of protein structure or function either with in vivo or,
after protein isolation and purication, in vitro context. Expressing a foreign
protein intra-cellularly however, is always risky as it can create negative eects
to host cell growth. There are many dierent types of metabolic burden that are
usually tied to growth defects. Apart from the competition for cell resources that
participate in the expression, folding, localization and degradation of proteins,
which constitutes the most common reason exerting a growth disadvantage even
if the protein's function is orthogonal to cell metabolism, there is a possibility of
toxicity due to a particular metabolic eect of a protein. This type of toxicity
is apparently commonplace as depicted in a study where absence of colonies in
transformed BL21(DE3) strains by chemical transformation was observed in 38%
of proteins under the control of an inducible promoter with basal activity and
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96% toxicity (overexpression) with the inducer [147]. The detrimental eects
which commonly appear during overexpression of recombinant proteins led to
the development of techniques to overcome these eects. The derivative strains
C41(DE3) and C43(DE3) are results of these endeavours. There strains were
selected by random mutagenesis of BL21(DE3) genotype and the ability to grow
in the presence of IPTG inducer for a plasmid controlling the expression of an
otherwise toxic protein for BL21(DE3) [148]. There are other tools for mitigating
potential toxicity of a recombinant gene introduced to an organism through a
plasmid. The pET-151/DTOPO vector used in this study for expression of
the uorinase, harbours a lacI repressor which binds both to the T7 lacUV5
promoter controlling expression of T7 polymerase in the chromosome and the lacO
operator in the plasmid forbidding T7 polymerase binding in the promoter, thus
further reducing basal expression levels. Except for toxicity resulting from direct
interference of the overexpressed protein in cell metabolism under normal growth
conditions, there is also a possibility of an indirect eect of a heterologous protein's
or pathway's products to the host metabolism. For example the biopolymer PHB,
consumes large amounts of key metabolites NADPH and acetyl-CoA subsequently
inuencing growth [149]. In this case, the stability of genetic modications which
lead to such phenotypes is at risk especially if the source of modication is a
plasmid. The reason is that the growth disadvantage of the modied genotype,
can become a growth advantage when loss of function occurs randomly. The
clones that harbour such a loss would very quickly dominate the culture because
of the growth advantage with respect to the functional phenotype which exhibits
growth inhibition due to the burdensome metabolism [150].
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5.1.2 Eects of uorinase expressing plasmid in growth of
E. coli BL21(DE3) with Gaussian Process analysis
Table 4.8 shows all the strains that have been developed for this work using
BL21(DE3) as a base host. Many of these strains harbour expression vectors for
the A1 gene based on pET-151/DTOPO backbone or pJ61002. In all cases,
the transformations were successful yielding ample amounts of colonies even with
the strong constitutive promoter, therefore the uorinase gene does not appear
to exert toxic eects in E. coli and this is consistent with the absence of such
reports in relevant studies (see references from section 2.3). This observation
was further tested in growth experiments for a denitive statement of the eect
in growth by the presence of plasmids harbouring the A1 gene in BL21(DE3).
Strains BL21(DE3), MK003 and MK007 were grown to saturation in LB liquid,
with or without antibiotics accordingly. They were subsequently diluted 100-fold
and were put in 96-well plates for time-series OD measurements as described in
section 3.3.1. Each experiment was repeated in 6-8 technical replicates (same
ancestral clone, dierent wells) and three biological replicates (dierent ancestral
clones). The obtained measurements were then subjected to analysis with the
implemented method of GP regression with the use of a Gompertz prior function
as described in chapter 3.
Specically from equation 3.9 and m(t) = G(t) with G(t) as dened in equation
3.2 and GP (t) = E[f ∗] denotes the tted curve. To obtain the derivative
GP ′(t) for estimation of the growth rate, the quantities in LHS and RHS are
dierentiated:
GP ′(t) = E[(f ′)∗] = ∂1m(T
∗) + ∂1K(T
∗, T )[K(T, T ) + σ2I]−1(y −m(T )) (5.1)
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Figure 5.1: Extrapolation of lag phase from the tted growth curve.





Instead of looking at one quantity, namely maximum OD, the capacity of GP
to t bacterial growth curves accurately, without overtting, oers the ability to
extract more information from a curve. The extrapolated quantities chosen for
comparison are the following:
• Maximum growth rate: The maximal rate of increase in OD which corre-
sponds to the maximum rate of bacterial mass accumulation by the culture.
This is obtained by the derivative of the tted GP (GP ′(tmax)) from equa-
tion 5.1.
• Lag phase: The time needed by the culture in order to reach exponential
growth. This is calculated as:






where y0 is the starting OD of the time series, GP
′(tmax) is the maximum
CHAPTER 5. The eects of uorinase expression in E. coli 129
growth rate and GP (tmax) is the tted OD of the culture at the time point
when this rate is achieved (see gure 5.1).
• Mean OD in the stationary phase: Instead of looking at maximum OD,
which is achieved only in one time point the mean OD over the stationary
phase gives a more weighted value for maximum growth. The mean is
obtained from the time points corresponding to the maximum value of the
tted GP curve up to the nal measurement.
Calculation of these 3 attributes for strains BL21(DE3), MK003(pA1),
MK007(pET151(-)) yields gure 5.2. One way ANOVA shows no signicant dif-
ference in lag time and maximum rate of growth, however there is signicant dif-
ference in mean OD during the stationary phase between BL21(DE3) and MK007,
MK003 and MK007 but not between BL21(DE3) and MK003. Apparently, with
introduction of the plasmid that does not contain the uorinase gene, there is
a slight decrease in viability during the stationary phase. This is not surprising
as there is some burden from the replication of the plasmid itself, the ampicillin
resistance protein and the proteins that constitute the T7 expression system. The
restoration of this small detriment from the introduction of the uorinase gene,
even when expressed in very low basal levels hints to an interesting eect which
will be illustrated further in the next section.
5.1.3 Eects of controlled overproduction of uorinase in
E. coli BL21(DE3)
The experimental measurements of OD values in table 4.2, corresponding to
hours after IPTG induction of strains MK003 and MK007 suggest that there
is an signicant increase in the OD value after IPTG induction and subsequent
overexpression of the uorinase. All experiments performed as part of this work,























































































































Figure 5.2: Mean values of 3 biological replicates for the attributes of growth in
strains with or without plasmids. In the case of mean stationary growth there is
signicant dierence between strains.
entailing end-point OD measurements in the liquid cultures of these strains,
showed consistently higher OD in the strain bearing the pA1 plasmid. To
illustrate reproducibility of this result including the pure BL21(DE3) strain, an
analogous experiment as in the previous section was run for the same strains
but also including the conditions in which strain MK007 is grown with IPTG
induction within a small range of concentrations where the expression levels vary.
This was determined by another experimental dataset (obtained from A. De Las
Heras) after analysis of T7 promoter activity with BL21(DE3) grown in dierent
IPTG concentrations, with the methods developed in chapter 3.
As before, 3 dierent pre-cultures (biological replicates) for each strain/condition
have been prepared and left to grow o/n in separate tubes. Fresh LB tubes were
then inoculated with a 1:500 ratio resulting in a lower starting OD, which would
enable a more pronounced determination of the dierential lag time. A 96-well
plate was inoculated with a number of technical replicates from each tube and
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(a) Lag times
(b) Max growth rates
Figure 5.3: Lag times and maximum growth rates of strains BL21(DE3), MK007
and MK003 in varying IPTG concentrations. Lag times of strain MK003 grown in
IPTG 0.02 mM or more exhibit statistically signicant increase with respect to the
other strains/conditions.
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(a) Mean OD in stationary phase
(b) Growth curves of representative conditions
Figure 5.4: Mean stationary OD and mean growth curves of strains BL21(DE3),
MK007 and MK003 in varying IPTG concentrations. The higher ODs in IPTG induced
cultures is a statistically signicant result.
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OD measurements were performed over 18 hours with a time step of 10 minutes.
The chosen IPTG concentrations where 0 mM, 0.02 mM, 0.04 mM and 0.08 mM
corresponding to around 10%, 20%, 40% and 80% of maximum expression levels
respectively (reached with 0.5 mM and 1 mM). Strains MK007 and BL21(DE3)
were not tested in the presence of IPTG as in a recent study, BL21(DE3) growth
shows an identical trend [151]. In the same study, it is also highlighted that the
overexpression of a neutral control protein imposes a burden to cell growth, albeit
small.
The time series obtained were subjected to the same analysis with GP tting as
in section 5.1.2 and the same 3 attributes were extracted. In gures 5.3 and 5.4,
the means and deviations of these attributes are illustrated.
From gure 5.3a, it is evident that there is an increasing trend in the lag times
with the strains harbouring the uorinase with increasing IPTG concentrations,
however between neighbouring conditions the dierences are borderline or not
signicant. However, between strains BL21(DE3) and MK003 with 0.08 mM
IPTG induction, the statistical signicance in lag time is indisputable, with the
latter exhibiting a higher delay in reaching exponential phase. This is a result
to be expected as the induction of high level protein expression diverts a good
portion of resources towards this task, thus there is congestion in usage of the
same resources for cell growth.
The maximum rates of growth are illustrated in gure 5.3b. The only mentionable
result is that the statistically signicant dierence, based on ANOVA, in the
maximum growth rate achieved between MK007 with IPTG of 0.08 mM and
all other strains/conditions. The remainder cultures of MK007 with IPTG
concentrations 0, 0.02, 0.04 mM do not show signicant dierence between them
or with strain BL21(DE3) however they show signicant dierence with MK003.
The most profound result is seen in the mean OD during stationary phase where
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there is a denite increase in OD observed with strain MK003 grown in all non-
zero concentrations of IPTG. Specically, even in the low-level overexpression
(20% according to the calibration experimental data from A. de las Heras), the
highest OD is reached as shown in gure 5.4a. The dierence of means with
strain BL21(DE3) grown in pure LB, is 23%. All non-zero IPTG concentrations
reach OD values very close to each other (no statistical signicance). This is a
stunning result, in the sense that, not only there seems to be a positive eect
in the E. coli cells with overexpressed uorinase, since they outgrow simple
BL21(DE3) cells grown in rich medium, but this eect takes place in low and
persists in high overexpression levels. In order to identify the source of this
eect, possible mechanisms of action where envisaged, such as the dechlorination
of LB, which contains NaCl, by the duality of function of the uorinase as a
chlorinase [4]. This was however not the case, as the same dierences in OD
were observed with media prepared in the absence of NaCl (data not shown).
Another plausible scenario is that the SAM binding of the enzyme could create
a transient imbalance in intracellular SAM, as recognised by SAM riboswitches,
which could subsequently lead to higher intracellular SAM production, in turn
stimulating further growth. In any case, not excluding the possibility of a non-
specic reaction of the uorinase, the reason for this positive growth eect is most
probably tied to substrate binding in the enzyme.
The signicance of the above observation extends in the usability of this enzyme
within in vivo reactions in E. coli. As mentioned in section 5.1.1, in most
procedures involving recombinant protein expression in a foreign host, the risk
of gene instability is imminent with the extra metabolic burden imposed by this
protein. The positive eect of uorinase expression in E. coli not only eliminates
the need for a gene stabilization strategy, but also provides a metabolic surplus for
the potential encumbrance from the participation of this enzyme in recombinant
pathways.
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(a) Lag times with increasing uoride
(b) Max growth rates with increasing uoride
Figure 5.5: Lag times and max growth rates of strains MK003 and MK007
with/without IPTG. In IPTG-induced strain MK003 with 100mM KF, lag time and
max growth rate cannot be determined as the measurements nished before entering
the exponential phase.
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Figure 5.6: Mean stationary OD of strains MK003 and MK007 with/without IPTG.
5.1.4 Fluoride dependent growth of BL21(DE3)
Strains MK003 and MK007 were grown as before, but including various concentra-
tions of potassium uoride in order to quantify its eect on the growth attributes
of these strains in basal expression levels or in maximum overexpression. To this
end, the strains were grown both in 0 and 0.5 mM of IPTG and the increments
in concentrations of uoride were performed in a logarithmic manner. After GP
analysis and extraction of attributes, results are collectively illustrated in gures
5.5 and 5.6.
A few interesting observations can be made with respect to these measurements.
First of all, in uoride concentrations up to 20 mM there is little to negligible
eect in all aspects of growth without IPTG addition. This is to be expected, as in
these concentrations, the functional uoride eux channel keeps the intracellular
concentration more than 100-fold less of the extracellular (see gure 4.7). In 50
and 100 mM, as the detrimental eect of uoride sets in, there is a large increase
in lag times, and a measurable decrease of max growth rates, while stationary
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OD remains at similar levels. Evidently, at concentrations when uoride begins
to exhibit a deleterious eect, it impacts mostly on lag time, with max growth
rates and stationary OD's being aected considerably less. In IPTG-induced
growth, lag times of strain MK007 remain roughly the same up to 50 mM and
in similar ranges with the uninduced strains. On the other hand, the induced
MK003 strain (expressing the uorinase), shows higher lag times than the rest
of the strains but also reaches higher stationary ODs, and maximum growth
rates, illustrating the positive eect of uorinase overexpression on growth, in
accordance with the experiments of the previous sections. Interestingly, there is
a negative eect on stationary OD of the IPTG-induced MK007 in comparison to
the uninduced state. Eects on lag times and stationary ODs in IPTG induced
strains take place in 100 mM of uoride and in the case of uorinase overexpression
they are much more pronounced indicating a synergistic detrimental eect of
uoride and uorinase. However, because of the competitive nature of the CrcB
channel expelling uoride, it is dicult to draw conclusions about the eect of
the uorinase in dierent uoride concentrations, therefore an analogous growth
experiment was conducted but with strains MK010 and MK013 instead where the
CrcB channel is knocked-out and the extracellular uoride concentration is more
representative of the intracellular (see next section).
5.2 Growth curves of theΔcrcB andΔcrcBΔdeoD
strains with uorinase expression
Argumentation for the deletion of the uoride eux channel and the E. coli PNP
genes (crcB and deoD) was presented in the previous chapter. A gene deletion,
even when its function has been determined, as is the case with crcB and deoD,
cannot rule out secondary eects in combination with other conditions. Therefore,
while it is expected that there would be similar behaviour in the conditions tested
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(c) Mean stationary OD
Figure 5.7: Mean stationary OD and mean growth curves of strains MK009, MK013
and MK010 in varying IPTG concentrations.
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with BL21(DE3), the question rises whether the positive eects from uorinase
expression, extend to strains accommodating these deletions.
5.2.1 Growth of ΔcrcB and ΔcrcBΔdeoD strains
First of all, the single deletion strain with crcB KO was tested. Specically,
strains MK009 (ΔcrcB no plasmids), MK013 (ΔcrcB pET151(-)) and MK010
(ΔcrcB pA1) were grown in a 96-well plate and an OD time-series of 10 minute
intervals over 18 hours was obtained as previously described. This time, in order
to test the eect of IPTG without the pA1 plasmid, strains MK009 and MK013
were grown in 0.08 mM IPTG in addition to no IPTG. The results are collectively
illustrated for all measures extracted from growth curves in gure 5.7.
In comparison to BL21(DE3), there is similar behaviour in these strains with
and without plasmids. In general, growth attributes do not show a decline as
a result of this deletion. Similarly, lag times show an increasing behaviour with
higher levels of expression, as do max rates of growth, but most importantly
the positive eect of uorinase from low to high levels of expression persists in
this strain, leading to higher accumulation of bacterial mass. Another interesting
observation is the behaviour of MK013 under induction of IPTG which shows a
considerable decrease in stationary OD. This is not an eect of the IPTG itself,
as strain MK009 with induction does not show a similar behaviour, therefore it
is probably related to a polar overexpression eect in plasmid pET151(-) after
removal of the uorinase gene.
Growth in strains bearing the double deletion genotype exhibit similar eects,
however, compared to the ΔcrcB or BL21(DE3) phenotypes, growth of these
strains appear somewhat decreased. These results are not shown as this particular
deletion does not ultimately aect the ability of E. coli to produce uorometabo-
lites (see section 5.4).
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5.2 Growth curves of the ΔcrcB and ΔcrcBΔdeoD strains with uorinase
expression
(a) Lag times with increasing uoride
(b) Max growth rates with increasing uoride
Figure 5.8: Lag times and max growth rates of strains MK009 and MK010 in
various IPTG concentrations.
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(a) Mean stationary OD with increasing uoride
(b) Growth attributes in 0.7 mM uoride and varying expression levels
Figure 5.9: Mean stationary OD of strains MK009 and MK010 and growth
attributes of strain MK010 with uoride 0.7 mM and in various IPTG concentrations.
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5.2 Growth curves of the ΔcrcB and ΔcrcBΔdeoD strains with uorinase
expression
5.2.2 Fluoride dependent growth of ΔcrcB and uorinase
expression
As previously described by a number of studies (see 4.2.3) and conrmed by
phenotype validation, strains with a crcB deletion are expected to show a
reduction in growth with added uoride in molarities starting from micromolar
up to 2 mM. With the uoride eux channel deleted, the uoride molarity of the
growth medium is more descriptive of the intracellular molarity and can be easily
ne-tuned. To this end, a range of linearly increasing uoride molarities have
been tested, from 0 mM to 1.2 mM with 0.2 mM increments. In this instance,
only strains MK009 and MK010 have been tested as the unexpected eect of
plasmid pET151(-) in growth of MK013 under IPTG induction, illustrated in the
previous section, disqualied this strain as a reliable negative control for growth
curve comparison. It will however be used as a negative control for 5'-FDA
production (see section 5.4). Three values of IPTG molarities have been tested
in strain MK010 corresponding to basal, low-level expression and overexpression
(0, 0.02 and 0.5 mM).
The value of 0.02 mM has been chosen from an optimization experiment whose
results are shown in gure 5.9b. The latter has been performed with a growth-
reducing concentration of 0.7 mM uoride and in varying expression levels,
in order to identify eects in growth from the action of dierent amounts
of intracellular uorinase. The dierence in lag times is consistent with this
seen in previous experiments and has to do with the devotion of resources in
overexpression. There is a clear dierence both in max growth rates and in
mean stationary ODs in dierent expression levels following the same pattern.
In comparison to basal expression, there is a large increase in growth rate with
low level (0.02 mM IPTG) which shows further increase in mid-level (0.04 mM),
while in high level there is a decline back to the same value as the basal level.
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With stationary OD the same eect is observed but the highest value is achieved
with low level of expression. This is an insightful result which shows that indeed
the presence of intracellular uorinase in low to mid-levels does exert a positive
eect in growth in the presence of a uoride concentration that negatively impacts
growth. It is also noteworthy that this eect reverts in higher levels of expression.
Back to the experiment with increasing uoride, the growth attributes have been
extracted by GP analysis and the results are shown in gures 5.8 and 5.9a.
In all cases, lag times follow an almost linear increasing pattern with uoride
concentrations. There is no dierence in this trend with dierent expression levels.
Growth rates on the other hand show a dierent behaviour. Both in strain MK009
and MK010 with basal expression, there is an abrupt drop even with 0.2 mM KF,
to less than half of the max growth rate without uoride and it is maintained in
up to 1.2 mM. However, in MK010 with low overexpression, in 0.2 mM KF there
is even an increase in growth rate which drops in higher KF concentrations but
is always at 50% more than the one seen in strains with no uorinase or basal
expression thereof. In maximum overexpression, growth rate drops gradually but
faster than with lower expression and is maintained in higher values up to 1.2
mM where it drops to even lower levels than in basal or no expression. The
stationary OD also exhibit a profound eect. In basal or no expression there is a
similar decreasing pattern starting with values lower than 2 (OD au). In 0.02 mM
IPTG induction, apart from the increase in OD due to the positive eect of the
uorinase itself in growth, as shown in previous sections, there is even an increase
in stationary OD with 0.2 mM KF which slowly drops up to 0.8 mM at which
point it becomes roughly equal to OD without added KF, still above the value of
2. On the other hand, with overexpression there is a decrease starting from 0.2
mM KF ultimately reaching a value lower than any other condition in 1.2 mM
KF. This is an example where the metabolic surplus created from the positive
action of uorinase in growth takes eect and maintains the level of stationary
OD at values that are higher than in the cases where uorinase expression is basal
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Figure 5.10: Increasing SAM eect on E. coli without a SAM transporter (MK017)
and below, even in concentrations of uoride that are proven to be detrimental
in the growth of crcB KO strains.
5.3 Eects of increasing SAM concentration in
growth
The last modication towards the creation of a uorination-enabled E. coli host,
described in the previous chapter, is the expression of SAM transporter from R.
prowazekii. The kinetics of this membrane protein have been characterized, and
interestingly they dier between its native host and when expressed heterologously
in E. coli [124]. According to this study, the process of SAM uptake reaches a
plateau in R. prowazekii within 8 minutes of exposure to 10 μM extracellular SAM
and it still achieves an in:out ratio of more than 10. In E. coli the uptake process
maintains a steady rate for at least 20 minutes. It has not been yet determined
if a maximum is reached after 20 minutes. Moreover, it has been shown from the
same group (Wood) that the metK deletion strain complemented by the SAM
transporter (MOB1490) shows optimal growth in 17.5 μΜ of added SAM [142]
and the intracellular SAM concentration during exponential phase of growth has
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been measured to be 180 μΜ [123]. From these data it is safe to assume that in
E. coli the inside to outside ratio is more than 10 at least in low molarities. The
advent of SAM transporter expression in E. coli is the ability to vary intracellular
SAM levels at will, since SAM is the key substrate in the uorinase reaction and
since intracellular presence of uoride has been established from the crcB KO.
It is of interest therefore, to identify the eects of increasing SAM molarity in
E. coli growth, in milimolar levels (100 times more than has been tested before)
with or without a functional transporter or metK gene.
5.3.1 SAM chloride dihydrochloride eect in growth of E.
coli without SAM transporter
SAM, apart from being a cation, it is also highly unstable in room temperature or
higher, and spontaneously degrades to 5-MTA and homoserine lactone by cleavage
[152]. Therefore, it is normally obtained in a chemical form where stability
is somewhat increased (SAM chloride dihydrochloride - SIGMA). However,
dihydrochloride will alter the pH of the growth medium, and during a full-day
incubation, the degradation products will constitute a considerable percentile of
the total substrate added and may also exert secondary eects to bacterial growth.
Therefore, as a control experiment, strain MK017 (double KO - no plasmids) was
grown in the presence of varying SAM concentrations (0 to 6.25 mM) in order
to identify secondary eects of SAM in this chemical form that are irrelevant
to transporter functionality. Results for these growth experiments are shown in
gure 5.10.
Lag times in strain MK017, exhibit an increasing behaviour with higher values
of SAM but the dierences are minor and within two measurement time steps
(20 minutes). This changes in the last increment from 3.12 mM SAM to 6.25
mM where lag time is more than doubled from this change. Clearly, there is a
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detrimental eect of high molarity SAM in the lag phase of growth which is not
related to SAM uptake. Regarding max growth rate and mean stationary OD
there is a decreasing trend in both, with minor dierences in between changes,
however in the extremes of no SAM addition and mM levels of SAM they add
up to a considerable dierence. Again this shows that there is a secondary cause
of altering growth attributes in higher molarities of SAM which is most probably
connected to the change of pH towards acidic with the addition of hydrochloride
molecules, without excluding the possibility of the degradation products from
SAM cleavage inhibiting growth.
5.3.2 Growth of metK deletion strains with SAM trans-
porter
In this growth experiment, SAM concentration was pumped-up to millimolar
levels in order to identify the eects of high concentrations in the metK deletion
strain bearing the SAM transporter. Both strains carrying constructs with
the samT gene were tested, namely MOB1490, the strain originally used for
the identication of transporter functionality, and strain MOB100S, which was
derived from MOB1490 with a plasmid exchange method and carries p100-SAMT
(see tables 4.6 and 4.7). The results after GP analysis are shown in gure 5.11.
There are measurable dierences between strains in two aspects of growth, lag
time and mean stationary OD, both favourable for strain MOB100S. These strains
dier in two ways. First of all, in MOB100S the gene was synthesized in a codon-
optimized manner while in MOB1490 the original sequence from R. prowazekii
was used. Second, in MOB100S, a dierent backbone plasmid was used and
the promoter fusion was J23100 resulting in strong constitutive expression, while
in MOB1490 the backbone used was pSMART and the gene expression was
constitutive but with the native promoter.
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(a) Lag times
(b) Growth rates
(c) Mean stationary OD
Figure 5.11: Growth attributes of strains MOB1490 and MOB100S in various
concentrations of SAM chloride dihydrochloride.
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Some observations are noteworthy. In gure 5.11, 0 mM is actually 3.5x10−5 mM
because there was a 1000-fold dilution in LB from a pre-culture containing 0.035
mM SAM. Interestingly, there is zero growth in this concentration of SAM in
MOB1490 but there is a slight growth curve in MOB100S. This is evidence that
higher expression levels of this active one-way transporter, promotes growth in
extremely low concentrations of SAM. In 1 μM there is not a signicant dierence
in stationary OD between strains but there is around 50% dierence in lag time
with MOB100S being faster in growing showing again a more ecient uptake
process. In higher concentrations, the dierences in lag times become lower but
are always in favour of MOB100S, while in mean stationary ODs the dierences
increase and equilibrate at a level of 15% higher in MOB100S, in the highest
concentration of SAM tested (7 mM). Interestingly, in this concentration, max
growth rate is also higher in MOB100S. Compared to growth of ΔcrcBΔdeoD
in various concentrations, the negative eect seen in 6.25 mM does not seem
to appear in neither of MOB1490 or MOB100S. A possible explanation is that
excessive SAM promotes growth and counterbalances the inhibition. Evidently,
the higher amounts of SAM transporter being expressed in MOB100S enhance
the ability of cells to uptake SAM from the medium.
5.4 In vivo uorination
The growth attributes in several combinations of strains/conditions have been
illustrated in the previous sections, indicating some synergistic eects from
the levels of uorinase expression, SAM transport functionality and uoride
concentration, however the most important question is whether the reaction
is happening inside the living and dividing modied E. coli host and which
uorometabolites are produced. In the following sections, the validation of in
vivo direct uorination in E. coli will be illustrated. Specically, a range of
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chemical analysis methods were utilized for the identication of uorometabolites,
namely High Performance Liquid Chromatography (HPLC), Fluorine-19 Nuclear
Magnetic Resonance (19F-NMR) coupled and decoupled, Proton nuclear magnetic
resonance (1H-NMR) and High Resolution Mass Spectrometry (HRMS). In
particular, 19F-NMR was quite useful in this experimental context, as it only
detects molecules with uorine atoms embedded.
This series of experiments presented in the sections below were envisaged by
the author but in their details, they were jointly designed with collaborators
from the chemistry department of the University of St. Andrews Dr. Phillip
Lowe and Professor David O'Hagan. The incubations of E. coli for assaying 5'-
FDA productivity were performed mostly by the author but with a signicant
contribution from Mr Liam Davidson-Gates. Chemical analysis of samples
derived from incubations were performed, with all methods listed in the previous
paragraph and presented throughout this section, by Dr Phillip Lowe.
5.4.1 Experimental conditions
Strains MK015 and MK019 were picked as most promising for demonstrating the
capacity to produce uorometabolites in vivo. It also seemed possible that any
potential degradation from E. coli PNP which is not deleted in MK015 would
elaborate additional uorometabolites in the cytoplasm E. coli and this would
also constitute an important nding.
Incubation conditions
Colonies of strains that have been previously validated with PCR, chosen for
each separate condition/strain combination, were picked from agar plates and
used for starting fresh liquid LB cultures. These were grown to saturation and
subsequently diluted 100-fold in 250 mM Erlenmeyer asks containing 100 mL of
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LB. SAM chloride dihydrochloride was also added at this point according to the
conditions of the particular experiment and the asks were put at 37 oC in a rotary
shaking incubator (170 rpm). When each culture reached mid-log phase (OD of
0.5-0.7, approximately 2 hours) it was induced with 0.2 mM of IPTG. According
to the calibration experiment (see section 5.1.3), this molarity of IPTG results in
protein expression just below the maximum levels. After 5 hours, when according
to the pilot expression experiment (see 4.1.3), maximum uorinase expression is
achieved, potassium uoride was added at a nal concentration determined by
the specic conditions of each incubation. Cultures are subsequently incubated
for 24 more hours to allow for the uorination reaction to equilibrate and then
centrifuged in 3,000 rpm for 20 minutes. This low speed ensures minimal breakage
of cells from stress and unintentional release of 5'-FDA in the S/N. Cell pellets
and S/Ns were kept in -20 oC before chemical analysis.
Denaturing and lysis of cells
For analysis of the intracellular metabolites, the cells were denatured/lysed as
described in [153]. Pellets acquired after incubation were added 70% ethanol in
water solution pre-warmed at 70 oC and vortexed for 30 seconds. Then they were
put in 95 oC and left to boil for 5 minutes followed by 5 minutes in 4 oC. The
denatured cells were then subjected to a 5 minute centrifuge cycle in 14,000 rpm
to separate cell debris from the lysate.
5.4.2 Establishment of the products of uorination in the
cytoplasm
Two pairs of concentrations of the reactants were tested for each of strains MK015
and MK019 and their negative control strains (MK016 and MK020), 2 mM/50 μM
and 15 mM/250 μΜ of KF/SAM respectively, adding up to a total of 8 samples.
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The goal of this experiment was to detect uorometabolites in E. coli and identify
dierences between strains/conditions. The rst step was HPLC analysis in both
the S/N and lysate corresponding to each sample. Results are shown in gure
5.12.
In the HPLC trace of the lysates (g. 5.12a), there is a distinct dierence in
the intensity of the peak corresponding to 5'-FDA in strain MK019 compared to
the peak appearing in strain MK020 in both conditions. This is an encouraging
observation but not denitive of the presence of 5'-FDA. Moreover, there does not
seem to be a dierence in the intensity of peaks between conditions 15 mM/250
μM and 2 mM/50 μM of KF/SAM. This could be attributed to a saturation of
the process intracellularly or the debilitation of cells and subsequently of proteins,
due to the extra metabolic burden imposed by such a high molarity of uoride.
According to [113], an intracellular concentration of 15 mM is not enough to kill
the cells after >24h of exposure to uoride, although it halts growth and reverts
the cells back to lag phase, contrary to lower cytoplasmic uoride which does
inhibit growth but cells remain in exponential phase as shown when growth is
resumed in the absence of uoride. High uoride exposure must therefore induce
a stress response to the cells probably leading to a decrease in protein levels
as they struggle to maintain a minimal metabolic demand. Strains MK015 and
MK016 (functional CrcB) were also analysed and exhibit the same behaviour.
The HPLC traces of the S/Ns exhibit a small peak in the same retention time,
however it is present in the negative control strain MK020 as well, therefore it
cannot be attributed to extracellular 5'-FDA. Apparently, this peak belongs to
compound(s) that make up LB with similar retention times as the trace of plain
LB also exhibits this peak (data not shown).
Validation with 1H-NMR, 19F-NMR and HRMS
Strain MK015 lysate was subjected to 19F-NMR analyis and results are shown
152 5.4 In vivo uorination
(a) Lysate
(b) S/N
Figure 5.12: HPLC traces of the cell lysates and S/Ns of strains MK019 and MK020
after 24h of incubation with 2 mM or 15 mM KF and 50 μM or 250 μM of SAM
respectively. The HPLC trace of pure 5'-FDA was also obtained as a reference under
the same conditions and its retention time is 14 min.
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Figure 5.13: Left : Full 19F-NMR spectrum of strain MK015. The potassium
uoride peak can be seen in -151ppm. Right: Zoomed 19F-NMR spectrum around
the uorometabolite peak. 5'-FDA reference (blue), cell lysate of strain MK015 spiked
with synthetic 5'-FDA (red, H-coupled and H-decoupled) and cell lysate of the same
strain non-spiked (green).
in gure 5.13. The resulting coupled 19F-NMR spectrum of the lysate clearly
encompasses a multiplet which exhibits the same peaks with 5'-FDA. In order
to further validate the identity of this compound, a reference sample of 5'-
FDA and the lysate sample spiked with synthetic 5'-FDA were also tested. As
shown in gure 5.13, the spiked sample showed no other peaks appearing in
both coupled and decoupled spectra, but only an increase of the existing peaks
of the lysate. This proves almost without a doubt the presence of 5'-FDA
in the lysate. Analysis of strain MK019 shows similar results. Interestingly,
no other multiplets appear in the spectrum suggesting the absence of other
uorometabolites in both MK015 and MK019. This result is somewhat surprising
and shows either the incompatibility of 5'-FDA with both adenosine deaminase
and PNP of E. coli, otherwise 5'-FDI or 5-FDRP would also be present, or that
a compartmentalization of sorts exists in E. coli, resulting in the deaminase not
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coming in contact with cytoplasmic 5'-FDA. The latter is also suggested for S.
cattleya [43].
There are other possibilities such as the intermittent production of these uo-
rometabolites during incubation and subsequent degradation towards deuori-
nated products. However, absence of 5'-FDI in strain MK019 as well, diminishes
this probability as 5'-FDI should at least be present since E. coli PNP, which
processes 5'-FDI is deleted in this strain. All in all, 5'-FDA is produced and ap-
pears to persist inside the cells after a 24-hour incubation, regardless of the deoD
gene being present or not. Although more experimentation is needed to conrm
this result, uorination does not appear to be hampered by the E. coli PNP in
vivo, even though it is suggested that in a cell-free extract it does [52].
Although the above method is pretty much denitive of the identity of the
compound, strain MK019 grown in 2 mM/50 μM of KF/SAM, which also
demonstrated capacity for 5'-FDA production, was analysed with 1H-NMR and
HRMS in addition to 19F-NMR. The results are shown in gure 5.14. The 1H-
NMR spectra (g. 5.14a) consist of the crude lysate, the eluate from HPLC
corresponding to the 5'-FDA peak (tR = 14 min) and a synthetic 5'-FDA as
reference. For both types of NMR analysis the solvent used was methanol-d4. The
frequencies used for 1H-NMR and for 19F-NMR were 500.1 MHz and 470.6 MHz
respectively. The multiplets appearing in the pure 5'-FDA sample are also clearly
present in the HPLC eluate along with some unidentied peaks of a compound
that is co-eluted in the same fraction. Some of the 5'-FDA peaks can also be
discerned even in the crude lysate. For HRMS analysis, only the eluate was used
and the highest peak appearing in the spectrum corresponds to the predicted
m/z = 270 for cation [M+H]+ with M equal to the mass of 5'-FDA. There is
also presence of the peak with m/z = 292 for the sodium cation [M+Na]+. It
is therefore validated with 3 dierent spectral methods that the only uorinated
compound being produced intracellularly is 5'-FDA. As expected, the negative
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(a) 1H-NMR spectra of 5'-FDA synthetic sample, isolated HPLC fraction and crude lysate
(b) HRMS spectrum of the HPLC eluate
Figure 5.14: Top: 5'-FDA synthetic reference (Blue), isolated HPLC fraction
(tR=14 min, corresponding to known the retention time of 5'-FDA, Red) crude cell
lysate of strain MK019 (2 mM KF) (Green). Bottom: HRMS analysis of isolated
HPLC fraction.
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control strains MK016 and MK020 grown in conditions 15 mM/250 μM KF/SAM
did not reveal any peaks apart from KF in their 19F-NMR spectra.
Due to the profound impact from establishing in vivo uorination in E. coli, the
possibility of production of 5'-FDA from released enzyme because of incomplete
denaturing should be dismissed. For this test, the same conditions of growth
were employed for strains MK015 and MK019 but with the absence of KF. The
pellets were then normally lysed as described above but in the prewarmed aqueous
ethanol, 15 mM of KF was added. If 5'-FDA detected in the previous experiments
was produced due to incomplete denaturing then 5'-FDA would also be detected
under these conditions. 19F-NMR spectra did not reveal the presence of other
uorinated molecules apart from KF, concluding the series of experiments for the
establishment of in vivo production of the uorometabolite.
5.4.3 Contribution of modications and quantitative anal-
ysis of 5'-FDA in the production strains
Following the conrmation of 5'-FDA production from the modied E. coli, in
particular strains MK015 and MK019, it was evident that deletion of PNP does
not aect intracellular 5'-FDA accumulation. At that point the question was
raised which modications and conditions contribute in the realization of in vivo
uorination. To this end, the dierent modications were tested in an iterative
manner. Initially, strains MK004, MK010 (2 mM KF/NO SAM) and MK015,
MK019 (2 mM KF/500 μM SAM) were tested in otherwise same conditions as
described in section 5.4.1. Strain MK004 was not expected to show production of
5'-FDA as in a concentration of 2 mM KF, uoride anions would not be able to
persist in the cell with a functioning CrcB channel. Surprisingly, no production
was seen even in strain MK010, which means that intracellular SAM produced by
the strain is either not enough for starting the reaction, or that it is concentrated
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Figure 5.15: 19F-NMR spectra of cell lysates to test for the production of 5'-FDA
in vivo after 24h of incubation with 2 mM of KF. The modications were tested in
an iterative fasion. Lysates were spiked with 2-Fluoroethanol as a reference standard
(-227 ppm). Upper-Left: Strain MK004 (No SAM), Lower-Left: Strain MK010 (No
SAM). Upper-Right: Strain MK015 (500 μM SAM). Lower-Right: Strain MK019 (500
μM SAM). The multiplet appearing in -232.5 ppm belongs to 5'-FDA. The product
cannot be detected on the strains lacking the SAM transporter.
in a particular sub-cellular location and out of reach for cytoplasmic uorinase.
To determine the intracellular concentration of 5'-FDA in the strains that showed
5'-FDA production, scaled-up quantities of lysates obtained with the procedure
described in 5.4.1, were freeze-dried (liquid nitrogen) and subjected to 19F-NMR
as follows: First of all, preliminary 19F-NMR experiments were performed using
a solution of synthetic 5'-FDA and 2-uoroethanol at the same concentration in
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methanol-d4, in order to identify a sucient relaxation delay. The longest delay
between the uorinated products was incorporated into the 19F-NMR parameters
to allow for accurate comparison of the uorine peaks of 2-uoroethanol and 5'-
FDA. The freeze-dried lysates were added 700 μL of methanol-d4 spiked with
a known concentration of 2-uoroethanol. The suspension was vortexed and
sonicated to ensure dissolution of 5'-FDA, then centrifuged for 5 min at 12,000
rpm to remove any precipitate. The solution was then analysed by 19F-NMR on
a Bruker Advance 500 instrument (NS = 220, D1 = 15, O1P = -229.75). The
peaks for 2-uoroethanol and 5'-FDA were integrated and the ratio was used to
determine the 5'-FDA concentration. The latter was then used along with Dry
Cell Weight (DCW) measurements to obtain mg/g values of 5'-FDA production.
The results from one replicate for strains MK004, MK010, MK015 and MK019
are shown in gure 5.15. The intracellular concentration of 5'-FDA that has been
achieved, as determined from 2 replicates, is 0.73 (± 0.33) mg/g DCW in strain
MK015 and 0.59 (± 0.03) mg/g DCW in MK019. The incubation conditions
were 2 mM KF, 500 μM SAM, 24 h in 37 oC. Assuming a 10−15 L of volume
per cell, 109 cells/mL in 1 OD and 0.33 g/L of DCW in the same OD, yields
0.33mg/109 cells, therefore 33x10−14g of DCW/cell and subsequently 24.1x10−17g
of 5'-FDA per cell. In terms of molarity, this is equivalent to 24.1x10−17g/10−15
L, hence 241 mg/L. 5'-FDA molar mass is ≈ 270 g/mol, therefore the intracellular
concentration is 0.89 (± 0.4) mM in strain MK015 and similarly, 0.72 (± 0.04)
mM for strain MK019.
5.4.4 Identication of the critical modications for in vivo
uorination
The total absence of 5'-FDA in strains lacking the SAM transporter, warranted
more exhaustive testing with combinations of strains/conditions in order to
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unravel or dismiss secondary eects. Three concentrations of SAM were tested
in strains MK015 and MK019 (20 μM 100 μM and 500 μM). In addition, strain
MK008 was also tested with 500 μΜ of SAM and strains MK004, MK010 were
tested in 0 and 500 μM of SAM. The results from these experiments are presented
in a manner were production or non-production is determined (table 5.1). From
the results, it is evident that both the deletion of the crcB gene and SAM
transporter expression are key modications for enabling in vivo uorination in an
E. coli host expressing a uorinase enzyme. This synergy of actions is profound by
the non-productivity of 5'-FDA when each of these modications exist separately
in a strain combined with uorinase expression (MK008 and MK010). Strains
with combinations including the PNP deletion (ΔdeoD) were not tested as its
absence did not seem to exert a positive eect on the production of 5'-FDA.
Testing of a saturating concentration of SAM (500 μM) in strains lacking the
SAM transporter also dismissed the possibility of a secondary eect other than
the inux of SAM from the transporter (e.g. higher uoride accumulation from
alteration of pH). Additionally, 20 mL of S/N collected from 5'-FDA producing
strains MK015 and MK019 in 2 mM/500 μM KF/SAM, and non-producing
strains was freeze-dried and subjected to 19F-NMR. No 5'-FDA (or any other
uorometabolite) was observed, indicating that the product accumulates in the
cytoplasm and is not exported.













































































































































































































































































































































RS is gaining increasing attention as a non-invasive, non-destructive, label-free
method for the determination of chemical composition in the context of live cells
or tissues. A small part of the present work is therefore dedicated in exploring the
potential for characterizing and possibly identifying the substrates and products
of enzymatic uorination with this spectroscopic method based on ngerprint
spectra for these compounds.
This chapter presents previously unreported Raman spectra for SAM chloride
dihydrochloride, 5'-FDA and 5'-ClDA. Novel ndings include:
1) The ability to monitor the spontaneous degradation of SAM with Raman.
2) Raman enabled determination of SAM uptake from E. coli cells.
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6.1 Experimental set-up
This section presents the experimental set-up for Raman spectral acquisitions,
spectral and spatial resolution measurements, as well as the methods utilized for
cosmic ray spike and baseline removal.
6.1.1 Instrument and lens
The instrument used for the spectral acquisitions is a Renishaw InViaTM Raman
Microscope specically designed for the acquisition of Raman spectral signatures
from biological samples (see gure 6.1). The excitation light that this instrument
utilizes has a 785 nm wavelength (near infra-red range) and an output power
of 60 mW. The power of light that reaches the sample however, was measured
to be lower, around 40 mW due to the cumulative eect of small aberrations of
the various elements along the optical path. These low-intensity and near infra-
red wavelength photons do not ionize the sample and are therefore appropriate
for non-destructive spectral acquisition. The only concern is thermal damage
potentially caused to living cells from long exposure times. In the following series
of experiments, this is not a concern as measurements are performed with limited
exposure times (10 - 30 seconds) and the majority of spectral acquisitions involve
inert samples. The lens used was a Leica HC PL FLUOTAR 50x/0.80 DB. The
moving stage features a minimum step of 0.5 μm in the XY axes (lateral) and 1
μm in the Z axis (axial).
6.1.2 Spatial Resolution
In confocal microscopy, the focused light beam spot size is representative of the
spatial resolution that can be achieved. A small focal spot will generally yield a
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(a) Renishaw Raman InViaTM
(b) Layout and components
Figure 6.1: The instrument and layout used for the acquisition of Raman spectra.
Taken from [10].
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Figure 6.2: Spectrum of a polyesterene bead. The higher intensity peak appears in
1000 cm−1.
better spatial resolution in the sample. There is a trade-o however in the signal
intensity, as a smaller focal spot will encapsulate a proportionally lower volume
from the sample. On the other hand, a larger spot size will encompass a higher
volume and yield a higher signal, but will be harder to resolve dierences in the
sample. Many factors must be considered in choosing the optimal objective lens
for each experiment such as the heterogeneity (as is the case for mammalian cells),
and density of the sample. In this work, measurements involve homogeneous
samples of pure powders, solutions and populations of dried or live bacteria, thus
the measured spatial resolution is satisfactory. The theoretical minimum of axial
and lateral resolution for an objective lens can be derived from the Rayleigh
criterion (eq. 6.1).








Substituting with λ = 785 nm and NA = 0.8 as per the instrument and lens
specications, the resulting theoretical resolution is:
RLateral = 0.6 μm RAxial = 2.45 μm (6.2)
Where n is the diraction index of air and equals 1. This is the diraction-
limited maximum resolution that can be achieved and is a quantum phenomenon.
The real resolution is always lower (higher in terms of length) than this and is
dependent on the quality of optical elements. Another aspect of measurement
that could pose a limit for the spatial resolution are the minimum steps of the
moving stage for X,Y and Z axis, which are 0.5, 0.5 and 1 μm respectively. In
this case it is lower than the diraction limit for this lens and does not constitute
a limiting factor.
Experimental spatial resolution
For experimental determination of the spatial resolution, 30 μl of liquid containing
small polyesterene spherical beads (1 μm) was poured onto a quartz substrate,
subjected to a short centrifuge pulse for the liquid to be eectively dispersed and
left to dry. The substrate was then placed onto the instrument stage and the laser
was focused on an isolated bead with a suciently empty surrounding space. A
spectral acquisition was obtained with a 2 second exposure and 10 accumulations
to determine the best focus based on signal strength. The resulting spectrum is
shown in gure 6.2. The highest intensity peak appears at ≈1000 cm−1. A linear
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(a) X-axis resolution
(b) Y-axis resolution
Figure 6.3: Determination of spatial resolution based on measurements of intensity
with a moving focal spot.
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Figure 6.4: Z-axis resolution.
mapping measurement was set up overlapping the sphere by at least 10 times its
diameter on each side. With every moving step, as the focal spot passes through
the polyesterene sphere, the intensity increased reaching a maximum when the
sphere was located at the centre of the focal spot and subsequently decreased as
the spot moved away. The varying intensity of the highest peak (≈1000 cm−1)
from the movement of the focal spot along each axis are shown in gures 6.3 and
6.4. The Full-Width Half-Maximum (FWHM) resolution is calculated based on
a Gaussian curve t for each series of measurements. The X and Y axis feature a
FWHM of 1.15 and 1.75 μm respectively. The highest FWHM length is considered
as the lateral resolution and it is ≈3 times the minimum resolution length (eq.
6.2). The measured axial FWHM resolution is 8.78 μm and ≈3.5 times higher
than the theoretical minimum for this lens.
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6.1.3 Spectral resolution
The spectral resolution of a Raman spectrometer is dened as the minimum
wavelength dierence at which two adjacent spectral lines (peaks in the spectrum)
can be distinguished. There are several factors that determine the spectral
resolution [154]:
• The natural spectral line widths of the substance itself. There is a
lower limit which is tied to the uncertainty principle. Other factors also
contribute to the natural line width such as the temperature, homogeneity
and crystallinity of the sample.
• The number of grooves (lines) per millimetre of the grating. A higher
number of lines will disperse the dierent wavelengths of the signal over
a wider area in the CCD detector. One trade-o is that the spectral
window will be lower for one acquisition. Thus, choice of grating must
be accompanied with considerations specic for each sample.
• The detector slit size and the pixel size of the CCD.
• System specic diraction eects, aberrations and the laser line width.
The spectral resolution was determined experimentally using FWHM by Gaussian
curve tting plus a non-zero constant. The latter was calculated in two substances,
rst using the peak that appears in≈ 520.5 cm−1 from a silicon sample and second,
using the peak in ≈ 1000 cm−1 from a polyesterene bead. The silicon sample is
also used for the internal calibration procedures of the Raman instrument. The
grating utilized for these and all subsequent measurements contained 600 l/mm
(Figure 6.5). There is a dierence in the measured FWHM resolution between
substances, in particular, 7.75 cm−1 in silicon and 6.02 cm−1 in polyesterene. This
can be justied by the fact that there is a dierence in wavenumbers (520.5 cm−1
vs 1000 cm−1) an eect also illustrated in [155].
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(a) FWHM resolution of silicon peak (520.5 cm−1)
(b) FWHM resolution of polyesterene peak (1000 cm−1)
Figure 6.5: Determination of spectral resolution from intensity peak variation within
a single acquisition.
170 6.1 Experimental set-up
(a) Raw spectra (b) Spectra with the baseline removed and
normalized to the highest intensity peak (≈
1002 cm−1)
Figure 6.6: Example application of the baseline removal algorithm.
6.1.4 Baseline removal
Raman spectra, apart from the peaks that are produced from scattered, Raman-
shifted photons that are particular to vibrational modes of molecular bonds being
excited, contain a smooth signal which appears due to the absorption of photons
by atoms in the sample and excitation of their electrons in higher energy states.
The atoms subsequently fall into the ground state and re-emit photons of a
particular frequency. This is a dierent eect from Raman scattering, termed
autouorescence and manifests itself as a baseline in the spectrum. It is more
pronounced with higher energy photons comprising blue or green wavelength laser
beams. With a 785 nm laser used in this study the eect is not detrimental to
the signal/noise ratio, but still needs removing as each acquisition suers from
dierent intensities of autouorescence (see gure 6.6a). Usually, preprocessing
steps include algorithms for removing this baseline from the acquisition. In this
case, an automated small window moving average approach is utilized and the
algorithm was kindly provided by the author of the original work [156]. This
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(a) Spiked spectra (b) Despiked spectra
Figure 6.7: Example application of the spiking removal algorithm.
algorithm provides a highly robust approach for eectively removing baselines
from spectra in which even manual removal would be problematic. The algorithm
works in an iterative manner by performing peak-stripping/window-size enlarging
and then determines the optimal number of iterations based on the areas below
the signal line being removed. It is important to note that the spectra acquired for
section 6.2, required an adaptation of the algorithm. A rst pass of the algorithm
was used to extract the number of iterations for each individual spectrum and
the average of this number was used statically for the second pass. This enabled
the correct alignment of spectra (shown in gure 6.6b).
6.1.5 Cosmic ray spike removal
The detector used during acquisitions of Raman spectra is a CCD camera which
consists of an array of pixels each with a size of 22 μm x 22 μm. The detector
collects Raman-shift generated photons from the light beam re-emitted from the
sample, eectively separated from the grating in its constituent wavelengths and
dispersed to dierent pixels. Cosmic rays are highly energetic nuclei mostly
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originating from outside the solar system that continuously bombard the earth.
During long exposure/acquisition times, there is a probability that a cosmic ray
will "hit" a particular pixel in the CCD and this event is recorded by the detector,
appearing as a cosmic ray spike in the nal spectrum. There are several pre-
processing methods for removing these undesired artefacts. The technique used
here is an adaptation from the method laid out in [157] and requires a number
of replicated "similar spectra". Specically, the measurement raw le is an array
of wavenumbers and their corresponding intensities. With a number of spectra
at hand, one of them will occasionally exhibit a cosmic ray spike at a particular
wavenumber that others will not. This spike will constitute an outlier and can
be removed by setting an upper-limit of 4 times the standard deviation of the
intensities in this particular wavenumber. Measurements that do not satisfy this
limit will be recognized as spikes and levelled o. The algorithm should ideally
be applied in spectra with removed baseline. An application example is shown in
gure 6.7.
6.2 SAM characterization
The spectra and assignments of bonds for SAM will be presented here. SAM
degradation will be illustrated with measurements taken in dierent days and the
decrease of a particular peak will be linked to this eect. The uptake of SAM at
high molarities from the function of the SAM transporter will be argued for based
on the statistically signicant dierence of the highest peak present in SAM, also
appearing in the spectral signatures of strains with SAM transporter expression
grown in the presence of SAM.
The importance of SAM in biological processes has been laid out in section 4.4.
Surprisingly, almost two decades after the burst of RS application in a biological
context, a Raman spectrum of this important molecule has yet to be reported
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Figure 6.8: Mean spectrum of 48 spectral acquisitions of SAM chloride dihydrochlo-
ride powder in ngerprint region baseline removed and normalized (10 second expo-
sure).
(to the best of the author's knowledge). The reason behind this profound gap
could be the fact that SAM is a cation and unstable outside of the intracellular
environment, therefore measurements of this sort are inherently problematic.
In market, it can be obtained as a salt. For all SAM-dependent experiments
performed as a part of this project, the molecule in this chemical form (obtained
from SIGMA) was used. The molecule, albeit being more stable as a salt, it
stills suers from instability which is temperature-dependent. The mechanism of
spontaneous cleavage is mentioned in [152]. SIGMA guarantees 75% of purity at
the time of purchase and reports that it can lose up to 10% of purity per day in
room temperature [158].
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Figure 6.9: Spectral acquisitions of SAM in dierent days after exposure in 25
oC. ANOVA shows statistical signicant dierences between all days and a decreasing
trend.
6.2.1 Impure SAM spectrum and degradation monitoring
A small quantity of the product, which appears as an o-white powder, was placed
on a quartz substrate and a number of Raman measurements were performed
with the above setup, in dierent locations of the substrate with powder presence
(10 second exposure - 3 accumulations). The spectra were subjected to anti-
spiking, baseline removal and normalization to the highest peak which appears
at approximately 725 cm−1. An average spectrum is shown in gure 6.8. Error
curves are too narrow to be visually distinct and are not included.
It is worth noting that because of SAM instability a large percentage (up to
25%) of the substance was expected to have transformed to the degradation
products (mostly 5-methylthioadenosine and homoserine lactone) at the time of
the rst measurement. Because of this instability, most peaks cannot be assigned
with certainty to SAM-specic bonds. The highest peak that appears in 725
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Figure 6.10: Exponential decay model based on the decrease in intensity of the
peak in 680 cm−1.
cm−1, however, can be assigned to the adenosine ring breathing mode (see also
[159] and section 6.3). The instability of SAM fuelled the following experiment:
The SAM powder residue used for the rst spectral acquisition was left in a
closed but aerated box in room temperature and measurements were taken in
dierent days. Specically, 7 series of acquisitions (48 measurements for each)
were acquired in days 1, 2, 3, 4, 6, 9 and 29 including the one presented above.
Several peaks were monitored for changes in their relative intensity to the 725
cm−1 peak (normalization essentially yields ratios w.r.t. this peak). This peak
constitutes a solid choice for normalization not only because it is the most intense
but also the adenosine ring breathing mode producing this peak persists in the
degradation products. Indeed, several peaks undergo changes in their intensities,
others with an increasing trend and others show a decrease. There are also slight
shifts in the wavelengths of some peaks. The peak that appears in 680 cm−1
undergoes a consistently signicant (ANOVA) decrease between all measurements.
By studying the degradation products and in consistency with literature [160],
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this peak is assigned to the C-S bond connecting the adenosine part with the L-
methionine part of SAM (gure 6.10). In eect, the degradation products contain
2 C-S bonds out of 3 in the initial molecule.
An exponential decay model was subsequently tted using the intensity ratio and
accounting for the variance of each measurement. The result is shown in gure
6.10. It is interesting to quantify the half-life of SAM in room temperature and













= 1.27 d (6.3)
The result for t9/10 shows 10% of SAM is degraded in 1.27 days, therefore it is in
agreement with reported purity loss from SIGMA, serving as a validation for the
utility of this approach.
6.2.2 Raman enabled detection of SAM uptake in E. coli
cells
In this section, the detection of SAM uptake from E. coli grown in the presence
of SAM will be investigated, based on the measurement of characteristic Raman
peaks, which are prevalent in the spectrum of SAM chloride dihydrochloride
powder (see previous section), also found in spectra acquired from E. coli featuring
SAM transporter expression. The line of thought is adapted from [161] where the
detection of xylitol uptake in E. coli cells is described but instead of the pictorial
comparison that the aforementioned study employs, a statistical signicance
(ANOVA) approach will be followed here with a focus on the largest intensity
peak of SAM (≈ 725 cm−1). Two comparative experiments were designed for the
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Figure 6.11: Spectral ranges of dried out cells from strain MOB1490 grown in 5 μM
or 5 mM SAM. The highest SAM peak shows statistically signicant higher intensity
in the high SAM concentration.
identication of this eect. In the rst experiment, 2 liquid (LB) cultures (3 ml in
15 ml falcon tubes) of strain MOB1490 were grown containing 1000-fold dierent
SAM concentrations, limiting SAM (5 μM, non-optimal growth) and excessively
high SAM (5 mM). The cultures were left to incubate for 24 hours and then
centrifuged. The S/N was removed carefully and the pellet was re-suspended
in an equal amount of MiliQ water, and then centrifuged again. This washing
round was performed one time in the low SAM and four times in the high SAM
concentration to ensure that no residual SAM from the growth medium was left
in the samples. Finally, 5 μl of wet pellets were poured onto CaF2 substrates and
left to dry. Raman acquisitions were then taken from the sample in randomly
chosen XY positions of the substrate where dried cell residue was located. The
resulting spectra are shown in gure 6.11.
The peak of interest in the acquired spectra corresponds to the highest peak
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Figure 6.12: Spectral ranges of live strains MK017 and MK018 grown in 5 mM
SAM and then deposited in agar. The highest SAM peak shows statistically signicant
higher intensity in the MK018 strain.
appearing in SAM (≈ 725 cm−1) which corresponds to adenosine ring breathing
mode. In the spectra corresponding to growth in higher SAM concentration,
the peak is clearly more intense with indisputable statistical signicance shown
by ANOVA. The peak which appears closer to 680 cm−1 (the signature peak of
SAM), though exhibiting a higher average intensity, its mean compared to that of
low SAM is not signicantly dierent. This result provides strong evidence that
the dierence in the 725 cm−1 peak is indicative of more SAM being absorbed
from the SAM transporter but the dierence cannot be attributed entirely to the
molecule of SAM as the degradation product 5-MTA will also exhibit this peak
and there are transporters that could transport this molecule in E. coli. It was
therefore deemed necessary to conduct another comparative experiment, this time
the dierence being the expression of SAM transporter. To this end, LB liquid
cultures of strains MK017 and MK018 were grown as described above but they
were both added 5 mM of SAM and left to incubate for 2 days. This would allow
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any contribution from the degradation products to be pronounced. The pellets
were collected and washed 4 times as explained above and then were put to agar
plates and left to dry. Raman spectra were then acquired as shown in gure 6.12.
The peak assigned to adenosine ring breathing still shows a signicant but lower
dierence in intensities between strains. Combined with the previous result it can
now be stated that the dierence in intensity of this peak is indicative of SAM
uptaken by the bacteria. The mean value of the peak closer to ≈680 cm−1 is
higher but still does not show statistical signicance according to ANOVA. The
latter is representative of the limits of this particular spectroscopic method.
6.3 Raman spectra of the uorinase products
The above results show the potential of RS to identify interesting intracellular
compounds accumulating in bacterial cells. Therefore, RS as a selection method
for improved variants of a particular enzyme can be envisaged. It has also been
shown that simply utilizing Raman acquisitions suers from the limit of detection
of this particular method which is in the range of mM. Acquiring a statistically
signicant result for the above experiment suggests that SAM is accumulating in
high concentration inside the cells, which is expected from the reported rate of
uptake, but this is not generally the case for products of other enzymatic processes.
Therefore, a facile approach with the ability to monitor more subtle dierences
in product concentrations should be adopted. A solution can be formed with
the use of other RS variants such as CARS or SRS. Developing such methods
for DE experiments is promising but requires laborious steps which are out of
reach for this project's time-line. However, Raman spectral acquisitions of the
products of uorinase, namely 5'-FDA and 5'-ClDA, have not been previously
reported and could provide useful insight to the conguration of future CARS or
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Figure 6.13: Raman Spectrum of 5'-FDA.
SRS experiments. Therefore, Raman spectra of these compounds in powder form,
kindly provided by Prof. O'Hagan and Dr Philip Lowe, are presented.
6.3.1 5'-FDA
A small quantity of 5'-FDA powder was placed on a CaF2 substrate and several
Raman spectra were acquired in randomly selected locations. The substrate was
left in a close box in aerated conditions (room temperature) and the process
was repeated in 5 days. After baseline and cosmic ray spike removal, mean
Raman spectra of 5'-FDA in dierent days are shown in 6.13. Fist of all it
is important to note both the stability of the molecule and the robustness of
Raman spectral acquisition and spectrum processing technique utilized, as the
nal spectra virtually coincide between dierent measurements (mean error is
less than 0.5%). The highest peak of 5'-FDA lies in 725 cm−1 as it does in SAM.
This is expected as it is produced from the adenosine part of the molecule and
monitoring this peak will not provide information of the enzymatic transformation
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Figure 6.14: Raman Spectrum of 5-ClDA.
of SAM to 5'-FDA. The absence of a peak in 680 cm−1 and appearance in 710
cm−1 is interesting as it is consistent with the fact that the 680 cm−1 peak was
produced from the C-S bonds at the interface of L-methionine and adenosine parts
of the molecule. From the structure of 5'-FDA, (methionine replaced by uoride)
the peak appearing at 710 cm−1 can be tentatively assigned to the C-F bond.
Conrmation of this is provided in the next section where comparison with a
"brother" molecule is made.
6.3.2 5'-ClDA
Raman spectra of 5'-ClDA were acquired with a similar process as above (gure
6.14). This serves mostly as a comparison to 5'-FDA for distinguishing C-F related
peaks. The only dierence between the molecules is that the uoride atom is
replaced by a chloride atom. Therefore, any dierences between their spectra are
attributed to the C-Cl bond substituting C-F. There are many similarities and
some dierences between spectra, which is to be expected as the molecules are very
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similar. Again the adenosine peak (725 cm−1) is dominant in the spectrum. Most
of the peaks appear in both spectra with some of them in varying intensities.
The only dierence with considerable intensity however, is the 710 cm−1 peak
which appears to have shifted to 695 cm−1 and this is a conrmation of the
initial assignment of this bond to C-F in the 5'-FDA spectrum. This peak also
diers in wavelength with the "nearby" peak seen in SAM by 30 wavenumbers.
Therefore, it can serve as a distinguishing attribute in Raman congurations for
future experiments aspiring to monitor 5'-FDA intracellular production.
Chapter 7
Concluding remarks and future
prospects
In section 2.3.3, four genes with high sequence similarity to the established
uorinases, found by genome mining are reported. Especially the instances
encountered in two genomes, A. mzabensis and Amycolatopsis sp. CA-128772,
bear sequence identities comparable to the one among the other uorinases that
have been characterized (≈ 80%) and they are very likely to be uorinases
themselves. This is also strengthened by the fact that there are genes in
the genomes of the aforementioned species with identities exceeding 50% in
most of the genes that belong to the 4-FT pathway. However, studies of
enzyme characterization have not been published for the products of these
genes and although current works are probably in progress, uorinase enzyme
characterization is certainly a promising novelty hunting ground.
The analytical approach for modelling growth curves and uorescence presented
in chapter three, harnesses the capacity of GP for the regression of experimental
data, which has been recently shown to approximate derivatives of noisy biological
experimental data more accurately [71]. The translation of a particular FP is
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inuenced by other elements in the sequence such as the RBS [162] and terminator
sequences [163], [164]. Yet, most studies still use the absolute or relative value of
uorescence to show the dierences between promoter activities. The proposed
metric is not only quantitatively more accurate, but can also act to enable the
unravelling of observed dierences between alternative RBS and terminators.
The improvement in quantication capabilities of regulatory elements can be
expanded by constructing a more accurate model, for example by modelling
the degradation rate as a function of time rather than a constant based on the
availability of the proteases responsible for degradation or other internal processes
[165], incorporation of the copy number of the plasmid which hosts the fusion of
promoter and FP, or the strength of a particular FP.
The collection of strains that have been constructed (see tables 4.7 and 4.8),
used for the experimental validation assays of in vivo uorination and subsequent
growth curve analysis that is presented in chapter ve, comprise a solid basis for
future pathway engineering experiments. The realization of in vivo uorination
in E. coli by uorinase function is undoubtedly a major unprecedented result
and raises both questions and possibilities. First of all, the positive eect of
uorinase expression in E. coli growth shown in chapter ve, is an enabling feature
for the production of uorometabolites in bioreactors without suering from
genetic instability issues and is strengthened by the apparent orthogonality of the
actual reaction catalysed in strains producing 5'-FDA. The achieved intracellular
concentration of the latter (see 5.4.3), provides additional indirect evidence, in
addition to the Raman spectral acquisitions, that the constitutively expressed
SAM transporter in E. coli, is able to uptake SAM in higher concentrations
intracellularly, even with increased molarities of extracellularly provided SAM.
Enzymatic urorination is a reversible reaction and, as reported in section 5.4, no
exportation of 5'-FDA from the cell is detectable, therefore the concentration of
5'-FDA reaches a maximum corresponding to the chemical equilibrium between
the substrates and products. In particular, presence of L-methionine, which
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is one of the products, shifts the chemical equilibrium towards the substrates.
This represents a limit in the in vivo uorination capability demonstrated by
the engineered E. coli. In the natural occurrence of the uorination pathway
in S. cattleya, there is a ux of the nal product (4-FT) extracellularly. The
establishment of a similar exportation mechanism of uorinated products would
therefore constitute a desirable attribute for enabling the use of E. coli as a
microbial factory for uorometabolites. The implementation can either be in the
form of a transporter for 5'-FDA, or as another enzymatic process converting
5'-FDA to an exportable uorometabolite.
Regarding the development of a screening method, growth curve analysis per-
formed in chapter 5, reveals some synergistic eects of the uorinase and uoride,
however, this eect was present in strains that did not appear to produce 5'-FDA.
The relation of 5'-FDA production with growth eects is therefore deemed incon-
clusive. This is not surprising as the chemical equilibrium intracellularly does not
permit a continuous ux in order to alleviate uoride toxicity, leading to a growth
advantage. In this manner, establishing a ux with an irreversible reaction or ex-
portation of inert uorinated products would also be an enabling feature towards
genetic selection of improved variants. RS reveals dierences in spectra between
substrates and products, specically, the C-F assigned peak. The ability to detect
intracellular metabolites has also been demonstrated, specically for SAM, one of
the substrates which accumulates with high molarities in E. coli by function of the
SAM transporter. Unfortunately, the limit of detection of spontaneous Raman
scattering lies in tens of milimolars, concentration levels that are forbidding for
detection of the minute dierences required. However, alternative Raman-based
techniques than provide much lower detection limits can be potentially utilized for
monitoring intracellular production of 5'-FDA such as CARS, SRS and Surface
Enhanced Raman Spectroscopy (SERS). The latter in particular, has been shown
to exhibit sensitivity of less than micro-molar concentrations in the detection of
adenosine, a similar molecule to 5'-FDA [159].
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This project's main deliverable is an unprecedented engineered E. coli strain for in
vivo direct uorination, accomplished by a recombinant uorinase. Additionally,
the path towards construction of the engineered E. coli for uorinated production
yielded a collection of strains that were useful in addressing questions relevant
to the eects of the uorinase, intracellular SAM capacity and the potential of
Raman to monitor key metabolites. The Gaussian tting methods for growth
curve analysis presented in chapter three were extensively utilized in chapter ve,
however, the analytical approach for promoter activities constitutes a stand-alone
original piece of work. In general, the outcome of this project is deemed successful.
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